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Abstract	  	   There	  have	  been	  numerous	  efforts	  in	  the	  field	  of	  electronics	  with	  the	  aim	  of	  merging	  the	  areas	  of	  healthcare	  and	  technology	  in	  the	  form	  of	  low	  power,	  more	  efficient	  hardware.	  However	  one	   area	  of	   development	   that	   can	   aid	   in	   the	  bridge	  of	   healthcare	   and	   emerging	  technology	   is	   in	   Information	  and	  Communication	  Technology	   (ICT).	  Here,	  databasing	  and	  analysis	   systems	  can	  help	  bridge	   the	  wealth	  of	   information	  available	   (blood	   tests,	  genetic	  information,	   neural	   data)	   into	   a	   common	   framework	   of	   analysis.	   Also,	   ICT	   systems	   can	  integrate	   real-­‐time	   processing	   from	   emerging	   technological	   solutions,	   such	   as	   developed	  low-­‐power	  electronics.	  	  This	  work	   is	   based	   on	   this	   idea,	  merging	   technological	   solutions	   in	   the	   form	  of	   ICT	  with	  the	  need	  in	  healthcare	  to	  identify	  normality	  in	  a	  patients’	  health	  profile.	  In	  this	  work	  we	  develop	   this	   idea	  and	  explain	   the	  concept	  more	   thoroughly.	  We	  then	  go	  on	   to	  explore	  two	  applications	  under	  development.	  	  The	   first	   is	   a	   system	   designed	   around	   monitoring	   neural	   activity	   and	   identifying,	  through	   a	   processing	   algorithm,	   what	   is	   normal	   activity,	   such	   that	   we	   can	   identify	  anomalies,	  or	  abnormalities	   in	   the	  signal.	  We	  explore	  Epilespy	  with	  seizure	  detection	  and	  prediction	  as	  an	  application	  case	  study	  to	  show	  the	  potential	  of	  this	  method.	  The	  motivation	  being	   that	   current	  methods	   of	   prediction	   have	   proven	   to	   be	   unsuccessful.	  We	   show	   that	  using	  our	  algorithm	  we	  can	  achieve	  significant	  success	  in	  seizure	  prediction	  and	  detection,	  above	  and	  beyond	  current	  methods.	  	  The	   second	  application	  explores	   the	   link	  between	  genetic	   information	  and	   standard	  tests	  (blood,	  urine	  etc...)	  and	  how	  they	  link	  in	  together	  to	  define	  a	  personalised	  benchmark.	  	  We	  show	  how	  this	  could	  work	  and	  the	  steps	  that	  have	  been	  made	  towards	  developing	  such	  a	  database.	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Chapter	  1 –	  Introduction	  
This	   project	   was	   initiated	   by	   one	   question:	   what	   is	   normality?	   In	   healthcare	   there	   are	  numerous	   parameters	   used	   to	   define	   your	   current	   and	   future	   health.	   Given	   that	   we,	   as	  humans,	  are	  so	  different,	  using	  the	  same	  health	  parameters	  across	  all	  patients	  would	  seem	  a	  simplistic	  way	  to	  assess	  your	  health.	  The	  question	   is	   then:	   Is	  there	  a	  norm	  that	  is	  valid	  for	  
everyone	  and	  where	  there	  is	  not	  can	  we	  provide	  a	  more	  realistic	  view	  of	  our	  own	  health?	  
1.1 Motivation	  
With	   increased	   government	   regulations,	   e-­‐business	   challenges,	   rising	   patient	   health	  expectations	  and	  demand	  for	  lower	  healthcare	  costs,	  the	  worldwide	  healthcare	  industry	  is	  facing	   immense	   pressure	   to	   utilize	   information	   technology	   to	   streamline	   healthcare	  processes	   providing	   cost	   effective	   healthcare	   and	   personalised	   services	   with	   improved	  efficiency.	  	  
Technology	   should	   ideally	   help	   companies,	   physicians	   and	   patients	   by	   providing	  custom	   healthcare	   software	   development	   services	   to	   manage	   these	   challenges.	   The	  challenge	   is	   to	   offer	   expert	   custom	   healthcare	   software	   applications	   development	   and	  application	  management	   services	   in	   the	   areas	   of	   healthcare	   like	   pharmaceutical,	  medical	  and	  life	  sciences.	  	  
In	   the	   Centre	   for	   Bio-­‐Inspired	   Technology	   (CBIT),	   from	   which	   this	   work	   grew,	   a	  number	  of	  enabling	  technologies	  have	  been	  developed	  to	  extract	  biomedical	  parameters	  for	  diagnostics,	  early	  detection	  and	  therapy.	  Indeed	  this	  work	  first	  took	  this	  path	  in	  developing	  a	   sensor	   platform	   for	   Urea	   to	   Creatinine	   ratio	   calculation	   (to	   be	   discussed	   later)	   but	  we	  soon	   realized	   that	   there	  was	   a	   larger	  picture	   to	   consider	   in	   the	  way	   technology	   interacts	  with	  personalized	  healthcare.	  
Neural	  Anomalies	  Monitoring:	  Applications	  to	  Epileptic	  Seizure	  Detection	  and	  Prediction	  	  
15	  
Mainly,	   there	   is	   a	   need	   for	   healthcare	   solutions	   to	   come	   in	   the	   form	   of	   software	  implementations	  that	  aim	  to	  improve	  on	  existing	  healthcare	  systems	  for	  more	  presonalised	  healthcare	  analysis.	  	  
Furthermore	   the	   domain	   of	   organizational	   technologies	   in	   healthcare	   could	   thus	   be	  depicted	   as	   a	   rough	   circle	   around	   the	   nexus	   of	   four	   quadrants:	   policies,	   procedures,	  guidelines,	   and	   standard	   practices.	   Healthcare	   workers,	   according	   to	   this	   view,	   are	  necessarily	   knowledge	   workers,	   because	   even	   where	   health	   care	   is	   routine,	   individual	  differences	   among	   patients	   need	   to	   be	   accommodated.	   The	   appropriate	   administrative	  structure	  would	   be	  mixed,	   accommodating	   the	   need	   for	   clinicians	   to	   vary	   routines,	   solve	  problems,	  and	  be	  creative	   in	  meeting	  both	  clinical	  and	  management	  demands.	  To	  support	  this	  practice,	  health	  informatics	  would	  have	  to	  provide	  for	  communication	  to	  include	  ad	  hoc	  queries	   and	   responses,	   order	   entry,	   results	   reporting,	   vertical	   and	   horizontal	  messaging,	  and	   consultation.	   Decision	   support	   would	   include	   access	   to	   a	   variety	   of	   knowledge	  resources	  and	  databases,	  to	  algorithms	  and	  creative	  problem-­‐solving	  tools,	  and	  to	  policies,	  procedures,	  guidelines,	  and	  standard	  practices.	  
The	  ability	  of	   the	  clinician	   to	   incorporate	   these	   issues	   into	   the	  clinical	  decision	  with	  greater	   or	   lesser	   certainty	   and	   by	   intuitive	   or	   logical	   processes	   defines	   whether,	   in	   that	  moment,	  health	  care	  is	  being	  practiced	  predominantly	  as	  craft,	  routine,	  engineering,	  or	  non-­‐routine.	   The	   role	   of	   informatics	   is	   to	   reduce	   uncertainty	   in	   the	   human	   decision-­‐making	  process	  by	  delivering	  state-­‐of-­‐the-­‐art	  information,	  cues,	  and	  alerts	  and	  to	  offer	  well-­‐defined	  decision	   algorithms	   where	   possible.	   It	   remains	   a	   human	   grace	   and	   a	   professional	  responsibility	  to	  make	  intellectual	  leaps	  when	  uncertainty	  is	  unavoidable	  and	  to	  be	  creative	  when	  algorithms	  are	  inadequate	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The	  motivation	  is	  then	  to	  provide	  personalised	  health	  care	  to	  each	  individual.	  How	  can	  one	  combine	   information	   about	   me,	   myself	   and	   I	   to	   improve	   and	   manage	   our	   own	   health	  (Figure	  1.1).	  
	  Figure	  1.1	  –	  Me,	  myself	  and	  I	  –	  what	  it	  means.	  
1.2 Aims	  
This	   work	   aims	   to	   target	   two	   particular	   solutions	   that	   covers	   a	   range	   of	   health	   care	  activities	  including:	  
• Electronic	  Medical	  Records	  
• Patient	  Normal	  Values	  Solutions.	  
We	   aim	   to	   develop	   customized	   databases	   and	   portals	   for	   healthcare	   organizations	   that	  provide	  them	  with	  a	  platform	  to	  share	  information	  about	  patients.	  Our	  solutions	  are	  based	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on	  a	  content	  management	  architecture	  that	  facilitates	  and	  eases	  the	  task	  of	  publishing	  and	  managing	  content	  appearing	  on	  a	  website.	  	  
Further	   to	   this	   we	   aim	   to	   quantify	   what	   falls	   outside	   the	   norm,	   i.e.	   anomalies,	  associated	   with	   a	   pattern	   and	   customise	   this	   to	   each	   persons	   medical	   profile.	   The	  application	  chosen	   in	   this	  work	   is	   that	  of	   epilepsy	  and	  seizure	  prediction.	  This	   is	   an	  area	  that	  has	  seen	  multiple	  attempts	  to	  quantify	  prediction	  methods	  but	  still	  yet	  to	  find	  a	  reliable	  one.	  	  
1.3 Report	  Outline	  The	  project	  is	  organized	  in	  three	  key	  chapters.	  Chapter	  2	  briefly	  focuses	  on	  the	  model	  of	  developing	  databases	  and	  solutions	  as	  previously	  described.	  It	  discusses	  further	  how	  the	  model	   is	   envisioned	   and	   can	   be	   implemented.	   In	   addition	   it	   describes	   a	   novel	  implementation	  of	  low	  power	  electronics	  applied	  to	  a	  healthcare	  application.	  	  
The	  third	  chapter	  focuses	  on	  the	  application	  of	  signal	  processing	  methodologies	  that	  have	  been	  developed	  for	  seizure	  prediction	  and	  detection.	  Here	  we	  explore	  both	  the	  clinical	  and	   algorithmic	   perspective	   of	   brain	   signals	   relating	   to	   seizures	   and	   potentially	   their	  prediction.	  	  	  
Chapter	   4	   derives	   the	   implementation	   of	   our	   novel	   pattern	   recognition	   signal	  processing	   method	   and	   database	   structure	   to	   support	   the	   analysis	   of	   brain	   signals	   in	  epileptic	  patients.	  Chapter	  5	  then	  applies	  this	  to	  two	  clinical	  data	  sets	  to	  show	  its	  value	  for	  seizure	  prediction	  and	  detection.	  Both	  sets	  of	  data	  are	  published	  data	  sets	  used	  for	  several	  benchmarking	  trials	  in	  the	  literature.	  	  	  
Finally	  in	  Chapter	  6,	  we	  discuss	  the	  significance	  of	  this	  work,	  including	  future	  visions	  of	   extending	   the	   applications	   to	   more	   generalized	   personal	   healthcare,	   incorporating	  genetic	  and	  metabolic	  patient	  data.	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Chapter	  2 -­‐	  Healthcare	  and	  Technology	  	  
As	  we	  have	  stated	  in	  the	  introduction	  the	  aim	  of	  this	  work	  is	  towards	  databases	  and	  portals	  for	  personalizing	  healthcare.	  In	  this	  chapter	  we	  aim	  to	  expand	  this	  concept	  and	  how	  it	  has	  developed	  in	  the	  course	  of	  this	  work.	  	  
At	  the	  CBIT,	  as	  mentioned	  previously,	  there	  have	  been	  a	  number	  of	  projects	  involved	  with	  developing	   systems	  aimed	   towards	  personalized	  healthcare.	  One	  example	  work	   that	  this	  project	  initially	  started	  on	  is	  a	  sensor	  interface	  for	  monitoring	  kidney	  function	  [1]	  (see	  Appendix	  C	  -­‐	  Conference	  and	  Journal	  Paper).	  This	  is	  a	  good	  example	  of	  how	  technology	  can	  be	  used	  to	  improve	  personalized	  healthcare.	  
2.1 Example:	  Kidney	  Function	  monitoring	  
The	   group	   has	   a	   strong	   history	   on	   developing	   micro	   chemical	   sensors	   called	   ion-­‐sensitive	   field-­‐effect	   transistors	   (ISFET)	  and	   the	  circuitry	   that	   interfaces	  with	   them.	   In	  an	  attempt	  to	  understand	  this	  technology	  and	  application	  we	  worked	  on	  a	  sensor	  interface	  for	  monitoring	  the	  ratio	  between	  urea	  and	  creatinine.	  	  
2.1.1 ISFET	  Basics	  
There	   are	   generally	   three	   categories	   of	   chemical	   sensors:	  amperometric	   (applying	   a	  DC	   bias	   and	  measuring	   current),	   voltammetric	  (sweeping	  DC	   bias	   and	  measuring	   current	  [2])	  and	  potentiometric	  (passively	  measuring	  the	  potential-­‐	  without	  forcing	  a	  bias	  potential	  or	  current).	  Being	  passive	  in	  nature,	  the	  potentiometric	  approach	  is	  therefore	  best	  suited	  for	  interfacing	  biology.	  	  
One	  such	  potentiometric	  sensor	  that	  is	  becoming	  increasingly	  popular	  due	  to	  the	  fact	  that	  they	  can	  be	  fabricated	  in	  unmodified	  CMOS	  technology	  is	  the	  Ion-­‐sensitive	  field	  effect	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transistors	   (ISFETs).	   ISFETs	   have	   predominantly	   been	   used	   for	   pH	   measurements	   [3].	  These	   sensors	   use	   a	   membrane	   to	   electrostatically	   couple	   the	   charge	   to	   modulate	   the	  underlying	   active	   device.	   This	   can	   be	   achieved	   in	   CMOS	   by	   exploiting	   the	   silicon	   nitride	  passivation	   as	   the	   sensing	   membrane	   over	   a	   floating	   gate	   field-­‐effect	   transistor	   (FET)	  [CmosISFET].	  ISFETs	  can	  be	  made	  sensitive	  to	  specific	  ions	  (often	  referred	  to	  as	  ChemFETs)	  by	   the	   deposition	   of	   an	   appropriate	   polymer	   membrane	   (ionophores	   [4]),	   permeable	   to	  specific	   ions	   [3],	   on	   the	   device	   sensing	   area.	   The	   ChemFET	   response	   results	   from	   the	  potential	  that	  develops	  at	  the	  membrane-­‐electrolyte	  interface	  due	  to	  the	  reversible	  binding	  of	   the	   analyte	  with	   the	   ion	   carrier.	   An	   intermediate	   layer	   is	   often	   applied,	   to	   establish	   a	  reversible	  electron	  transfer	  pair	  at	  the	  ion-­‐selective	  membrane-­‐ISFET	  interface.	  
	  Figure	  2.1	  -­‐	  Figure	  of	  a	  CMOS	  FET	  (a)	  with	  modification	  to	  ISFET	  (b)	  and	  its	  model	  (c).	  
2.1.2 Application	  to	  Urea:Creatinine	  
It	  has	  been	  stated	  that	  the	  ratio	  of	  urea	  to	  creatinine	  concentration	  is	  an	  important	  indicator	  of	  renal	  failure	  [5].	  Urea	  is	  usually	  measured	  as	  the	  blood	  urea	  nitrogen	  (BUN)	  where	  BUN	  =	  urea/2.14.	  The	  BUN	  to	  Creatinine	  ratio	  has	  three	  main	  categories	  listed	  in	  	  Table	  2.1.	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  Table	  2.1	  –	  Significance	  of	  particular	  BUN	  to	  creatinine	  ratios	  BUN:Cr	  ratio	   Location	  of	  Renal	  Disorder	  >20:1	   Pre-­‐renal	  disease	  (before	  glomeruli)	  10-­‐20:1	   Normal	  or	  post	  renal	  disease	  (within	  ureter)	  <10:1	   Intrarenal	  disease	  (within	  kidneys)	  	  
Here,	  the	  golmeruli	  is	  a	  capillary	  that	  performs	  the	  first	  step	  in	  filtering	  blood	  to	  form	  urine	  and	  the	  ureter	  is	  a	  muscular	  tube	  that	  transports	  urine	  from	  kidney	  to	  bladder.	  Hence,	  this	  ratio	  is	  a	  strong	  indicator	  of	  renal	  failure.	  To	  be	  able	  to	  measure	  this	  ratio	  we	  developed	  a	  sensor	  based	  on	  the	  ion-­‐selective	  field	  effect	  transistor	  (ISFET).	  This	  is	  a	  modified	  transistor	  with	  gate	  removed	  and	  instead	  the	  gate	  charge	  is	  controlled	  by	  the	  pH	  of	  the	  solution	  as	  H+	  ions,	  which	  are	  related	   to	  pH	  modify	   the	   transistors	  behaviour	   (by	  bonding	   to	   the	  Silicon	  Nitride	  passivation)	  [3,	  6].	  Adding	  a	  membrane	  onto	  the	  transistor	  allows	  sensing	  of	  other	  chemical	   concentrations.	   In	   this	   example	   urease	   and	   creatinase	   can	   be	   immobalised	   to	  sense	  urea	  and	  creatinine	  respectively	  [7].	  
The	  other	   feature	   that	   these	  systems	  use	   is	   the	  weak	   inversion	  state	  of	  a	   transistor.	  This	  allows	  low	  power	  operation	  and	  since	  there	  is	  a	  log	  relationship	  between	  the	  chemical	  signal	   and	   the	   pH	   then	   weak	   inversion,	   which	   utilizes	   a	   log	   relationship,	   linearises	   the	  chemical	  recording.	  	  
The	  proposed	  circuit,	  published	  in	  [1]	  is	  shown	  in	  Figure	  2.2.	  Here	  Iurea	  and	  Icr	  are	  given	  by:	  
Iurea = I0eVGS/nUtKurea[urea]aurea /n 	   	   	   	   (1)	  
ICr = I0eVGS/nUtKCr[Cr]aCr /n 	   	   	   	   (2)	  
which	  is	  based	  on	  the	  weak	  inversion	  operation	  of	  a	  transistor	  [8,	  9].	  	  Using	  this	  principle	  of	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a	   translinear	   loop	  (a	  method	   for	  exploiting	  exponential	   relationships)	  we	  can	   formulate	  a	  linear	  relationship.	  
	  Figure	  2.2	  –	  Urea:	  Creatinine	  sensor	  using	  weak	  inversion	  transistor	  [1].	  In	   this	   case	   VGS1+VGS2	   =	   VGS3+VGS4	   so	   substituting	   the	   weak	   inversion	   currents	   we	  eventually	  obtain	  the	  equation:	  	  
Iout = Igain
Kurea[urea]aurea /n
KCr[Cr]aCr /n 	   	   	   	   (3)	  
Details	  of	  the	  derivation	  can	  be	  found	  in	  [1].	  We	  simulated	  this	  circuitry	  in	  a	  CMOS	  design	  environment	  (Cadence)	  and	  showed	  that	  the	  ratio	  can	  be	  computed	  as	  per	  	  Table	  2.1	  but	  with	  monitoring	  of	  the	  current	  output	  of	  Figure	  2.2.	  
2.2 Algorithm	  of	  biological	  system	  
The	  previous	  section	  describes	  a	  very	  simple	  example	  of	  how	  one	  can	  utilize	  technology	  in	  this	  form	  to	  derive	  novel	  solutions	  to	  existing	  medical	  problems.	  However,	  we	  soon	  came	  to	  realize	  that	  this	  type	  of	  technology	  is	  a	  small	  portion	  of	  the	  personalized	  healthcare	  space.	  In	  conventional	  medicine	  there	  is	  a	  large	  reliance	  on	  databases	  and	  Information	  Technology	  to	  produce	  more	  efficient	  healthcare	  solutions.	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2.1.1	  Initial	  concept	   	  
The	  initial	  concept	  is	  based	  on	  the	  need	  to	  gather	  a	  multitude	  of	   information	  available	  for	  one	   person	   to	   understand	   the	   person’s	   health	   status	   as	   a	   whole.	   These	   would	   include	  genetic,	  blood	  work	  and	  even	  neurological	  data.	  Based	  on	  an	  inter-­‐disciplinary	  study	  field	  that	   focuses	   on	   complex	   interactions	   in	   biological	   systems,	   this	   research	   will	   bring	   new	  perspective	   to	   diagnosis	   and	   health	   care	   by	   combining	   all	   this	   information	   into	   one	  framework.	  	  
Figure	  2.3	  aims	  to	  encompass	  this	  vision,	  which	  shows	  that	  a	  person	  has	  many	  inputs	  and	  outputs	  that	  can	  feedback	  to	  form	  a	  critical	  evaluation	  of	  a	  person’s	  health	  status.	  This	  model	  is	  applicable	  to	  both	  personalized	  healthcare	  in	  the	  sense	  of	  self-­‐evaluation	  to	  more	  in	  depth	  diagnostic	  and	  treatment	  solutions	  in	  the	  medical	  industry	  space.	  Technology	  such	  as	  the	  urea:creatinine	  sensor	  falls	  into	  this	  scope	  quite	  well.	  It	  is	  our	  aim	  to	  expand	  on	  this	  further	   and	   explore	   the	   need	   and	   model	   for	   such	   future	   generation	   of	   personalized	  healthcare	  systems.	  
Given	  the	  expertise	  available	  in	  CBIT,	  we	  chose	  to	  explore	  the	  neural	  signal	  processing	  space	  within	  this	  framework.	  The	  next	  chapter	  describes	  a	  novel	  algorithm	  developed	  with	  the	  aim	  of	  assessing	  neurological	  anomalies.	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Chapter 3 - A State of the Art Review: Neural Signal Analysis 	  
3.1 Introduction	  
Over	   the	   last	   several	   decades	   neuroscientists	   have	   interfaced	   with	   the	   nervous	   system	  through	  technology	  in	  a	  multitude	  of	  application	  spaces.	  These	  advanced	  neural	  interfaces	  have	  allowed	  us	  to	  capture	  single-­‐neuron	  recordings	  and	  in	  depth	  spatial	  mappings	  of	  brain	  function.	  One	  of	  the	  key	  challenges	  with	  handling	  these	  recordings	  is	  extracting	  the	  spatio-­‐temporal	  signatures	  related	  to	  activity	  and	  neurological	  function.	  	  
To	   overcome	   this	   challenge,	   signal	   processing	   techniques	   have	   acted	   as	   the	   bridge	  between	   recording	   and	   understanding,	   whether	   through	   statistical	   methods	   or	   complex	  nonlinear	   state-­‐space	  mapping.	   Apart	   from	   opening	   a	  window	   of	   understanding	   to	   brain	  function	  these	  methods	  also	  aim	  to	  act	  as	  a	  bridge	  between	  function	  and	  treatment.	  
For	  example,	  in	  Parkinson’s	  disease	  closed	  loop	  deep	  brain	  stimulators	  that	  have	  been	  designed,	  and	  have	  been	  clinically	  tested,	  show	  that	  medication	  and	  tremors	  can	  be	  reduced	  [1].	  These	  systems	  record,	  process	  and	  stimulate	  deep	  brain	  structure	  of	  the	  brain.	  	  
In	  general	  there	  are	  several	  neurological	  disorders	  of	  interest	  that	  could	  benefit	  from	  the	  utilization	  of	   technology.	  One	  of	   the	  bottlenecks	  of	   the	   research	   in	   this	  area	  has	  been	  data	   consistency;	   having	   data	   sets	   well	   annotated,	   defined	   and	   databased.	   From	   this	   it	  would	  already	  seem	  that	  it	  fits	  into	  our	  model.	  To	  better	  clarify	  this,	  we	  will	  briefly	  look	  at	  Neurological	   Disorders	   in	   general	   and	   focus	   on	   one	   -­‐	   Epilepsy.	   This	   will	   give	   us	   a	  perspective	  on	  what	  is	  missing	  that	  can	  help	  support	  work	  in	  this	  area.	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3.2 Neurological	  Disorders	  
The	  brain	  is	  estimated	  to	  contain	  up	  to	  100	  billion	  neurons,	  and	  the	  nerves	  that	  make	  up	  the	  communication	   network	   from	   brain	   to	   periphery	   is	   a	   45	   mile	   long	   network	   that	   can	  transmit	  at	  speeds	  of	  up	  to	  120	  m/s	  (270	  mph)1.	  	  Like	  many	  elements	  of	  the	  human	  body	  a	  lot	  of	  things	  can	  and	  do	  go	  wrong.	  This	  can	  be	   caused	   by	   injuries,	   diseases/viruses,	   cancer	   or	   other	   disorders.	   It	   is	   difficult	   to	   assess	  how	   a	   neurological	   disorder	   can	   affect	   individuals	   so	   in	   an	   attempt	   to	   do	   so	   the	  World	  Health	  Organisation	  (WHO)	  published	  an	  online	  book	  [2].	  
In	  it	  the	  top	  neurological	  disorders	  are	  stated	  (Figure	  3.1).	  Additionally,	  an	  attempt	  was	  made	  to	  quantify	  the	  effect	  of	  these	  disorders	  on	  individuals.	  To	  achieve	  this	  they	  use	  two	  measures:	  	  
1. Years	  of	  Life	  Lost	  due	  to	  Mortality	  (YLL)	  2. Years	  of	  Life	  Lost	  as	  a	  result	  of	  Disability	  (YLD)	  
Adding	   these	   two	   figure	   together	   results	   in	   a	  measure	   called	   the	  Disability	   Adjusted	   Life	  Years	  (DALY).	  In	  essence	  “One	  DALY	  can	  be	  thought	  of	  as	  one	  lost	  year	  of	  healthy	  life	  and	  the	  
burden	   of	   disease	   as	   a	   measure	   of	   the	   gap	   between	   current	   health	   status	   and	   an	   ideal	  
situation.”	  [2].	  	  
	  Figure	  3.1	  –	  A	  list	  of	  the	  most	  common	  and	  affecting	  neurological	  disorders	  [2].	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  www.hypertextbook.com/facts/2002/DavidParizh.shtml	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With	  this	  measure	  a	  projection	  was	  made	  as	  to	  the	  estimated	  DALY	  for	  2030.	  This	  is	  shown	  in	  Figure	  3.2	  that	  estimates	  that	  in	  the	  year	  2030,	  approximately	  103	  million	  DALYs	  for	  the	  top	  disorders.	  This	  would	  mean	  that	  for	  a	  life	  span	  of	  70	  years	  (for	  Brazil)	  this	  equates	  to	  10%	  of	  Brazil’s	  population	  or	  in	  the	  UK	  the	  whole	  population	  of	  Northern	  Ireland.	  	  
	  Figure	  3.2–	  The	  estimated	  DALY	  for	  2005,	  2015	  and	  2030	  [2].	  	  There	   are	   many	   other	   considerations	   to	   be	   made	   including	   the	   social	   and	   economic	  implications.	   Socially,	   it	   is	   difficult	   to	   assess	   because	   figures	   are	   harder	   to	   gather	   in	  developing	  countries.	   	  However,	  up	  until	   the	   late	  1800’s	  disorders	   such	  as	  Epilepsy	  were	  treated	  as	  being	  caused	  by	  evil	  influences	  [3]	  and	  still	  are	  in	  many	  places.	  	  
Epilepsy	  is	  a	  useful	  example	  of	  a	  neurological	  disorder	  and	  the	  one	  that	  the	  remainder	  of	  this	  work	  focuses	  on	  although	  future	  work	  will	  extend	  to	  other	  areas.	  	  
3.3 Epilepsy	  
Epilepsy	  is	  a	  neurological	  disorder	  that	  affects	  approximately	  1%	  of	  the	  world’s	  population	  [3].	   It	   manifests	   in	   most	   patients	   as	   seizures	   that	   can	   cause	   the	   patients	   to	   lose	  consciousness.	   	   There	   can	   be	   many	   causes	   but	   mostly	   it	   is	   described	   as	   idiopathic	   (no	  known	  cause).	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In	  the	  UK	  alone	  456,000	  people	  are	  recorded	  as	  having	  epilepsy	  (1	  in	  131	  people)	  of	  which	   only	   70%	   could	   be	   controlled	   with	   proper	   anti-­‐epileptic	   drugs	   (AED).	   Of	   the	  remaining,	  3%	  are	  eligible	   for	  surgery,	  but	   there	  are	  up	  to	  500	  new	  applications	  per	  year	  and	  surgery	  is	  back-­‐logged2.	  In	  the	  UK	  alone,	  it	  is	  estimated	  that	  the	  yearly	  cost	  will	  be	  £0.5	  billion	   to	   treat	   the	   current	   population	   of	   children	   with	   epilepsy3.	   In	   the	   US,	   the	   cost	   is	  estimated	   at	   $15	   billion	   per	   year	   from	   a	   population	   of	   3	   million	   Americans	   (1%	   of	   the	  population)	  with	  200,000	  new	  cases	  per	  year.	  Epilepsy	  in	  the	  US	  is	  the	  3rd	  most	  prevalent	  Neurological	  Disorder4.	  	  
Generally	   epilepsy	   is	   diagnosed	   based	   on	   clinical	   history	   and	   through	  electroencephalogram	  (EEG)	  analysis.	  EEG	   is	   a	  method	  whereby	  dozens	  of	   electrodes	  are	  placed	   on	   the	   scalp	   to	  measure	   the	   cumulative	   activity	   of	   several	   thousands	   of	   neurons.	  These	  electrodes	  can	  come	  in	  many	  forms,	  in	  some	  cases	  needing	  a	  gel	  or	  saline	  solution	  to	  improve	  conductivity	  or	  promote	  adhesion	  to	  the	  skin	  surface.	  There	  are	  many	  theories	  as	  to	   how	   the	   electrodes	   pick	   up	   the	   electrical	   activity	   and	   the	   distribution	   of	   this	  measurement.	  This	  however	  is	  not	  the	  focus	  of	  this	  work	  and	  as	  such	  we	  refer	  the	  reader	  to	  [4],	  which	  is	  a	  definitive	  publication	  on	  the	  topic.	  
There	   are	  many	   other	  ways	   of	   accessing	   brain	   activity	   (implanted	   electrodes,	   fMRI,	  MEG	   etc…)	   but	   given	   this	  work	   is	   tailored	   towards	   personalized	   healthcare	   systems	   and	  general	  use	  in	  hospitals	  EEG	  is	  still	  the	  optimum	  choice	  of	  analysis.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  http://www.epilepsysociety.org.uk/AboutEpilepsy/Whatisepilepsy/Epilepsy-­‐didyouknow	  3	  www.jointepilepsycouncil.org.uk	  4	  www.epilepsyfoundation.org	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3.4 Analysing	  EEGs	  
EEGs	   have	   been	   analysed	   through	   linear,	   nonlinear	   (state-­‐space)	   or	  multivariate	   analysis	  techniques	  depending	  on	   the	  application	   [5,	  6].	   In	   the	  clinical	   field	   there	  are	  a	  number	  of	  features	   used	   to	   assess	   the	   activity.	   With	   Epilepsy	   there	   are	   a	   number	   of	   particular	  syndromes	   associated	   with	   it	   that	   include5:	   West	   syndrome,	   Lennox-­‐Gastaut	   Sydrome,	  childhood	   absence	   epilepsy,	   benign	   partial	   epilepsies	   and	   juvenile	   myoclonic	   epilepsy.	  Although	  as	  mentioned	  a	  number	  of	  epilepsy	  conditions	  are	   idiopathic	  (no	  known	  cause).	  With	   each	   condition	   and	   in	   general	   EEG	   analysis,	   clinicians	   usually	   use	   frequency	  quantifiers	  (Table	  3.1)[7].	  
Table	  3.1	  –	  Frequency	  Measures	  used	  in	  analyzing	  EEGs.	  
Type	   Frequency/Hz	  Delta	   <	  4	  Theta	   4-­‐7	  Alpha	   8-­‐12	  Beta	   12-­‐30	  Gamma	   30+	  	  
Epilepsy	  studies	  have	  aimed	  to	  extract	  features	  from	  neurological	  recordings	  for	  prediction	  and/or	   detection	   of	   seizures.	  However,	   although	   excellent	  work	   has	   emerged	   [5,	   6,	   8,	   9],	  predicting	  seizures	  is	  still	  an	  open	  problem	  with	  mixed	  results	  as	  to	  the	  optimum	  approach,	  which	  we	  shall	  discuss	  later.	  	  
This	   is	   being	   tackled	   by	  many	   groups	   including	   through	   the	   European	   Union	   FP7	  grant6.	  The	  field	  is	  still	  open	  for	  new	  methods	  applied	  to	  neurological	  signals	  that	  can	  give	  more	  insight	  into	  the	  signal	  dynamics	  surrounding	  epileptic	  seizures.	  Although	  in	  the	  area	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  http://www.epilepsy.org.uk/info/syndromes	  6	  http://www.epilepsiae.eu/	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of	  Neonates	  where	   seizure	   detection	   is	   sought	   there	   has	   been	   some	   success	   [10-­‐12],	   but	  nothing	  translated	  to	  usable	  systems.	  
3.4.1 Seizure	  Prediction	  and	  Detection	  
Generally,	   seizures	  and	  EEG-­‐based	   signals	   are	   treated	   in	   two	  different	   frames	  of	   thought:	  detection	   and	  prediction.	   Prediction	   has	   seen	  work	   ever	   since	   the	   1950s	   applying	   linear,	  nonlinear	  (state-­‐space)	  or	  multivariate	  analysis	  techniques	  to	  the	  EEG	  and	  derivatives	  of	  it.	  The	   ability	   to	   predict	   a	   seizure	   would	   allow	   for	   intervention	   strategies,	   such	   as	   brain	  cooling,	  electrical	  stimulation	  or	  drug	  delivery	  [13-­‐15]	  to	  be	  administered	  for	  those	  patients	  where	  medication	  and	  surgery	  has	  had	   little	  or	  no	  effect.	  The	  state	  of	  prediction	   is	   really	  best	   summarised	   in	   [5,	   8]	   .	   In	   the	   1990’s	   up	   until	   2000	   there	   was	   an	   optimistic	   drive	  towards	  prediction	  and	  the	  methods	  and	  data	  used	  varied	  but	  all	  showed	  optimistic	  results.	  Chaotic	  measures	  such	  the	  Lyapunov	  Exponent	  [16]	  and	  Correlation	  Dimension	  [17]	  were	  presented	  as	  possible	  markers	  .	  	  
From	   2000	   until	   present	   a	   more	   formal	   approach	   emerged	   to	   validate	   results	   and	  organise	  results/data,	   including	  more	  robust	  statistical	  validation	  methods	  (e.g.	  surrogate	  data	   analysis,	   sensitivity	   and	   specificity	   quantifies	   [18, 19]).	   This	   quickly	   showed	   that	   all	  current	   methods	   were	   not	   much	   better	   than	   chance	   and	   that	   linear	   methods	   (energy,	  entropy	   etc…)	   were	   just	   as	   powerful	   as	   the	   more	   nonlinar	   and	   nonstationary	   methods.	  Indeed	  over	  that	  last	  couple	  of	  years,	  the	  momentum	  appears	  to	  have	  slowed	  with	  still	  no	  real	   answer	   to	  whether	   seizures	   can	   be	   predicted.	   Currently	   there	   are	   a	   number	   of	   new	  emerging	  theories	   including	  microseizures,	  high	   frequency	  activity	  and	  a	  high	  pre-­‐seizure	  state.	  There	  is	  also	  an	  emerging	  perspective	  that	  detection	  and	  prediction	  need	  to	  go	  hand-­‐in-­‐hand,	   which	   was	   discussed	   in	   the	   Freieburg	   Seizure	   Prediction	   Workshop	   of	   2007.	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However,	  not	  much	  significant	  work	  has	  emerged	  from	  this	  and	  prediction	  is	  still	  an	  open	  question.	  
Seizure	   detection	   in	   most	   cases	   has	   followed	   a	   different	   path.	   The	   majority	   of	  literature	  has	  focused	  on	  Neonatal	  EEG.	  Seizures	  in	  neonates	  can	  be	  indications	  of	  Neonatal	  Encephalopathy	   (NE)	   -­‐	   the	  manifestation	   of	   abnormal	   neonatal	   brain	   function	   -­‐	   and	   can	  affect	   from	  0.5-­‐4	  neonates	  per	  1000.	  The	   incidence	  of	  NE	  can	  have	  devastating	   long-­‐term	  effects,	  including	  cerebral	  palsy,	  blindness,	  deafness,	  autism	  and	  in	  10-­‐15%	  of	  cases	  can	  be	  fatal.	  As	  a	  result	  litigation	  claims	  for	  the	  NHS	  since	  1996	  number	  approximately	  £3	  Billion.	  One	  of	   the	   issues	  with	  neonatal	   care	   in	   the	  area	  of	   seizure	  detection	   is	   that	   there	  doesn't	  exist	   an	   automated	   system	   for	   aiding	  non-­‐expert	   clinicians	   in	   spotting	   seizure	  behaviour.	  Although	   the	   initial	  methods	   saw	   value	   in	   this	   observation	   their	   results	  were	   poor,	   even	  when	   retested	  with	   optimisations	  more	   recently	   [20].	   State-­‐of-­‐art	   developments	   of	   these	  approaches	   have	   extended	   to	   algorithms	   that	   include	   time-­‐frequency	   methods	   (wavelet	  transform	   [21]),	   information	   theory	   (entropy	   [22,	   23])	   and	   chaotic	   measures	   (Lypanov	  exponent	  [16]).	  Our	  interpretation	  of	  the	  results	  shows	  three	  main	  insights,	  which	  are	  key	  driving	  points	  for	  our	  approach.	  
Firstly,	   the	   characteristics	   of	   rhythmicity,	   frequency	   and	   complexity	   of	   the	   raw	  EEG	  signal	  are	  the	  three	  of	  the	  most	  important	  factors	  in	  quantifying	  EEG	  activity.	  Second	  is	  that	  although	  frequency	  pre-­‐processing	  steps	  can	  be	  used	  as	  a	  primary	  measure	  they	  can	  also	  be	  a	  valuable	  step	  to	  enhancing	  other	  quantification	  measures.	  For	  instance	  entropy	  measures	  are	   best	   suited	   under	   low-­‐noise	   conditions;	   hence	   denoising	   methods	   such	   as	   simple	  filtering	   to	   wavelet	   decomposition	   have	   proven	   to	   improve	   these	   results	   [20].	   Thirdly,	  complex	  methods	  such	  as	  chaotic	  measures	  do	  not	  seem	  to	  improve	  the	  analysis,	  at	  least	  for	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seizure	  detection.	  These	   types	  of	  methods	  are	  computationally	  expensive	  and	  rely	  on	  any	  chaotic	  nature	  of	  the	  EEG	  to	  be	  related	  to	  the	  seizure	  activity,	  which	  has	  not	  been	  shown.	  	  
The	  rhythmicity/frequency	  is	  related	  to	  spiking	  activity	  which	  can	  be	  associated	  with	  seizures	  while	  the	  signal	  complexity	  suggests	  quantification	  of	  gestational	  age	  and	  expected	  states	   of	   the	   neonate	   brain	   for	   that	   age	   (sleep/wake	   cycles).	   Conventional	   clinical	  evaluation	   of	   seizures	   in	   EEG	   is	   based	   on	   frequency	   and	   amplitude	   changes	   of	   particular	  frequency	  bands	  (such	  as	  theta	  and	  delta)	  and	  spiking	  activity.	  Spike	  activity	  and	  frequency	  band	   information	   have	   led	   to	   high	   sensitivity	   of	   detection	   of	   seizures	   but	   with	   poor	  specificity,	  showing	  false	  prediction	  rates	  (FPR)	  of	  0.66-­‐1.5	  per	  hour	  [24,	  25].	  The	  highest	  sensitivity	   was	   based	   on	   an	   optimisation	   of	   40-­‐60	   parameters	   across	   a	   neural	   network	  (91%	   sensitivity,	   1.17	   FDR)	   [26].	   This	  method	  was	   very	   powerful	   in	   optimising	   relevant	  features	   for	  seizure	  detection	   in	  data	  sets	  of	  different	  abnormal	  background	  activity	   [26],	  with	  one	  of	  its	  successes	  being	  the	  pre-­‐removal	  of	  artefacts	  prior	  to	  analysis.	  Other	  studies	  have	  been	  positive	  but	  have	  been	  very	  specific	  to	  the	  seizure	  itself	  and	  have	  not	  considered	  that	   it	  may	   be	   of	   clinical	   interest	   to	   detect	   and	   classify	   any	   activity	   that	  may	   be	   seizure	  related	  (e.g.	  inter/post	  ictal).	  	  
Below	  we	   outline	   in	   more	   detail	   the	   algorithms	   and	  methods	   used	   in	   the	   art	   of	   seizure	  prediction.	  This	  review	  is	  adapted	  and	  extended	  from	  [27].	  
3.4.2 Clinical	  EEG	  
Epileptologists	   use	   the	   frequency	   characteristics	   and	   direct	   observations	   to	   discern	  pathologies.	  Table	  2.3	  shows	  the	  typical	  characteristics	  that	  are	  noted	  in	  an	  EEG	  analysis.	  	  
In	   addition	   to	   these	   characteristics	   seizures	   are	   typically	   broken	   into	   different	  categories.	   Although	   there	   are	   currently	   several	   debates	   as	   to	   the	   best	   EEG	   and	   seizure	  classifications	   and	   an	   effort	   by	   the	   International	   League	   Against	   Epilepsy	   (ILAE)	   to	   re-­‐
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establish	  a	  classification	  norm	  [28].	  Regardless,	  the	  most	  common	  classification	  is	  shown	  in	  
Table 3.3.	  In	  addition	  we	  have	  partial	  seizures	  that	  may	  not	  result	  in	  loss	  of	  consciousness	  (this	  includes	  absence	  seizures)	  and	  complex	  partial,	  that	  are	  partial	  seizure	  that	  evolve	  to	  more	  generalized	  ones.	  
Table	  3.2-­‐	  Interpreting	  the	  EEG	  
Overall	  Amplitude	  Left/Right	  Symmetry	  Alpha/Beta/Theta	  Rhythm	  Generalised	  or	  Bilateral	  Delta	  Epileptiform	  Potentials	  Normal	  variants	  
Response	   to	   activation	   (photic	   and	  hyperventilation)	  Changes	  during	  sleep	  Correlates	  of	  notable	  behaviors	  Summary	  Comments	  	   Table	  3.3	  -­‐	  Typical	  seizure	  classifications	  
Generalised	  Seizures	  Tonic-­‐clonic	  Absence	  Typical/Atypical	  Mycolonic	  Tonic	  /	  Atonic	  Clonic	  	  	  Partial	   seizures	   are	   usually	   characterised	   by	   spike-­‐wave	   burst	   patterns	   of	   1-­‐10	   second	  durations.	  The	  period	  of	  these	  waves	  can	  help	  determine	  other	  types	  of	  syndromes,	  such	  as	  the	  Lennox-­‐Gostaut	  syndrome	  which	  is	  typically	  characterized	  by	  slow	  spike-­‐wave	  bursts.	  Seizures	  generally	  start	  with	  local	  EEG	  rhythms	  (e.g.	  alpha	  or	  theta	  waves),	  focal	  spiking	  or	  electrodecremental	   (low	   voltage	   and	   high	   frequency)	   activity.	   Tonic	   and	   clonic	   seizures	  contain	  muscle	  artifact	  with	  more	  high	  frequency	  and	  amplitude	  activity	  can	  be	  seen.	  
With	   waveform	   types,	   clinical	   symptoms,	   frequency	   and	   amplitude	   variations	   and	  spatial	  distribution	  we	  can	  discern	  relatively	  well	  the	  type	  of	  seizure	  it	  is	  likely	  to	  be.	  This	  is	  done	   with	   visual	   heuristics	   and	   can	   distinguish	   between	   non-­‐epileptic	   seizures	   (such	   as	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psychogenic	   seizures),	   artifacts	   (muscle,	   eye	   movement),	   partial/focal	   and	   generalised	  seizures.	  
Detection	   is	   done	   visually	   (by	   human	   eye),	   usually	   post-­‐seizure	   event	   (back	  annotation	  on	  EEG	  records).	  There	  are	  some	  forms	  of	  seizure	  detection	  algorithms	  used	  for	  trial	  purposes	  but	  as	  yet	  there	  is	  no	  standard.	  The	  majority	  of	  predictive	  elements	  are	  for	  commercial	  and	  research	  purposes,	  none	  of	  which	  have	  been	  realized	  in	  clinics.	  
3.4.3 Seizure	  Prediction	  
Prediction	  of	  seizures	  using	  EEG-­‐based	  signals	  has	  gone	  through	  several	  stages	  over	  the	  last	  several	   decades.	   Methods	   applied	   to	   EEG	   signals	   have	   evolved	   with	   science	   and	  technological	   developments.	   As	   methods	   were	   developed	   and	   computer	   infrastructures	  developed	   to	   allow	   these	   methods	   to	   be	   applied	   efficiently,	   nonlinear	   methods	   were	  introduced	  into	  the	  field.	  Since	  then	  a	  multitude	  of	  works	  in	  several	  disciplines	  has	  focused	  on	   specific	  measures,	   both	   linear	   and	   nonlinear	   in	   an	   attempt	   to	   distinguish	   three	   states	  surrounding	  an	  epileptic	  seizure.	  	  
These	  states	  are	  commonly	  referred	  to	  as	  pre-­‐ictal,	  ictal	  and	  inter-­‐ictal	  (ictal	  refers	  to	  seizure	  state).	  Excellent	  chronological	  reviews	  of	  the	  field	  of	  analysis	  on	  EEGs	  can	  be	  found	  in	   [5,	   6,	   9]	   among	   others.	  We	   also	   note,	   that	   some	  methods	   involve	   the	   use	   of	   multiple	  channels	  (multi-­‐variate),	   looking	  at	  correlations	  and/or	  synchronicity	  in	  localized	  areas	  of	  the	  brain.	  	  
In	   the	   next	   section	   we	   review	   some	   of	   the	   basic	   methods	   of	   linear	   and	   nonlinear	  analyses	  that	  has	  been	  applied	  to	  EEG-­‐based	  signals.	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3.4.4 Linear	  Analysis	  
In	   the	   1970	   S.	   S.	   Viglione	   [29]	   carried	   out	   linear	   analysis	   on	   generalized	   (Grand-­‐Mal)	  seizures.	  However,	  this	  was	  abandoned	  when	  the	  results	  were	  found	  to	  be	  inconclusive	  but	  more	  recently	  has	  been	  re-­‐examined.	  We	  will	  discuss	  the	  results	  of	  these	  methods	  later	  in	  this	  section.	  	  
After	   the	   initial	   linear	  work	   on	   EEGs	   in	   the	   1970s	   and	   80s,	   nonlinear	   analysis	  was	  introduced.	   This	   then	   overshadowed	   any	   linear	  work	   and	   as	   such	   it	   is	   only	   recently	   that	  work	  has	  re-­‐established	  the	  relevance	  of	  both	  types.	  Only	  by	  a	  comprehensive	  comparison	  between	   both	   linear	   and	   nonlinear	  methods	   can	   we	   establish	   the	   validity	   and	   statistical	  value	  of	  any	  algorithm.	  This	  is	  especially	  illustrated	  in	  the	  work	  of	  Mormann	  et	  al.	  [5]	  and	  McSharry	  et	  al.	  [30].	  
Part	  of	  the	  motivation	  of	  using	  linear	  methods	  is	  that	  in	  cases	  even	  though	  the	  general	  dynamics	  may	  be	   unpredictable,	   i.e.	   nonstationary	   and	  nonlinear,	   the	   feature/activity	  we	  are	  interested	  in	  may	  actually	  have	  linear	  characteristics	  or	  can	  be	  approximated	  as	  such.	  We	  note	   that	   the	   following	  methods	   are	   simply	   described,	   the	   equations	   and	   derivations	  can	  be	  found	  extensively	  described	  in	  [5,	  27].	  
Moments	  
In	  a	  time	  series,	  such	  as	  the	  EEG,	  the	  mean	  is	  actually	  referred	  to	  as	  the	  arithmetic	  mean.	  This	  is	  also	  known	  as	  the	  first	  moment	  or	  expected	  value	  (denoted	  E(X)	  in	  most	  text	  books).	  The	  second	  moment	  (variance)	  is	  a	  measure	  of	  the	  deviation	  from	  this	  expected	  value.	  The	  third	  moment	  (skewness,	  χ)	  and	  fourth	  moment	  (kurtosis,	  κ)	  give	  other	  indications	  such	  as	  symmetry	  (χ	  =	  0	  for	  symmetric	  waveforms)	  and	  peakedness/flatness	  of	  amplitudes	  [5,	  31],	  [32].	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These	  sorts	  of	  methods	  were	  applied	  based	  on	  the	  theory	  that	  seizures	  are	  as	  a	  result	  of	   hypersynchronous	   neuronal	   activity,	   which	   results	   in	   more	   periodic	   (stationary)	   and	  linear	  features	  that	  these	  moments	  can	  extract.	  	  
Hjorth	  Parameters:	   In	   the	   1970’s	  Hjorth	   [4] defined	   a	   set	   of	   parameters	   to	   be	   useful	   in	  clinical	  analysis	  of	  the	  EEG	  that	  are	  simple	  extensions	  of	  these	  classical	  moments	  we	  have	  just	   described.	   These	   measures	   are	   mobility,	   activity	   and	   complexity	   [5,	   31].	   Activity	   is	  proportional	   to	   the	   variance	   of	   a	   signal,	   complexity	   measures	   the	   variance	   of	   the	   slope	  changes	  in	  relation	  to	  an	  ideal	  sine	  wave,	  and	  mobility	  measures	  the	  variance	  of	  the	  slopes	  of	   the	   EEG	   normalized	   by	   the	   variance	   of	   the	   amplitude	   distributions.	   Mobility	   and	  complexity	  are	  estimated	   through	   the	   second	  and	   fourth	   statistical	  moment	  of	   the	  power	  spectrum.	  
Energy	  and	  Power	  
The	   energy	   of	   a	   signal	   is	   given	   by	   the	   sum	   of	   the	   square	   of	   its	   discreet	   values,	   which	   is	  essentially	   the	   variance.	   In	   [33]	   a	   measure	   was	   used	   which	   calculates	   the	   accumulative	  
energy.	   Each	   window	   is	   summed	   in	   order	   to	   extract	   the	   evolution	   of	   energy	   around	   a	  seizure.	  
Power,	  a	  measure	  of	  energy	  as	  a	   function	  of	  time,	  can	  be	  quantified	   in	  several	  ways.	  There	  are	  two	  measures	  of	  power	  that	  have	  been	  proposed	  in	  the	  EEG	  literature.	  The	  first	  is	  to	  split	   the	   frequency	  components	  of	   the	  signal	   into	   its	   frequency	  bands	  (Table 3.1).	  Then	  calculate	  the	  spectral	  band	  power	  of	  these.	  	  
The	  second	  power	  measure	  we	  have	  is	  an	  extension	  to	  this,	  known	  as	  the	  spectral	  edge	  
frequency,	  used	  by	  Stanski	  et	  al.	  in	  1984	  [34].	  This	  is	  defined	  as	  the	  minimum	  frequency	  in	  which	   50%	   of	   the	   power	   in	   the	   40Hz	   bandwidth	   is	   contained	   [5,	   31].	   This	   frequency	   is	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chosen	  since	   the	  majority	  of	   the	   frequency	  content	  of	  an	  EEG	   is	  believed	  to	  be	  within	   the	  40Hz	  range.	  	  
Autocorrelation	  Function	  
The	  autocorrelation	  function	  [5]	  measures	  how	  correlated	  a	  signal	  is	  to	  itself	  at	  a	  later	  point	  in	  time.	  The	  theory	  is	  that	  the	  autocorrelation	  function	  will	  vary	  from	  A(0)	  (i.e.	  τ	  =	  0).	  Close	  to	  A(0),	  the	  autocorrelation	  function	  decays,	  while	  for	  large	  values	  of	  τ	  the	  function	  varies	  around	  0.	  The	  slower	  the	  decay	  from	  A(0)	  the	  more	  linear	  correlations	  in	  the	  series.	  Hence	  a	  measure	   of	   the	   time	   of	   the	   first	   zero	   crossing	   of	   A(τ),	   can	   quantify	   the	   range	   of	   linear	  correlations	  in	  the	  signal.	  
Autoregressive	  modeling	  
The	  previous	  measures	  characterised	  statistical	  properties	  of	  a	  signal	  but	  another	  approach	  involves	  the	  use	  of	  modeling	  the	  signal.	  By	  assuming	  any	  point	  in	  the	  time	  series	  is	  a	  linear	  sum	   of	   previous	   values	   one	   can	   extrapolate	   a	   linear	   model	   for	   the	   system	   [35].	   This	   is	  known	  as	  linear	  regression.	  	  
We	   can	   also	   include	   multiple	   channels	   of	   data	   [36]or	   a	   random	   process	   into	   the	  equation	   [5,	   31].	  These	  models	   are	  known	  as	   an	  autoregressive	  moving	  average	   (ARMA).	  Once	  modeled	  we	  can	  calculate	  the	  error	  between	  model	  and	  original	  signal	   to	  define	  the	  changes	   taking	   place,	   then	   use	   the	   z-­‐transform	   of	   this	   error	   [35].	   The	   evolution	   of	   the	  transfer	  poles,	  coefficients,	  prediction	  error	  and/or	  model	  order	  can	  then	  be	  analysed.	  
Linear	  cross-­‐correlation	  
We	  mentioned	  that	  multiple	  channels	  can	  be	  used	  and	  measures	  between	  them	  extracted.	  The	   cross	   correlation	   is	   a	   standard	   metric	   used	   in	   many	   applications.	   Rosenblum	   [37]	  defined	  a	  measure	   that	  quantifies	   the	   similarity	  between	   two	  signals.	  The	  measure	   is	   the	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maximum	   value	   of	   a	   normalized	   cross-­‐correlation	   function	   [5].	   Correlation	   will	   vary	  between	  0	  and	  1,	  with	  0	  being	  no	  correlation	  between	  the	  two	  signals.	  	  
Coherence	  
Coherence	  is	  similar	  to	  the	  cross-­‐correlation	  except	  we	  define	  the	  synchronization	  between	  the	  two	  signals,	  at	  a	  particular	  frequency	  rather	  than	  over	  the	  full	  signal.	  
Linear	  Summary	  
These	   methods	   are	   the	   basic	   linear	   measures	   applied	   to	   seizure	   prediction.	   Very	   few	  additions	  have	  been	  made	  in	  the	  last	  several	  years	  and	  those	  we	  have	  listed	  here	  have	  been	  extensively	  retested	  in	  [5,	  32].	  Undoubtedly,	  other	  linear	  measures,	  such	  as	  those	  illustrated	  in	  [38],	  which	  aim	  to	  work	  on	  both	  spatial	  (electrode	  relationships,	  neural	  sources	  etc..)	  and	  temporal	  (time-­‐series	  of	  single	  channels)	  modeling	  can	  be	  used.	  What	  needs	  to	  happen,	  and	  is	  the	  reason	  for	  the	  retesting	  of	  so	  many	  of	  these	  prediction	  algorithms,	  is	  for	  a	  universal	  statistical	  testing	  method	  in	  which	  to	  test	  the	  results	  [5,	  18].	  This	  we	  will	  describe	  in	  later	  sections	  but	  for	  now	  we	  will	  describe	  the	  nonlinear	  methods	  applied	  to	  EEG	  signals.	  
3.4.5 Nonlinear	  Analysis	  
A	   nonlinear	   signal	   is	   any	   one	   that	   shows	   a	   higher	   order	   power	   relationship	   in	   the	  underlying	  equations	  that	  describe	  it.	  Many	  mechanisms	  can	  be	  classified	  nonlinear,	  some	  of	  which	  are	  illustrated	  in	  Figure 3.3.	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  Figure	  3.3	  -­‐	  Table	  from	  Strogatz,	  [39]	  illustrating	  the	  classification	  of	  various	  natural	  mechanisms,	  including	  biological.	  
To	  extract	   features	  from	  a	  time-­‐series	  we	  first	  translate	   it	   into	  a	  multi-­‐dimensional	  space.	  From	   a	   single	   time-­‐series	   or	   time-­‐correlated	   multi-­‐channel	   data	   we	   use	   either	   time-­‐	   or	  spatial	   embedding.	   Time-­‐embedding	   is	   a	   mapping	   of	   signal	   to	   a	   d-­‐dimensional	   space,	  D,	  defined	   as	  D(t)	  =	   x(t),	   x(t	   +	   δτ),…,	   x(t	   +	  N	  δτ)	  where	   δτ	   is	   some	   fraction	   of	   delayed	   time.	  Spatial	   embedding	   constructs	   this	   space	  as	  D	  =	  x1(t)	  +	  x2(t)	  +	  …+	  xN(t)	  where	  each	  of	   xi(t)	  represents	   the	   sample	   value	   of	   multi-­‐channel	   data.	   While	   time-­‐embedding	   extracts	   local	  dynamics	  (in	  relation	  to	  the	  source	  activity)	  spatial-­‐embedding	  extracts	  more	  global	  brain	  dynamics	  [40].	  	  
Time-­‐embedding	   assumes	   that	   the	   time-­‐series	   portion	   is	   small	   enough	   to	   be	  considered	   stationary.	   Therefore	   τ	   and	   δ	   are	   typically	   determined	   through	   empirical	  methods	  or	  entropy	  based	  derivations	   leading	   to	  debate	  as	   to	  whether	   the	   true	  nature	  of	  the	  signal	  dynamics	  is	  being	  captured	  [22,	  23].	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With	   this	   understanding	   we	   can	   described	   the	   nonlinear	   algorithms	   used	   for	  prediction.	  The	   two	   foundation	  methods	  are	   the	  Lyapunov	  exponent	   (LE)	  and	  correlation	  dimension	  (CD).	  These	  and	  the	  foundations	  of	  their	  formation	  are	  the	  basis	  of	  several	  of	  the	  following	  algorithms.	  Sets	  of	  measures	  such	  as	   local	  flow	  and	   loss	  of	  recurrence	  are	  similar	  to	   these	  other	  measures	  but	   follow	  the	   flow	  of	   trajectories	  more	   than	  measures	  based	  on	  distinct	  points.	  The	  final	  sets	  of	  algorithms	  we	  shall	  consider	  look	  at	  spatial	  multi-­‐channel	  patterns.	  
Lyapunov	  Exponent	  (LE)	  
This	  measure	  is	  described	  as	  an	  indication	  of	  how	  the	  signal	  flows	  in	  our	  constructed	  multi-­‐dimensional	  space	  and	  how	  this	  flows	  has	  a	  sensitive	  dependence	  on	  the	  initial	  conditions	  of	   the	   system.	  This	   sensitivity	  produces	   flows	  on	   this	   space	   that	  exponentially	  diverge	  or	  converge	  from	  each	  other	  in	  a	  seemingly	  random	  way.	  	  
Any	  positive	  LE	   is	   an	   indication	   that	   chaotic	  mechanisms	  exist	  on	   the	  attractor	   (the	  name	  for	  the	  signal	  plot	  in	  the	  multi-­‐dimenstional	  space).	  To	  measure	  it	  we	  have	  to	  quantify	  the	  exponential	  divergence	  of	   adjacent	   trajectories	  on	   the	  phase	   space.	  There	  are	   several	  methods	  in	  computing	  this	  from	  a	  time	  series	  for	  one	  channel	  [41].	  The	  basic	  concept	  is	  that	  in	   each	   dimension	   of	   the	   attractor	   there	   will	   be	   a	   divergence	   that	   characterizes	   that	  principal	  axes	  (x,	  y,	  z,	  etc...).	  
Under	   particular	   conditions	   it	   has	   been	   shown	   that	   the	   largest	   LE	   gives	   accurate	  insight	  into	  the	  trajectory	  divergences.	  By	  calculating	  the	  largest	  LE,	  the	  average	  divergence	  is	  known.	  	  
A	  group	  led	  by	  Iasemidis	  et	  al.	  defines	  a	  bivariate	  (two	  channels)	  measure	  known	  as	  
dynamical	  entrainment.	  Defining	  a	  vector	  Xi	  as	  the	  d-­‐dimensional	  point	  in	  the	  phase	  space	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they	   define	   the	   Largest	   Lyapunov	   exponent	   (STLmax).	   This	  measure	   is	   also	   extended	   to	  construct	  the	  second	  trajectory	  X(tj)	  from	  another	  time	  series	  for	  multi-­‐channel	  data.	  	  
For	   the	  number	  of	   dimensions	  of	   the	   system	   there	  will	   be	   an	   equivalent	  number	  of	  exponents	  we	   can	   extract.	   The	  main	  drawback	  with	   calculating	   LEs	   is	   their	   sensitivity	   to	  noise	  and	  signal	   fluctuations	   [42,	  43].	  Hence,	   although	  LEs	  can	  be	  used	  as	   indication	   that	  chaotic	   behaviour	   exists	   in	   the	   system,	   under	   noisy	   conditions	   the	   results	   can	   be	  misleading.	  	  
Another	   interesting	   insight	   into	   progress	   of	   this	  measure,	   such	   as	   in	   [16]	   indicates	  that	   there	   is	   predictive	   power.	   However,	   the	   statistical	   validation	   carried	   out	   in	   [44,	   45]	  considered	  the	  results	  insufficient.	  We	  will	  review	  these	  results	  later.	  The	  evolution	  of	  the	  LE	  measure	   from	   its	   first	  quantification	   is	   a	   good	  example	  of	  how	  a	   lot	  of	   the	  algorithms	  have	  progressed.	   Initially	   it	  was	  used	  with	  no	  knowledge	  of	   the	   system	  dynamics,	   but	   as	  time	  progressed	  it	  was	  apparent	  that	  some	  parameter	  optimisation	  was	  needed	  for	  specific	  EEG	  changes.	  
Correlation	  Dimension	  
Our	   second	   standard	   measure	   is	   the	   correlation	   dimension,	   which	   is	   an	   estimate	   of	   the	  dimension	   of	   attractor	   space	   (strange	   attractor	   in	   chaos).	   For	   strange	   attractors	   this	  dimension	   is	   not	   necessarily	   a	   rational	   number,	   such	   as	   the	   Lorenz	   system	   that	   has	   a	  correlation	   dimension	   of	   2.06.	   The	   general	   name	   given	   to	   this	   dimension	   is	   fractal	  dimension.	  
The	  correlation	  sum,	  an	  essential	  foundation	  to	  the	  dimension	  calculation,	  first	  defined	  by	  [46]	  and	  corrected	  in	  [47]	  count	  the	  number	  of	  vectors	  in	  state	  space	  that	  are	  within	  a	  hypersphere	  (a	  sphere	  that	  goes	  through	  all	  dimensions)	  of	  radius	  r.	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Using	   this	   measure	   we	   determine	   the	   dimension	   from	   the	   slope	   of	   the	   correlation	  sum.	  From	  the	  above	  it	  would	  appear	  that	  we	  would	  need	  an	  infinite	  set	  of	  data	  points,	  N.	  However	   Lehnertz	   and	   Elger	   [17]	   showed	   how	   an	   effective	   estimate	   of	   the	   correlation	  dimension	  can	  be	  found	  when	  an	  almost	  constant	  range	  of	  values	  is	  observed.	  	  	  
In	   relation	   to	   prediction	   there	   has	   been	   some	   speculation	   as	   to	   the	   ability	   of	   this	  computation	   to	   quantify	   any	   brain	   dynamical	   changes	   preceding	   a	   seizure.	   In	   fact	   the	  results	  on	  EEG	  analysis	  first	  cited	  by	  [17]	  have	  been	  found	  to	  be	  questionable	  in	  [48].	  They	  use	   the	  same	  computational	  procedure	  but	  have	  variations	   in	  normalising	   the	  correlation	  sum.	  
The	  above	   two	  measures,	   correlation	  dimension	  and	  LE,	  are	  probably	   the	  most	  well	  known	  measures	  in	  the	  field	  of	  chaos	  and	  the	  ones	  described	  now	  are	  derived	  from	  these.	  
Similarity	  Index	  
A	   similarity	   index	   was	   developed	   by	   Le	   Van	   Quyen	   et	   al.	   in	   1999	   [49].	   In	   it	   a	   time	  embedding	   of	   a	   predefined	   reference	   window	   is	   made	   and	   then	   is	   compared	   with	   time	  windows	  on	  the	  EEG	  through	  a	  cross-­‐correlation	  sum.	  
Their	  first	  task	  was	  to	  minimise	  data	  usage	  as	  time-­‐embedding	  and	  correlation	  sums	  for	   a	   large	   embedding	   dimension	   is	   computationally	   intensive.	   To	   do	   this	   they	   use	   the	  positive	   threshold	   crossings	   (such	   as	   in	   quantisation)	   of	   a	   signal	   as	   time	   markers	   and	  measure	  the	  time	  intervals	  between	  two	  successive	  crossings.	  This	  method	  is	  applied	  to	  test	  windows	  and	  compared	  to	  a	  reference.	  There	  have	  been	  doubts	  raised	  in	  these	  results	  from	  [50,	  51]	  in	  response	  to	  some	  of	  these	  results.	  However,	  the	  doubts	  were	  defended	  as	  being	  due	  to	  different	  testing	  procedures,	  including	  filtering	  and	  computation	  of	  the	  algorithm.	  
An	  improvement	  in	  the	  result	  of	  this	  algorithm	  has	  been	  published	  that	  uses	  an	  initial	  wavelet	  denoising	  [52].	  They	  use	  a	  slightly	  modified	  correlation	  sum	  that	  uses	  a	  Gaussian	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function	   instead	   of	   the	   Heavyside	   one.	   This	   allows	   for	   a	   softer	   boundary	   and	   as	   such	  changes	  will	  be	  smoother	  in	  calculating	  the	  similarity	  index.	  	  
Dissimilarity	  
Another	  measure,	  closely	  related	  again	  to	  the	  correlation	  sum	  is	  the	  dissimilarity	  measure.	  As	  in	  the	  similarity	  index	  a	  reference	  window	  is	  chosen	  and	  a	  probability	  density	  function	  is	  defined	   for	   each	   window	   based	   on	   it	   a	   multi-­‐dimensional	   phase	   space	   representation.	  Effectively	  a	  similar	  scheme	  is	  used	  on	  the	  test	  and	  reference	  window	  as	   in	   the	  similarity	  index	   but	   instead	   other	   measures	   are	   used,	   the	   χ2	   test	   and	   L1	   norm	   [53].	   The	   χ2	   test	  quantifies	   frequency	  discrepancies	  between	   the	   two	  signal	  while	  L1	  distance	   is	   related	   to	  the	  total	  invariant	  measure	  on	  the	  attractor	  [53].	  
Marginal	  Predictability	  
Another	  measure	  that	  is	  a	  derivation	  from	  the	  correlation	  sum	  is	  the	  marginal	  predictability	  [54].	   Intuitively,	   this	   measure	   is	   the	   conditional	   probability	   that	   given	   d	   points	   in	   the	  hypersphere	  of	  radius	  r,	  the	  (d	  +	  1)	  point	  will	  also	  be	  in	  this	  sphere.	  According	  to	  [54]	  this	  measures	  how	  much	  additional	  predictive	  information	  is	  contained	  in	  the	  data	  point	  (d+1)	  compared	  with	  the	  prediction	  information	  of	  the	  previous	  d	  samples,	  reflecting	  in	  some	  way	  the	  Markovian	  nature	  of	  the	  signal.	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Local	  Flow	  
Used	  by	  [64]	  and	  additionally	  described	  in	  [5]	  the	  local	  flow	  looks	  at	  how	  trajectories	  pass	  through	  overlapping	  hypercubes	  in	  the	  multi-­‐dimensional	  space.	  The	   jth	  hypercube	  will	  be	  passed	  n	   times	  by	  a	  given	  trajectory.	  Each	  of	   these	  vectors	   is	  summed	  and	  normalized	  by	  the	  number	  of	  passes.	  
This	  measure	  allows	  us	   to	  distinguish	  between	  a	  nonlinear	  deterministic	   flow	  and	  a	  linear	  stochastic	  one.	  The	  thinking	  is	  that	  in	  a	  deterministic	  system	  there	  will	  be	  trajectories	  in	  the	  state-­‐space	  close	  to	  each	  other	  and	  moving	  in	  the	  same	  direction.	  While	  in	  a	  random	  system,	  such	  closeness	  of	  trajectories	  is	  not	  present.	  	  
Algorithmic	  Complexity	  
This	   is	  a	  measure,	  described	  by	  Mormann	  et	  al.	   [31],	   that	   is	  based	  on	  symbolic	  dynamics.	  The	  time	  series	  is	  transformed	  into	  a	  symbol	  sequence	  by	  partitioning	  the	  sampling	  values	  and	  denoting	  each	  by	  a	  symbol	  that	  denotes	   its	   interval	  (analogous	  to	  quantisation).	  Each	  value	  of	  the	  time	  series	  is	  then	  replaced	  by	  its	  corresponding	  symbol.	  The	  resulting	  symbol	  sequence	   is	  then	  investigated	  for	   its	  complexity	  by	  some	  manner	  (in	  [44]	  the	  Lempel-­‐	  Ziv	  parsing	   was	   used	   [55]).	   Finally,	   the	   algorithmic	   complexity	   is	   defined	   as	   this	   value	  normalized	  by	  the	  expected	  asymptotic	  value	  of	  such	  a	  random	  sequence	  of	  symbols.	  
Recurrence	  Loss	  
This	  measures	   the	  degree	  of	  nonstationarity	  of	   the	  system	  which	   is	  not	  a	  straightforward	  task.	  Rieke	  et	  al.	   [56]	  describes	  this	  algorithm	  by	  considering	  the	  state-­‐space,	  constructed	  through	   time-­‐embedding.	   Vectors	   that	   are	   the	   nearest	   neighbours	   in	   this	   space	   are	  extracted	  and	  counted.	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This	  is	  then	  compared	  with	  an	  expected	  time-­‐lag	  if	  the	  system	  was	  assumed	  stationary	  and	  the	  difference	  is	  compared	  using	  a	  distribution	  function.	  So	  then	  the	  measure	  reflects	  the	  systems	  loss	  of	  recurrence	  of	  the	  signal	  to	  a	  state-­‐space	  area	  over	  time.	  The	  stationary	  distribution	  function	  interpolated	  from	  the	  reference	  signal	  helps	  quantifies	  this.	  	  
Interdependence	  
For	  multichannel	   or	   bivariate	   data	   analyses	  we	   consider	   nonlinear	   correlation	  measures.	  First	   is	   the	   interdependency	  of	   two	  EEG	  signals.	  Consider	  two	  time-­‐series	  signals	  xi	  and	  yi	  which	  are	  both	  time-­‐embedded	  to	  generate	  their	  state	  space,	  xn	  and	  yn	  respectively.	  
We	   define	   the	   points	   which	   are	   considered	   nearest	   neighbours	   of	   xn	   and	   yn	   and	  denote	   the	   time	   indices	   of	   these	   k	   points	   as	   rn,j	   and	   sn,j	   respectively	   (j	   =	   1,	   ...,	   k).	   Four	  correlations	   are	   quantified	   that	   measure	   the	   interdependence	   of	   xn	   to	   its	   nearest	  neighbours	  and	  to	  yn	  based	  on	  the	  distance	  between	  these	  points.	  The	  same	  is	  done	  for	  yn	  to	  itself	  and	  xn.	  
With	  this	  definition	  insight	  into	  the	  dependence	  of	  the	  two	  signals	  can	  be	  extracted.	  A	  good	   discussion	   of	   the	   various	   types	   of	   measures	   and	   adaptations	   in	   the	   way	   these	   are	  defined	  can	  be	  found	  in	  [57].	  	  
Phase	  Synchronization	  
The	   final	   measure	   we	   shall	   consider	   in	   detail	   is	   in	   relation	   to	   synchronisation.	  Synchronization	   in	   systems	  has	  been	   identified	   for	  many	  hundreds	  of	   years	   starting	  with	  Hyugens	  in	  1673	  who	  noticed	  synchronization	  of	  clocks	  on	  his	  wall	  [5,	  6].	  	  
There	  is	  a	  lot	  of	  interest	  in	  this	  topic	  because	  of	  the	  insight	  it	  can	  give	  to	  the	  coupling	  between	  different	  signals.	  There	  is	  a	  lot	  of	  work	  to	  study	  synchronization	  as	  a	  general	  topic	  [6]	  but	  the	  work	  we	  shall	  consider	  here	  is	  EEG	  related.	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In	  the	  application	  of	  EEG	  signals,	  the	  type	  of	  synchronization	  that	  has	  been	  of	  interest	  is	  phase	  synchronisation.	  The	  three	  described	  in	  [5]	  are	  the	  ones	  we	  will	  refer	  to	  here	  and	  then	  we	  will	  describe	  some	  other	  concepts	  of	  synchronisation	  from	  general	  sources.	  	  If	  two	  oscillatory	   systems	   are	   phase	   locked,	   then	   there	   is	   a	   constant	   phase	   difference	   between	  them.	  In	  [58]	  a	  measure	  called	  the	  mean	  phase	  coherence	  is	  used.	  
Under	   a	   phase	   locking	   condition	   coherence	   will	   reach	   the	   value	   1	   when	  unsynchronized	  and	  0	  when	  it	  is.	  Another	  measure	  used	  by	  Rosenblum	  et	  al.	  [37]	  is	  based	  on	  the	  Shannon	  entropy	  (the	  uncertainty	  of	  a	  random	  variable).	  	  
Nonlinear	  Summary	  
There	   are	   several	   ways	   to	   quantify	   the	   nonlinearity	   of	   single	   and	   multi-­‐variate	   signals.	  Indeed	  there	  are	  a	  lot	  of	  techniques,	  both	  statistical	  and	  algorithmic,	  which	  have	  not	  been	  mentioned	  here,	  such	  as	  nonlinear	  forecasting	  and	  mutual	  dimension	  measures	  [6].	  Most	  of	  the	  algorithms	  and	  measures	  we	  have	  described	  are	  relevant	  as	  they	  have	  been	  applied	  to	  EEG-­‐based	  signals	  and	  more	  specifically	  seizure	  prediction.	  	  
There	   are	   several	  methods	   that	  have	   emerged	  over	   the	   last	   several	   years,	   including	  cross-­‐frequency	  coupling	  [59],	  patient	  specific	  bivariate-­‐synchony	  [60],	  rule-­‐based	  system	  [61]	  to	  new	  studies	  showing	  other	  features	  in	  EEG-­‐based	  signals,	  including	  high	  frequency	  oscillations	   [62]	   and	   studies	   of	   cortical	   excitability	   using	   transmagnetic	   stimulation	   [63]	  and	  more	  are	  emerging	  all	  the	  time.	  	  
Within	   the	  prediction	   field	   there	  have	  been	  a	  number	  of	   testing	  and	  retesting	  of	   the	  above	   algorithms	   on	   different	   data	   sets.	   Although	   not	   all	   results	   are	   illustrated	   here,	  sufficient	  summaries	  will	  be	  made	  based	  on	  the	  most	  significant	  findings	  of	  these	  works.	  To	  understand	  them	  we	  must	  first	  look	  at	  the	  methods	  that	  quantify	  their	  accuracy.	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3.4.6 Statistical	  Measures	  
There	  are	   several	  measures	  used	   to	  quantify	   the	  ability	  of	  an	  algorithm	   to	  detect	   specific	  features	  of	  data.	  These	  are	  summarised	  in	  the	  following	  table:	  
Table	  3.4	  -­‐	  Table	  describing	  the	  typical	  metrics	  used	  in	  prediction	  results.	  	   	   Condition	   	  




True	   Positive	  (TP)	   False	   Positive	  (FP)	   =	  Positive	  Predictive	  value	  
Negative	  
False	   Negative	  (FN)	   True	   Negative	  (TN)	   =	  Negative	  predictive	  value	  
	   	   =	  Sensitivity	   =	  Specificity	   	  
	  
1. Sensitivity	   -­‐	   This	   is	   a	  measure	   of	  TPTP +FN 	  which	   highlights	   how	  many	   events	   (i.e.	  seizures)	  of	  the	  total	  that	  are	  considered	  important	  (true)	  were	  detected.	  	  
2. Specificity	   –	   This	   measures	   TN TN +FP 	  which	   quantifies	   the	   algorithms	   ability	   to	  identify	  areas	  where	  no	  events	  (i.e.	  seizures)	  occurred.	  	  
3. False	   prediction/detection	   rate	   (FPR/FDR)	   measures	   the	   number	   of	   false	  predictions/detections	  made	  within	   a	   time	   interval,	   e.g.	   1/h	   (false	  prediction	   /	   hour).	  This	  is	  sometimes	  used	  instead	  of	  or	  to	  complement	  specificity,	  as	  with	  specificity	  it	   is	  difficult	  to	  assess	  true	  negatives	  and	  specificity	  does	  not	  track	  linearly	  with	  data	  size.	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  Surrogate	  Data	  Analysis	  
In	  an	  attempt	  to	  further	  validate	  the	  above	  measures,	  a	  surrogate	  time-­‐series	  is	  constructed	  (see	   [18]	  and	   references	   therein).	  Here,	  with	  EEG	  data,	   the	   seizures,	  or	  detectable	  events	  are	  left	  where	  they	  are	  and	  all	  other	  data	  is	  removed.	  This	  data	  is	  then	  replaced	  with	  data	  from	  the	  same	  patient	  but	  during	  the	   interictal	  (between	  seizure)	  period	  but	  with	  similar	  statistics	  (mean,	  variance	  etc…).	  The	  above	  measures	  are	  re-­‐evaluated	  on	  this	  new	  series,	  and	   if	   performance	   is	   poor	   compared	   with	   the	   original	   data	   set	   then	   the	  methodology/algorithm	  under	  test	  is	  further	  validated.	  
Prediction	  Specific	  
In	  prediction,	  you	  not	  only	  want	  to	  determine	   if	  a	  seizure	  will	  occur	  but	  when	  one	  would	  expect	  it	  to.	  In	  an	  effort	  to	  aid	  prediction	  validation,	  in	  2003	  a	  framework	  was	  established	  to	  compare	  and	  assess	  prediction	  methods	  [50].	  The	  key	  aspect	  of	  this	  framework	  is	  a	  defined	  
seizure	   prediction	   horizon	   (SPH)	   and	   a	   seizure	   occurrence	   period	   (SOP).	   As	   illustrated	   in	  Figure	  A2,	  the	  alarm	  indicates	  that	  in	  a	  certain	  period	  of	  time	  (SPH),	  the	  patient	  will	  enter	  the	  SOP,	  a	  period	  in	  which	  a	  seizure	  may	  occur.	  
	  
	  
	  Figure	  3.4	  -­‐	  Figure	  highlighting	  the	  seizure	  prediction	  and	  occurrence	  areas.	  In	   addition	   to	   this	   recent	   work	   has	   derived	   measures	   of	   determining	   what	   a	   random	  predictor	  should	  be	  able	  to	  achieve	  given	  a	  specific	  SOP	  and	  SPH	  [18,	  19].	  Here	  a	  binomial	  probability	  defined	  for	  the	  number	  of	  independent	  features	  (r)	  and	  electrodes/channels	  (n)	  for	  prediction	  k	  of	  N	  seizures:	  
Seizure	  Prediction	  Horizon	   Seizure	  Occurrence	  Period	  
Alarm	   Seizure	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d 	   	   	   	   (1)	  
where,	  d	  is	  the	  number	  of	  independent	  features	  given	  as	  ranging	  from	  1	  to	  𝑑𝑚𝑎𝑥,𝑟 𝑛 = 𝑛𝑟 .	  The	   upper	   and	   lower	   sensitivity	   given	   by	   this	   range	   of	   d	   is	   determined	   as	  
𝑆 = 𝑚𝑎𝑥𝑘 𝑃𝑏𝑖𝑛𝑜𝑚,𝑑 𝑘;𝑁;𝑃 >   𝛼 ∗ 100% 	  where	   α	   is	   a	   significance	   level	   of	   0.05.	   P	   is	   a	  probability	  defined	  as	  the	  SOP*SPH.	  
3.4.7 Results	  Prior	  to	  and	  including	  2006	  there	  were	  a	  number	  of	  papers	  aiming	  to	  analyse	  the	  current	  state	   of	   the	   art	   methods	   (those	   we	   have	   previously	   described)	   and	   determine	   their	  predictive	  power.	  These	   include	  those	  of	  Mormann	  et	  al.	   in	  2005	  [31],	  Winterhalder	  et	  al.	  2003	  [50],	  Mormann	  et	  al.	  again	  in	  2006	  [5]	  among	  many	  smaller	  studies.	  	  
This	   was	   all	   prior	   to	   the	   observation	   that	   all	   methods	   need	   to	   be	   studies	   with	  statistical	  analyses	  to	  validate	  the	  strength	  of	  them	  versus	  chance.	  Mormann	  et	  al.	  of	  2005	  studies	  a	  variety	  of	  linear	  and	  nonlinear	  measures	  using	  surrogate	  data	  to	  validate	  them.	  	  
The	   data	   used	   in	   this	   work	   compromised	   5	   patients	   (of	   which	   4	   were	   used	   for	  surrogate	  data	  analysis)	  with	  46	  seizures	  over	  a	  311	  hours	  of	  recording	  time.	  The	  data	  were	  tested	  under	  4	  categories,	  to	  distinguish	  the	  measures’	  ability	  to	  determine	  a	  preictal	  state	  based	  on	  single	  channel	  measures	  for	  each	  seizure	  separately	  and	  universally.	  
Two	   methods	   were	   used	   to	   assess	   the	   data.	   First,	   a	   threshold	   that	   distinguishes	  preictal	   and	   interictal	   is	   defined.	   This	   threshold	  would	   then	   have	   to	   be	   consistent	   for	   all	  seizures	   analysed.	   	   Secondly,	   given	   the	   number	   of	   electrode	   sites	   and	   seizures	   different	  evaluations	  can	  be	  made	  based	  on	  the	  following	  four	  schemes:	  (1)	  All	  seizures	  are	  analysed,	  (2)	   Each	   channel	   was	   tested	   separately,	   (3)	   Each	   seizure	   is	   analysed	   separately	   on	   each	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channel	  and	  (4)	  Is	  the	  same	  as	  in	  scheme	  3	  except	  the	  preictal	  period	  is	  only	  compared	  with	  the	  previous	  interictal	  state.	  This	  is	  to	  account	  for	  any	  baseline	  shift	  that	  may	  be	  present	  in	  the	   signals.	   Finally	   tests	  were	   carried	   out	  with	   different	   preictal	   periods	   (5/30/120/240	  minutes)	  and	  using	  an	  ROC	  (sensitivity	  vs.	  specificity)	  curve	  preictal	  and	  ictal	  states.	  
The	   conclusions	   from	   these	   results	   are	   that	   linear	   and	  nonlinear	  measures	  perform	  just	   as	  well	   as	   each	  other.	  Also	  univariate	  measures	  are	  able	   to	  distinguish	   changes	   for	   a	  shorter	   preictal	   period	   (5	   mins)	   compared	   with	   more	   significant	   changes	   measured	   by	  bivariate	  measures	  for	  larger	  periods	  (240	  mins).	  	  
With	  the	  introduction	  of	  the	  seizure	  prediction	  horizon	  a	  more	  extensive	  assessment	  can	   now	   be	   made.	   Winterhalder	   et	   al	   who	   originally	   proposed	   it	   determined	   that	   both	  similarity	   index,	   accumulated	   energy	   and	   correlation	   dimension	   did	   not	   have	   significant	  predictive	  value.	   	  Mormann	  et	  al	  continued	  their	  assessment	   in	  2006	  indicating	  that	  most	  methods	  have	  no	  statistical	  validation	  so	  could	  not	  be	  differentiated	  from	  chance.	  	  
This	  has	  led	  to	  studies	  that	  counter	  previous	  claims.	  For	  example	  Harrison	  et	  al.	  in	  two	  papers	   related	   to	   correlation	   dimension	   [48]	   and	   accumulated	   energy	   [64].	   The	   original	  work	  on	  correlation	  dimension	  claimed	  that	  a	  preictal	  state	  is	  detectable	  with	  a	  prediction	  time	  of	  up	  to	  12	  minutes.	  In	  Harrison	  et	  al.	  [48]	  the	  changes	  found	  in	  these	  signals	  that	  the	  previous	   studies	   revealed	  was	  a	   result	  of	   the	   time-­‐frequency	  characteristics	  of	   the	   signal.	  Using	  surrogate	  data	  analysis	  they	  showed	  that	  methods	  based	  on	  the	  correlation	  sum,	  such	  as	  the	  dimension	  and	  similarity	  index,	  provide	  no	  real	  prediction	  for	  these	  signals.	  	  
	   Some	   of	   the	   more	   recent	   studies	   have	   employed	   the	   statistical	   methods	   we	   have	  previously	  described	  [65,	  66].	  In	  these	  they	  determine	  the	  significance	  of	  seizure	  prediction	  based	   on	   a	   binomial	   probability	   of	   seizures	   being	   predicted.	   Aarabi	   et	   al.	   [65]	   recently	  showed	  that	  predicting	  at	  10	  seconds	  prior	  to	  the	  seizure	  onset	  zone	  leads	  to	  a	  prediction	  of	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90%.	  Although	  this	  is	  with	  a	  50	  minutes	  seizure	  occurrence	  period	  and	  it	  is	  not	  clear	  where	  the	  seizure	  occurs	  relative	  to	  this	  start	  point.	  In	  [66]	  a	  comparison	  between	  subclinical	  and	  clinical	  seizures	  is	  made	  showing	  sensitivities	  of	  20-­‐40%	  with	  not	  many	  several	  exceeding	  the	  lower	  and	  upper	  critical	  sensitivity	  values.	  
3.4.8 Seizure	  Prediction:	  Conclusions	  
In	   the	   previous	   sections	   we	   have	   looked	   at	   a	   number	   of	   methods	   applied	   to	   EEG-­‐based	  signals	  with	  the	  aim	  of	  predicting	  epileptic	  seizures.	  We	  have	  looked	  at	  the	  EEG	  signal	  as	  a	  time-­‐series	  of	  a	  single	  channel	  in	  which	  we	  apply	  linear	  and	  nonlinear	  measures.	  	  
With	  EEG	  signals	  there	  is	  no	  guarantee	  that	  this	  assumption	  holds	  true.	  If	  it	  were,	  then	  periodic	  solutions	  would	  exist	  and	  as	  such	  this	  whole	  work	  would	  be	  solved.	  But	  we	  don’t	  have	  a	  periodic	  solution,	  nor	  can	  we	  assume	  that	  a	  full	  sinusoidal	  cycle	  will	  occur	  (which	  is	  needed	   to	  assume	  a	   signal	   contains	  a	  particular	   frequency	   in	   fourier	  analysis).	  Unless	  we	  are	  talking	  about	  instantaneous	  frequencies	  of	  course,	  then	  we	  can	  make	  such	  assumptions	  (we	  will	  discuss	  this	  in	  later	  chapters).	  	  
What	  we	  have	  presented	  here	  is	  by	  no	  means	  the	  full	  spectrum	  of	  work	  carried	  out	  on	  the	  area	  of	  brain	  dynamics.	  Instead,	  we	  chose	  here	  very	  specific	  pieces	  of	  work	  to	  illustrate	  the	   topic	  of	   seizure	  prediction.	  Of	   course	   the	  explanation	  of	   the	  epileptic	  process	  and	   the	  population	  statistics	  was	  important	  in	  justifying	  the	  motivation	  of	  this	  work.	  
The	   algorithms	   (linear	   and	   nonlinear)	   described	   have	   mostly	   been	   applied	   to	   EEG	  signals	  with	  the	  aim	  being	  to	  determine	  and	  distinguish	  states	  within	  the	  brain	  surrounding	  an	  epileptic	  event	  (seizure	  and	  nonseizure).	  
	   What	   is	   clear	   is	   that	   statistical	  methods	  need	   to	  be	  applied	   to	  all	  methods	   to	   truly	  quantify	  their	  predictive	  capabilities.	  A	  few	  recent	  progresses	  have	  helped	  this	  cause.	  First	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is	   the	  work	  describing	   the	  generally	  accepted	  methods	   to	  apply	   [5,	  18,	  50].	   Second	   is	   the	  understanding	  that	  a	  universal	  database,	  well	  annotated	  and	  described.	  Although	  not	  able	  to	  be	  utilised	  in	  this	  project	  a	  database	  has	  just	  been	  come	  available	  as	  part	  of	  an	  EU	  project	  (http://epilepsy-­‐database.eu/).	   Similar	   work	   is	   being	   pursued	   with	   the	   Mayo	   Clinic	   and	  Brian	  Litt	  in	  the	  USA	  (http://mayoresearch.mayo.edu/).	  
3.5 Conclusions	  This	   chapter	   as	   a	   whole	   has	   aimed	   to	   give	   the	   reader	   insight	   into	   how	   epileptic	   seizure	  forecasting	   is	   addressed	   both	   in	   clinical	   and	   academic	   environments.	   Although	   only	   a	  snapshot	   of	   the	   field	   it	   gives	   us	   insight	   into	   the	   complex	   ever	   growing	   world	   of	   seizure	  prediction.	  	  
Interestingly,	  in	  the	  large	  studies	  of	  seizure	  prediction,	  we	  have	  seen	  that	  results	  favour	  a	  patient-­‐specific	  approach.	  The	  results	  in	  those	  cases	  outweighed	  any	  generalised	  trends.	  In	  retrospect	  we	  should	  probably	  not	  be	  surprised	  given	  the	  pure	  complexity	  of	  the	  human	  brain.	  
Whether	  seizures	  can	  be	  solved	  so	  that	  the	  millions	  of	  people	  suffering	  from	  it	  can	  be	  given	   an	   alternative	   treatment	   employing	   technology	   depends	   wholly	   on	   good	   research	  outcomes.	  As	  we	  have	  described	  in	  Chapter	  2,	  this	  also	  depends	  on	  the	  ability	  to	  integrate	  computing,	  engineering	  and	  biology	  into	  a	  framework	  that	  support	  this	  type	  of	  research.	  	  
As	  a	  first	  step	  in	  this	  work,	  we	  next	  present	  a	  novel	  method	  that	  has	  been	  designed	  to	  analyse	   biopotential	   signals	   and	   extract	   dynamics	   that	   can	   then	   be	   used	   for	   seizure	  detection	  and	  prediction.	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Chapter	  4 - WiNAM: A novel tool for analyzing biosignals	  	  
In	   the	   previous	   chapters	   we	   discussed	   our	   objectives	   in	   defining	   a	   system	   that	   is	   (1)	   a	  patient	  specific	  analysis	  of	  patients	  and	  (2)	  a	  system	  that	  integrates	  an	  ICT	  infrastructure	  to	  support	  such	  an	  analysis.	  	  
Towards	   this,	   in	   this	   chapter,	   we	   describe	   a	   novel	   algorithm	   applied	   it	   to	   seizure	  prediction	  and	  detection.	  Here	  we	  shall	  first	  describe	  the	  original	  methods	  from	  which	  the	  algorithm	  was	  developed,	  followed	  by	  the	  extensions	  to	  it	  we	  have	  implemented	  to	  make	  it	  applicable	  to	  time-­‐series	  data.	  
4.1 Pattern	  Recognition	  
Any	  system	  designed	   to	  classify	  data	   (such	  as	   seizure/non-­‐seizure)	  has	   three	  main	  steps:	  (1)	  data	  acquisition,	  (2)	  data	  representation	  and	  (3)	  decision	  making	  [1].	  	  
One	   of	   the	   more	   popular	   methods	   of	   pattern	   recognition	   is	   a	   statistical	   approach	  where	   features	   of	   the	   data	   are	   extracted	   through	   methods	   such	   as	   Linear	   Discriminant	  Analysis	   or	   Independent	   Component	   Analysis	   (ICA)	   and	   then	   selected	   according	   to	   some	  criteria.	   Once	   extracted	   classification	   methods	   are	   used,	   such	   as	   template	   matching	   or	  nearest	   neighbour	   models.	   An	   excellent	   review	   of	   all	   these	   methods	   and	   the	   future	  perspective	  on	  this	  topic	  see	  [2]	  and	  references	  therein.	  The	  method	  that	  we	  originally	  took	  inspiration	  from	  is	  called	  an	  ngram.	  	  
4.2 Ngrams	  
Traditionally	  ngrams	  have	  been	  applied	  to	  language	  models.	  An	  ngram	  model	  extracts	  and	   counts	   the	   subsequences	   of	   a	   particular	   symbolic	   sequence.	   These	   subsequences	   or	  patterns	  can	  be	  directly	  translated	  to	  probabilities	  of	  words	  occurring	  given	  the	  previous	  n-­‐
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1	   words	   [3,	   4].	   Hence	   ngrams	   can	   give	   direct	   insight	   into	   the	   Markovian	   nature	   of	   the	  sequence.	  For	  language	  learning	  models	  this	  is	  useful	  as	  a	  language	  can	  be	  modelled	  as	  the	  probability	  of	  a	  word	  occurring	  given	  a	  certain	  subset	  of	  previous	  ones.	  	  
Ngrams	   are	   derived	   from	   the	   	   original	   work	   of	   C.	   Shannon,	   who	   used	   the	   ngram	  approach	  of	  symbolic	  dynamics,	  entropy	  and	  complexity	  measures	  for	  the	  analysis	  of	  time-­‐series,	  which	  is	  now	  widely	  used	  [5].	  However,	  little	  attention	  has	  been	  given	  to	  an	  ngram	  approach	  for	  pattern	  recognition;	  applying	  probability	  and	  significance	  measures	  based	  on	  found	  patterns	  to	  quantify	  change	  in	  time-­‐series	  dynamics.	  	  
Instead,	  a	  number	  of	  works	  have	  derived	  extensions	  of	  the	  Shannon	  entropy	  through	  symbolic	   dynamics	   and	   phase	   space	   reconstruction	   [6]	   in	   an	   effort	   to	   define	   complexity	  measures	  [7]	  and	  track	  signal	  dynamics.	  The	  most	  extensive	  being	  in	  the	  use	  of	  entropy	  and	  probability	   distributions	   in	   language	   series	   partitioning	   and	   segmentation	   [8].	   The	   latter	  using	  ngram	  data	  mining	  to	  define	  sequence	  probabilities.	  
As	  we	  mentioned,	  typically,	  the	  target	  for	  ngram	  based	  approaches	  is	  language	  based,	  aiming	   to	   segment	   non-­‐separated	   character	   sequences	   into	   meaningful	   sentences	   [8]	  regardless	  of	   language.	   In	   this	  work	  we	   consider	   an	  alternative	  method	   for	  using	  ngram-­‐based	  analyses	  for	  pattern	  recognition	  in	  time-­‐series	  analyses.	  	  
To	  understand	   then	  how	  we	  can	  apply	   this	  approach	   to	   time-­‐series	  we	  need	   to	   first	  transform	  the	  data	  into	  a	  symbolic	  representation.	  	  
4.2.1 Symbolic	  Representation	  
Data	  can	  be	  compressed	  and	  represented	   in	  a	   symbolic	   fashion	   in	  one	  of	  many	  ways.	  We	  have	   mentioned	   some	   that	   look	   at	   phase	   space	   reconstruction	   but	   given	   the	   doubts	   of	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embedding	  methods	  we	  chose	  one	  that	  compressed	  the	  signal	  in	  the	  one	  dimensional	  space.	  The	  most	  popular	  one	  being	  quantization.	  Quantisation	  here	  defined	  as:	  
€ 
















2N 	  where	  
€ 
Vref+ 	  and	  
€ 
Vref− 	  are	  the	  analog-­‐to-­‐digital	  reference	  voltages	  and	  N	  	  the	   bit	   level	   representation.	   Finer	   resolution	   can	   be	   achieved	   by	   having	   a	   non-­‐binary	  divisor.	   This	   compressed	   signal	   can	   be	   represented	   in	   hexadecimal,	   hence	   in	   a	   symbolic	  way.	  Although	  we	  note,	  this	  is	  not	  necessary	  for	  the	  remaining	  methodology,	  it	  simply	  aids	  in	   showing	   the	   analogy	   to	   symbolic	   pattern	   recognition	   and	   the	   ngram	   approach.	   Also,	  biological	  data	  is	  generally	  acquired	  through	  some	  form	  of	  data	  acquisition	  using	  an	  analog-­‐to-­‐digital	  converter.	  The	  conversion,	  depending	  upon	  the	  application	  can	  result	   in	  8-­‐16bit	  data	  which	  when	  stored	  for	  software	  this	   information	  is	  represented	  at	   its	   lowest	   level	   in	  binary,	  but	  in	  a	  higher	  level	  of	  abstraction	  in	  hexadecimal	  (HEX).	  Hence,	  the	  data	  is	  already	  available	  in	  an	  alphanumeric	  format	  [9]	  (see	  Appendix	  C	  -­‐	  Conference	  and	  Journal	  Paper).	  
With	   EEG	   signals	   one	   typically	  measures	   a	   signal	   of	   up	   to	   100µV	   or	   1-­‐2mV	   [10]	   if	  measured	   using	   electrocorticogram	   (ECoG,	   surface	   of	   the	   brain).	   An	   example	   of	  quantization	  of	  an	  EEG	  signal	  is	  shown	  in	  Figure	  4.1.	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  Figure	  4.1	  –	  Figure	  showing	  a	  sample	  EEG	  data	  set	  re-­‐quantised	  from	  its	  original	  16	  bit	  to	  6	  bit	  using	  our	  outlined	  methodology.	  The	  algorithmic	  methods	   is	   summarised	   in	  Figure	  4.2	  with	   the	  addition	  of	  a	  divide	  down	  factor	   (first	  block	   in	  pre-­‐processing).	  Here	  we	   re-­‐quantise	   the	  data	  at	   a	   lower	  bit	   level	   in	  order	  to	  minimize	  noise	  contributions.	  We	  will	  discuss	  the	  implications	  of	  this	  later.	  So	  an	  N	  
=	  16bit	  number	  could	  be	  divided	  down	  by	  D	  =	  8	  bits	  resulting	  in	  an	  8	  bit	  number.	  	  
	  Figure	  4.2	  –	  Overview	  of	  how	  the	  Ngram	  technique	  is	  used	  with	  real-­‐data	  	  This	  will	  result	  in	  a	  list	  of	  HEX	  numbers	  each	  one	  of	  which	  represents	  a	  decimal	  value	  and	  can	  be	  used	  in	  the	  ngram	  pattern	  search.	  An	  example	  sequence	  is	  shown	  in	  Table	  4.1.	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  Table	  4.1	  -­‐	  Example	  of	  transition	  from	  sampled	  value	  to	  HEX	  value.	  
Sampled	  Value	  (+/-­‐	  
10mV,	  16bit)	   16	  bit	  value	  (signed)	   8	  bit	  value	  (signed)	   HEX	  Value	  -­‐0.9726	   -­‐3187	   -­‐12	   F4	  -­‐0.9726	   -­‐3187	   -­‐12	   F4	  -­‐0.9067	   -­‐2971	   -­‐12	   F4	  -­‐0.7761	   -­‐2543	   -­‐10	   F6	  -­‐0.5942	   -­‐1947	   -­‐8	   F8	  -­‐0.3815	   -­‐1250	   -­‐5	   FB	  -­‐0.2863	   -­‐938	   -­‐4	   FC	  	  
This	  table	  of	  values	  would	  result	  in	  the	  ngram	  of	  size	  2	  would	  count	  as:	  
Pattern	   Count	  F4	  F4	   2	  F4	  F6	   1	  F6	  F8	   1	  etc…	   …	  	  
With	  the	  time-­‐series	  now	  in	  a	  symbolic	  representation	  we	  apply	  our	  ngram	  methodology	  to	  it,	   analogous	   to	   the	   time	   series	   being	   a	   language	   and	   then	   deriving	   sentences	   or	   word	  sequences	  from	  it.	  	  
4.2.2 Multiresolution	  Ngram	  An	  ngram	  will	  produce	  a	  tree	  representing	  individual	  sequences	  and	  their	  counts.	  However,	  it	  by	  no	  means	  gives	  unique	  sequences	  but	  all	  possible	   combinations.	  This	  gives	  us	   some	  idea	   of	   the	   pattern	   spread	   but	   not	   on	   how	   the	   sequence	   should	   be	   separated	   into	   a	  meaningful	  one.	  This	   is	  analogous	   to	  segmenting	  words	   in	  a	  sentence	   into	  one	  defined	  as	  meaningful	  [8].	  	  
We	  periodically	  break	  a	  signal	  into	  segments	  (realizing	  a	  real-­‐time	  analysis	  tool)	  and	  analyse	   each	   segments	   patterns	   and	   associated	   counts	   to	   determine	   the	   evolving	  significance	   of	   patterns	   in	   time	   segments	   of	   data.	  We	   construct	   a	   single	   one	   dimensional	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ngram	   table,	   implemented	  using	   a	   combination	  of	  Matlab	  v7.12	  and	   the	  ngram	  statistical	  package	   [77]	   for	   each	   data	   segment.	   A	   pattern	   is	   considered	   if	   it's	   count	   is	   beyond	   a	  particular	  threshold,	  Th.	  The	  total	  count	  for	  the	  ith	  time	  window	  of	  significant	  patterns	  are	  then	  calculated	  as:	  	  
€ 
CNTi = (l(c(s1n ),c(s2n ),....,c(skn )) > Th)WINi 	   	   	   (2)	  
where	  
€ 
c(s1n ) 	  is	  the	  count	  of	  symbol	  sequence	  s1	  of	  ngram	  length	  n,	  	  l(…)	  is	  the	  length	  of	  the	  vectors	  contained	  within	  it	  and	  WINi	  is	  the	  ith	  window.	  	  In	  this	  simplified	  form	  we	  have	  no	  indication	  of	  the	  pattern	  sequence	  nor	  it's	  temporal	  evolution	  between	  the	  (i-­‐1)th	  and	  ith	  window.	  It	  will	  however,	  capture	  changes	  of	  periodicity	  within	   a	   signal	   over	   short	   time	   frames,	   details	   of	   which	   are	   dependant	   on	  Δ	   and	   ngram	  length,	  n.	  	  
This	   is	   shown	   in	   the	   same	   sample	   EEG	   signal	   shown	   in	   Fig.	   Here	   the	   seizure	   is	  characterised	  by	  the	  first	  3	  seconds	  of	  delta	  spikes	  (0-­‐4Hz)	  then	  electrodecremental	  activity	  (low	   amplitude	   high	   frequency	   for	   7	   seconds)	   followed	   by	   larger	   delta	   spike	   burst	   for	   a	  further	  10	  seconds.	  	  
	  Figure	  4.3	  -­‐	  Figure	  showing	  the	  pattern	  counts	  for	  three	  ngram	  sizes	  with	  three	  different	  quantisation	  levels:	  (a)	  8,	  (b)	  6	  and	  (c)	  4.	  Thus	  we	  clearly	  see	  a	  few	  cases.	  A	  decrease	  in	  pattern	  size	  can	  be	  due	  to	  two	  reasons:	  (1)	   the	  quantisation	   to	   transform	  the	  signal	   to	   the	  symbolic	  domain	   fails	   to	  compress	   the	  








































Chapter	  4-­‐	  WiNAM:	  A	  novel	  tool	  for	  analyzing	  biosignals	  	  
64	  
variabilities	   between	   similar	   symbol	   sequences	   such	   that	   they	   do	   not	   get	   counted	   and	  rather	   than	   see	   an	   increase,	   we	   see	   a	   decrease	   in	   pattern	   counts	   or	   	   (2)	   an	   increased	  periodicity	  results	  in	  fewer	  patterns.	  	  An	  increase	  in	  patterns	  may	  capture	  increases	  in	  the	  signal	  activity,	  such	  as	  intermittent	  activity.	  This	  can	  also	  be	  a	  result	  of	  larger	  patterns	  being	  broken	  up	  such	  that	  they	  appear	  as	  smaller	  pattern	  sizes.	  	  
What	   is	   clear	   is	   that	   on	   its	   own	   the	   ngram	   approach	   poses	   more	   questions	   than	  answers	   and	   needs	   to	   be	   improved	   to	   truly	   quantify	   the	   signal	   dynamics.	   	   This	   can	   be	  improved	  to	  have	  a	  refined	  pattern	  inference	  by	  searching	  for	  unique	  patterns.	  Quantisation	  which	  reduces	  signal	   states	  by	  a	   factor	  of	  2	  and	   inclusion	  of	  nonstationary	  and	  nonlinear	  processes	  that	  will	  misalign	  patterns,	  assigning	  them	  to	  different	  states,	  can	  result	  in	  similar	  patterns	   being	   considered	   separately.	   This	   can	   be	   countered	   by	   searching	   for	   similar	  patterns	  between	  those	  found.	  	  
To	  address	  uniqueness	  we	  propose	  to	  use	  a	  multi-­‐resolution	  ngram	  that	  searches	  for	  the	  most	  significant	  non-­‐overlapping	  patterns	  at	  a	  subset	  of	  pattern	  lengths.	  So	  we	  apply	  a	  methodology	  that	  during	  the	  ngram	  process	  derives	  the	  unique,	  non-­‐overlapping	  patterns	  at	   all	   levels	   of	   pattern	   length	   from	   the	   ngram	   lengths	   of	  Ngram	  =	  (N1,...,Nn)	  with	  Nn	  >	  N1.	  Hence	   for	   a	   time	   series	   in	   symbolic	   representation	   we	   search	   for	   the	   unique	   and	   most	  significant	  (highest	  count)	  pattern	  sizes	  in	  the	  ngram	  range.	  The	  process	  is	  described	  for	  a	  sequence	  x	  of	  length	  n	  and	  current	  symbol	  index	  i	  (note	  we	  start	  by	  searching	  for	  the	  largest	  ngram	  size):	  
1. Extract	  pattern,	  
€ 
Pk = {xi,xi+1,...,xi+Nn −1} 	  2. Lookup	   in	   the	   table	   of	   patterns	   of	   length	  Nn-­‐j	  where	   j	  =	  0,...,n-­‐1	   is	   the	   index	   of	  Ngram	  length,	  initially	  j=0.	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a. If	  this	  exists,	  c(Pk)	  =	  c(Pk)	  +	  1,	  signal	  index	  i	  =	  i	  +	  Nn-­‐j,	  is	  incremented.	  	  Determine	  patterns	   in	  Ngram	   tables	  with	   same	   first	   location	   and	   remove	   (see	   step	   3	   and	  note),	  return	  to	  step	  1.	  b. If	   doesn't	   exist	   and	   Nn-­‐(j+1)}	   ≥	   N1	   then	   j	   =	   j	   +	   1	   and	  
€ 
Pk = {xi,xi+1,...,xi+Nn− j } 	  and	  return	  to	  step	  2,	  else	  step	  3.	  3. Since	  no	  pattern	  pre-­‐exists	  in	  the	  lookup	  tables	  each	  patter,	  Pk	  is	  stored	  in	  a	  table	  with	  last	  location	  address,	  i	  recorded	  and	  i	  =	  i	  +	  N1	  and	  returned	  to	  step	  1.	  
Note:	  The	  largest	  pattern	  that	  repeats	  is	  considered	  dominant	  over	  any	  others	  with	  the	  same	  
last	  location	  address	  regardless	  of	  whether	  in	  the	  overall	  scheme	  another	  pattern	  would	  have	  
dominated.	  This	  significantly	  reduces	  the	  complexity	  of	  the	  process.	  
To	   explain	   further	   in	   the	   case	   that	   a	   no	   pre-­‐found	   pattern	   is	   found	   in	   the	   pattern	  tables,	  then	  the	  pattern	  will	  be	  added	  to	  the	  pattern	  list	  for	  all	  pattern	  sizes	  with	  a	  specific	  unique	   flag.	  These	   flags	  allow	  us	   to	  determine,	  once	  all	  patterns	  are	   located,	  which	   is	   the	  dominant	  pattern	   and	   thus	   remove	   the	  others.	  Thus	  what	   remains	   is	   to	   some	  degree	   the	  
unique	  set	  of	  patterns.	  An	  example	  on	  the	  same	  data	  set	  is	  shown	  in	  Figure	  4.4.	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  Figure	  4.4	  –	  Figure	  showing	  the	  results	  of	  the	  implementation	  of	  the	  unique	  multiresolution	  ngram	  approach.	  	  What	   this	   shows	  us	   is	   that	  during	   the	  seizure	  onset,	   the	  number	  of	  unique	   large	  patterns	  reduces	  (due	  to	  periodicity),	  while	  the	  smaller	  pattern	  sizes	  increase	  somewhat.	  The	  latter	  is	   partially	   due	   to	   variations	   in	   patterns	   symbols	   that	   are	   in	   fact	   subsets	   of	   the	   larger	  pattern	   lengths;	   a	  member	  of	   the	   smaller	  pattern	   size	   varies	   in	   symbol	   classification	   it	   is	  missed	  as	  being	  a	  subset	  of	  the	  larger	  pattern.	  This	  can	  be	  partially	  resolved	  using	  similarity	  metrics.	  
This	   is	   the	   algorithmic	   framework	  within	  which	  we	   have	   implemented	   our	   system.	  Although	  preliminary	  code	  (Appendix	  A)	  was	  implemented	  in	  Matlab,	  we	  wanted	  to	  create	  an	   environment	   that	   is	  more	   efficient	   for	   uploading	  mass	   amounts	   of	   data	  with	   included	  metadata.	  	  
4.2.3 System	  Implementation	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work	   is	   to	   establish	   such	   a	   framework	   for	   future	  work	   and	   to	   support	   signal	   processing	  methods,	  including	  our	  own.	  Any	  biomedical	  signal	  processing	  technique	  needs	  to	  be	  built	  into	   a	   framework	   that	   allows	   efficient	   processing	   and	   storage	   of	   results.	   We	   envision	   a	  system	   that	   follows	   the	   trends	  of	  biomedical	  healthcare	   in	  bringing	  a	   sensor	   front-­‐end	   to	  processing	  and	  backend	  visualisation	  (or	  closed-­‐loop	  functionality)	  into	  a	  modular	  system	  where	  different	  components	  can	  be	  placed	  in	  different	  modules	  (Figure	  4.5).	  
	  Figure	  4.5	  -­‐	  General	  system	  overview	  envisioned	  for	  implementing	  a	  signal	  processing	  method	  for	  biological	  data.	  	  In	   this	   figure	  we	   have	   a	   data	   acquisition,	   user	   interface	   and	   processing	   blocks.	   In	   theory	  each	  of	  these	  components	  could	  be	  placed	  in	  a	  different	  technological	  implementation,	  such	  as	  the	  acquisition	  being	  an	  implantable	  neural	  monitoring	  device,	  user	  interface	  on	  mobile	  phone	   or	   PC	   and	   processing	   units	   being	   a	  web-­‐accessed	   cloud.	   The	   distribution	   of	   these	  elements	   will	   vary	   depending	   upon	   the	   signal	   processing	   requirements	   (computational	  complexity)	  and	  application	  space.	  The	  ngram	  method	  would	  ideally	  fall	  into	  the	  processor	  section	  of	  the	  web	  system.	  	  
We	   implemented	   this	   system	   on	   an	   online	   system	   using	   an	   SQL	   database	   structure	  (www.winam.net).	   	  The	   fundamental	  page	  where	   the	  processing	  parameters	  are	  stored	   is	  displayed	   in	   Figure	   4.6.	   Here	   there	   are	   parameters	   that	   are	   associated	   with	   a	   case	   (i.e.	  patient)	  and	  specific	  information	  related	  to	  the	  data	  to	  be	  analysed	  for	  that	  patient.	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  Figure	  4.6	  –	  The	  main	  user	  interface	  for	  accessing	  the	  database	  and	  analysis.	  	  So	   for	  each	  user	  (such	  as	  a	  doctor),	   they	  can	  have	  multiple	  cases	  (patients)	  of	  which	  they	  have	  multiple	  data	  sets	   	   (ECG,	  EEG	  etc…)	  at	  potentially	  different	   times.	  Each	  of	   these	  sets	  will	   then	   be	   subjected	   to	   analysis	   (runs)	   with	   different	   intervals/sections	   of	   the	   data	  analysed.	  The	  analysis	  being	  the	  multiple	  pattern	  sizes	  (A-­‐D)	  searched	  for	  using	  the	  ngram	  analysis.	  This	  is	  all	  illustrated	  in	  Figure	  4.7.	  	  
The	   case	   and	   run	   parameters	   used	   were	   based	   on	   some	   preliminary	   database	  parameters	  and	  common	  metadata	  used	  in	  analysis	  (patient	  age	  etc…).	  Once	  the	  database	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structure	   and	   analysis	   were	   implemented	  we	   developed	   some	   visualization	   and	   printing	  tools	  to	  debug	  and	  analyse	  each	  stage	  of	  the	  system.	  	  
	  Figure	  4.7	  –	  Image	  of	  the	  hierarchy	  employed	  in	  the	  WiNAM	  database.	  	  
4.2.4 Data	  Requirements	  
The	  following	  set	  of	  information	  tables	  outlines	  some	  of	  the	  metadata	  to	  which	  we	  built	  the	  database.	  At	  present	  we	  have	  implemented	  most	  of	  these	  parameters	  and	  continue	  to	  build	  them	  as	  the	  database	  grows.	  Those	  with	  an	  ??	  indicate	  that	  they	  are	  not	  at	  present	  relevant	  to	  our	  studies,	  but	  have	  been	  included	  for	  future	  work.	  
1.	  Patient	  
1a	   Age	  Groups	   Adult	  (>16)	  1b	   Sex	   Mixed	  1c	   Ethnicity	   ??	  1d	   *Impairments	  (ICIDH-­‐2)	   ??	  *	  In	  reference	  to	  J.	  Engel	  Jr.	  “ILAE	  classification	  of	  epilepsy	  syndromes”,	  Epilepsy	  Research	  70S	  (2006):	  S5-­‐S10.	  
2.	  Epilepsy	  
2a	   Generalised	  Classification	   Idiopathic,	  symptomatic,	  cryptogenic	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2b	   Syndrome	  Classifications	   ??	  2c	   Disease	  Classification	   ??	  2d	   Age	  of	  first	  onset	   ??	  2e	   AED	  response?	   ??	  
	  
3.	  Seizure	  
3a	   Onset	  Classifications	   Idiopathic,	  focal,	  generalized	  3b	   Focal	  seizure	  types	   Any	  3c	   Generalized	  seizure	  types	   Any	  3d	   Status	  Epilepticus	  (continuous	  seizure	  types)	   Yes	  3e	   Percipitating	  stimuli	  (reflex	  seizures)	   ??	  3f	   Brain	  onset	  areas	  (if	  focal)	   Any	  3g	   Seizure	  frequency	   ≥1	  per	  month	  3h	   Seizure	  duration	   All	  durations	  3i	   Other	  Seizure	  types	   Electrographic,	  clinical,	  benign	  
	  	  
4.	  Data	  Gathering	  
4a	   Sampling	  Frequency	   ≥256Hz	  4b	   Recording	  montage	   10-­‐10,	  10-­‐20,	  monopolar	  4c	   Type	  of	  electrode	  /	  invasiveness	   Intracranial	   (ECoG/Deep	   Brain),	  EEG	  4d	   Data	  acquisition	  resolution	   8-­‐16bit	  4e	   Number	  of	  Patient	  data	  sets	   100	  4f	   Number	  of	  non-­‐epileptic	  controls	   20	  4g	   Hours	  of	  data	  per	  patient	   ≥24	  4h	   Number	  of	  seizures	  per	  record	   ≥2	  (ideally	  several)	  4i	   Number	   of	   significant	   epilepsy	  signatures	   ≥2	  4j	   Interictal	  duration	  (hours)	   ≥10	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5.	  Other	  Specifications	  
5a	   Artefacts	  (independent)	   	  Sweating,	   heart,	   electrical,	   chewing,	   tongue,	  blinking	  5b	   Artefacts	  (with	  seizures)	   As	  per	  5a	  5c	   Number	  of	  artefacts	  in	  data	   ≥30	  	  
4.2.5 Data	  Input	  
The	  first	  stage	  is	  the	  uploading	  of	  the	  data	  (after	  case/run	  parameters	  have	  been	  inputted)	  –	  Figure	  4.8.	  After	  this	  one	  can	  view	  the	  data	  graphically	  as	  shown	  in	  Figure	  4.9.	  	  
	  	  Figure	  4.8	  -­‐	  The	  uploading	  file	  interface	  (top	  right)	  and	  the	  viewed	  data	  in	  its	  raw	  ascii	  form	  (engineering	  format)	  and	  processed	  (after	  weighting).	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  Figure	  4.9	  –	  Graphical	  representation	  of	  the	  seizure	  (blue)	  and	  nonseizure	  (red)	  area	  that	  can	  be	  viewed	  from	  the	  interface.	  
4.2.6 Data	  Analysis	  
After	  loading	  the	  data	  pattern	  counts	  can	  be	  chosen	  (A-­‐D	  with	  A>B>C>D)	  and	  analysed	  as	  per	  the	  description	  of	  the	  ngram	  process.	  This	  can	  be	  viewed	  by	  clicking	  on	  the	  magnifier	  icon	  ( )	  on	  the	  WiNAM	  NBP	  Counts	  part	  of	  (Figure	  4.10).	  This	  also	  tells	  us	  the	  number	  of	  
anomalies	  or	  non	  patterns.	  	  
4.2.7 WiNAM	  Parameters	  






Pattern	  length	   0-­‐24	  Minimum	  occurrence	   2-­‐8	  Standard	  deviation	  (SD)	   0.5-­‐4	  Opt.	  Intervals	   0-­‐9	  Pattern	  Weight	   8-­‐1024	  Frame	  length	   00:00:00-­‐99:99:99	  
Amplitude	  filter	   	  
Frequency	  filter	  bandwidth	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The	  filtering	  tools	  have	  yet	  to	  be	  implemented	  at	  the	  time	  of	  writing	  this.	  Although	  some	  of	  our	  results	  (presented	  in	  the	  next	  chapter)	  carry	  out	  offline	  filtering	  in	  Matlab.	  	  
	  Figure	  4.10	  –	  Showing	  the	  ngram	  pattern	  count.	  Finally,	  for	  all	  cases,	  one	  can	  look	  at	  the	  number	  of	  anomalies	  for	  all	  the	  runs	  of	  a	  given	  case	  (Figure	   4.11).	   To	   elaborate	   from	   this	   figure,	   there	   are	   380	   significant	   patterns	   in	   the	   file	  meaning	  9,602	  non-­‐patterns	  which	  means	  96.19%	  are	  anomalies.	  
	  Figure	  4.11	  –	  The	  summary	  of	  the	  runs	  ratio	  (expressed	  as	  anomalies	  percentage)	  for	  a	  case.	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4.3 Summary/Conlusions	  	  In	  the	  work	  presented	  here	  we	  aimed	  to	  quantify	  and	  database	  neurological	  data	  with	  the	  aim	  of	   assessing	  normal	  behaviour	  and	  quantifying	  anomalies	  within	   it.	  To	  do	   these,	   two	  elements	  had	  to	  be	  developed,	  the	  database	  and	  a	  quantifying	  measure.	  
The	  measure	  chosen	  was	  a	  novel	  one,	  based	  on	  a	  pattern	  recognition	  method	  called	  ngram.	  To	  develop	   this	  work	   further	  we	   first	   needed	   to	  develop	   the	   analysis	   system	  and	  database	   so	  we	   could	   analyse	   large	   amounts	   of	   data	   sets	   automatically,	   in	   real-­‐time	  with	  multiple	  patterns.	  Ambulatory	  recordings	  and	  more	  data	  will	  help	  develop	  a	  more	  rounded	  analysis	  scheme	  for	  quantifying	  neurological	  behaviour.	  	  
In	   the	  next	  chapter	  we	  apply	   this	  methodology	   to	   the	  real	  data,	  quanitifying	  seizure	  prediction	  and	  detection	  capabilities	  of	  our	  system.	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Chapter	  5 -­‐	  Clinical	  Studies	  and	  Results	  
In	  the	  previous	  chapter	  we	  developed	  our	  novel	  pattern	  recognition	  method	  for	  analysis	  of	  various	  brain	  signals	  (including	  EEG	  and	  ECoG).	  In	  this	  chapter	  we	  apply	  this	  method	  to	  the	  area	  of	  seizure	  detection	  and	  prediction,	  which	  was	  discussed	  in	  Chapter	  3.	  The	  aim	  being	  to	   quantify	   the	   ability	   of	   our	  method	   to	   predict	   seizure	   in	   a	   specified	   time	   prior	   to	   their	  onset	  and	  benchmark	  the	  results	  against	  current	  state	  of	  the	  art	  significance	  tests.	  	  
5.1 EPI	  Data	  The	  data	  obtained	  from	  the	  EPI	  Epilepsy	  Centre	  in	  Zurich	  is	  a	  single	  case	  with	  36	  hours	  of	  data,	   sampled	   at	   256Hz.	   	   At	   approx.	   18	   hours	   a	   seizure	   occurred	   (Figure	   5.1).	   We	   pre-­‐filtered	  the	  data	  at	  low	  pass	  frequencies	  (-­‐3dB	  cut-­‐off)	  of	  5,	  10,	  15,	  20,	  30	  and	  70Hz	  using	  a	  4th	  order	  Butterworth	  implementation.	  	  
	  Figure	  5.1	  –	  Figure	  showing	  the	  results	  using	  WiNAM	  at	  different	  low-­‐pass	  filtering	  frequencies	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What	  is	  clear	  from	  this	  figure	  is	  that	  the	  seizure	  is	  detectable	  at	  all	  filtering	  frequencies	  but	  we	   see	   similar	   patterns	   associated	   with	   the	   sleep	   periods.	   Hence	   we	   analysed	   the	   5Hz	  filtered	  data	  with	  different	  voltage	  reference	  levels	  to	  account	  for	  the	  reduced	  amplitude	  of	  the	  data	  (due	  to	  filtering).	  This	  is	  shown	  in	  Figure	  5.2,	  where	  we	  clearly	  see	  that	  the	  seizure	  onset	  is	  much	  higher	  than	  the	  associated	  sleep	  patterns.	  The	  two	  large	  spikes	  at	  approx.	  20	  hours	  and	  just	  post	  25	  hours	  are	  signal	  artefacts	  (due	  to	  movement).	  
	  Figure	  5.2	  –	  Figure	  showing	  a	  5Hz	  filtered	  version	  of	  the	  EPI	  data	  with	  voltage	  reference	  levels	  set	  to	  the	  maximum	  and	  minimum	  of	  the	  signal.	  This	  is	  the	  extent	  to	  which	  we	  have	  analysed	  and	  worked	  with	  this	  data	  but	  it	  proved	  that	  initially	   our	  methodology	   extracts	   dynamics	   of	   the	   signal	   associated	  with	   significant	   and	  relevant	  features	  of	  the	  data	  set.	  	  
We	   are	  working	  with	   EPI	   to	   generate	   a	  well-­‐annotated	   data	   set	   similar	   to	   this	   case	  (including	   sleep	   and	   artefact)	   to	   quantify	   and	   analyse	   the	   signal	   behaviour	  more	   closely.	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Interestingly	  the	  seizure	  is	  predicted	  up	  to	  10	  minutes	  prior	  to	  onset	  although	  in	  this	  case,	  these	  changes	  are	  associated	  with	  typical	  ictal	  discharge	  phenomena.	  
	  
5.2 Freiburg	  Data	  Following	  this	  analysis	  we	  obtained	  a	  freely	  available	  data	  set	  from	  the	  University	  Hospital	  of	   Freiburg	   Epilepsy	   Centre,	   Germany.	   The	   data	   used	   were	   pre-­‐sampled	   at	   256Hz	   and	  quantised	  using	  a	  128	  channel	  16-­‐bit	  data	  acquisition	  [1-­‐3].	  This	  data	  is	  extracted	  from	  grid	  and	  depth	  electrode	  using	  6	  channels,	  3	  near	  the	  focus	  and	  3	  not.	  	  
We	  carried	  out	  two	  separate	  tests	  on	  this	  data	  set.	  The	  first	  a	  proof	  of	  concept	  that	  we	  published	   in	   2010	   [4],	   the	   second	   a	   study	   quantifying	   the	   detection	   further	   and	   also	   the	  prediction	  capability.	  	  
	  Figure	  5.3	  –	  Figure	  showing	  the	  patient	  details	  breakdown,	  taken	  from	  https://epilepsy.uni-­‐freiburg.de/freiburg-­‐seizure-­‐prediction-­‐project/eeg-­‐database	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5.3 Test	  1	  -­‐	  Initial	  Results	  All	  21	  patients’	  first	  seizure	  was	  used	  (to	  initially	  avoid	  any	  inter-­‐ictal	  phenomenon)	  from	  this	  data	  set.	  We	  use	  a	  preictal	  period	  of	  up	  to	  1	  hour	  in	  most	  cases	  (where	  such	  time	  was	  available)	  with	  seizure	  durations	  varying	  from	  15-­‐170	  seconds.	  There	  were	  multiple	  types	  of	  seizures	  present	  including:	  simple	  partial,	  complex	  and	  general	  tonic-­‐clonic.	  	  
The	  basic	  analysis	  we	  first	  used	  [4]	  analysed	  the	  difference	  between	  non-­‐seizure	  (in	  the	  pre-­‐ictal	  period)	  and	  seizure	  occurrence	  areas	  (Figure	  5.4).	  	  
The	  non-­‐seizure	  areas	  were	  gathered	  from	  3	  randomly	  selected	  areas	  (of	  the	  same	  length	  as	  the	  seizure	  areas)	  and	  pattern	  count	  averaged.	  Each	  set	  was	  reduced	  to	  8bits	  and	  various	  ngram	  sizes	  ranging	  from	  10	  to	  14	  were	  used.	  The	  quantifier	  used,	  was	  the	  ratio	  between	  the	  pattern	  count	  of	  the	  two	  areas.	  	  
	  
Figure	   5.4	   -­‐	   Example	   of	   how	   seizure	   and	   non-­‐seizure	   areas	   are	   selected	   and	  compared.	  
	  
Table	  5.1	   taken	   from	  [4]	  shows	  an	  example	  of	   the	   types	  of	   ratios	   found.	  From	  this	  table	  we	  identified	  18	  out	  of	  the	  21	  patients	  seizures	  were	  detected	  on	  these	  criteria	  alone,	  whereby	   a	   change	   of	   ratio	   greater	   than	   25%	   indicated	   seizure	   onset.	   Recently	   we	   have	  shown	  that	  the	  ratios	  by	  combining	  information	  on	  pattern	  sizes	  10	  and	  12	  can	  lead	  to	  a	  19	  out	  of	  21	  success	  (90%	  sensitivity).	  	  This	  proof-­‐of-­‐concept	  warranted	  further	  study	  into	  the	  use	  of	  this	  method	  to	  initially	  detect	  seizures.	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Table	  5.1	  -­‐	  Taken	  from	  [4]	  showing	  the	  initial	  results	  aiming	  to	  quantify	  the	  ratio	  of	  patterns	  between	  seizure	  and	  non-­‐seizure.	  
	  
5.3.1 Towards	  Real-­‐time	  detection	  
Real-­‐time	  detection	  requires	  analyzing	  segments	  of	  data	  and	  comparing	  the	  pattern	  counts	  to	   some	  predefined	   adaptive	   threshold.	  There	   are	   several	  ways	   to	   implement	   thresholds,	  most	  based	  on	  some	  statistics	  of	  the	  data,	  such	  as	  standard	  deviation.	  
Towards	   this	   goal	   of	   real-­‐time	   some	   initial	   results	  were	   presented	   in	   this	   paper	   on	  single	   patterns,	   an	   example	   of	   which	   is	   shown	   in	   Figure	   5.5.	   Here,	   we	   can	   clearly	   see	   a	  pattern	  count	  change	  at	  the	  onset	  (note:	  at	  the	  exact	  onset,	  not	  just	  high	  amplitude)	  of	  the	  seizure.	  This	  was	  done	  by	  analyzing	  the	  pattern	  count	  every	  10	  seconds.	  	  
To	  further	  study	  this,	  as	  simple	  thresholding	  was	  found	  to	  be	  unsuccessful	  we	  qualified	  the	  results	  by	  eye,	  to	  determine	  what	  types	  of	  changes	  are	  seen	  at	  the	  onset	  of	  seizure	  compared	  to	  normal	  activity.	  	  This	  is	  shown	  in	  Table	  5.1	  using	  ngram	  sizes	  of	  10	  and	  14	  with	  10	  and	  5	  second	  windows	  of	  analysis.	  With	  this	  the	  sensitivity	  reduced	  to	  17	  out	  of	  21	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(81%).	  However,	  some	  of	  the	  changes	  were	  difficult	  to	  quantify	  and	  this	  requires	  further	  automated	  studies.	  	  
	  Figure	  5.5	  –	  Shows	  a	  typical	  ECoG	  signal	  (top)	  with	  seizure	  occurrence	  (shaded	  area)	  and	  the	  pattern	  count	  (bottom)	  for	  a	  10	  second	  window	  	  Table	  5.2	  –	  Showing	  the	  qualified	  results	  of	  full	  analysis	  using	  single	  pattern	  counts	  over	  the	  full	  preictal	  period	  available.	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There	  are	  some	  trends	  such	  as	  a	  sharp	  increase	  followed	  by	  a	  decrease	  that	  ones	  see	  quite	  often	  (Figure	  5.6)	  in	  these	  data	  sets.	  	  
	  Figure	  5.6	  –	  Shows	  the	  quick	  increase	  and	  slow	  decrease	  seen	  in	  some	  sample	  data.	  
5.4 Test	  2	  -­‐	  Detection	  and	  Prediction	  Test	   2	   involves	   a	   more	   extensive	   analysis	   of	   the	   Freiburg	   data	   set.	   Based	   on	   the	   work	  defining	   a	   seizure	   prediction	   horizon	   we	   initially	   chose	   a	   65-­‐minute	   window	   prior	   to	  seizure	  onset	  to	  study	  predictive	  markers	  but	  also	  the	  detective	  ability	  of	  the	  algorithm.	  A	  summary	   of	   the	   data	   extracted	   from	   each	   patient	   is	   shown	   below	  where	  we	   identify	   the	  maximum	  data	  we	  could	  extract	   from	  what	  was	  available	  and	  by	  observation	  determined	  which	  channels	  were	  optimum	  and	  which	  may	  have	  contained	  GTC	  seizures.	  
Patient	   No	  Seizures	   Precital	  /	  hrs	   Location	   Electrode	   Interictal	  /	  hrs	  1	   4	   4.65	   F	   g,s	   23.00	  2	   3	   3.62	   T	   d	   24.00	  3	   5	   6.65	   F	   g,s	   24.00	  4	   5	   5.51	   T	   d,g,s	   24.00	  5	   5	   6.03	   F	   g,s	   24.00	  6	   3	   3.31	   T/O	   d,g,s	   24.00	  7	   3	   4.08	   T	   d	   24.61	  8	   2	   2.68	   F	   g,s	   23.16	  9	   5	   6.10	   T/O	   g,s	   23.93	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10	   5	   7.05	   T	   d	   24.46	  11	   4	   4.65	   P	   g,s	   24.05	  12	   4	   5.91	   T	   d,g,s	   24.81	  13	   2	   2.38	   T/O	   d,s	   24.00	  14	   4	   5.41	   F/T	   d,s	   23.86	  15	   4	   6.13	   T	   d,s	   24.00	  16	   5	   6.53	   T	   d,s	   24.00	  17	   5	   8.80	   T	   s	   24.07	  18	   5	   8.20	   F	   s	   22.87	  19	   4	   4.60	   F	   s	   24.38	  20	   5	   8.42	   T/P	   d,g,s	   25.62	  21	   5	   7.66	   T	   g,s	   23.94	  	   T:	  Temporal,	  F:	  Frontal,	  O:	  Occipital,	  P:	  Parietal	  (seizure	  area)	  g:	  grid,	  s:	  strip,	  d:	  depth	  (electrode	  type)	  	  
5.4.1 Detection	  The	   data	   was	   analysed	   with	   the	   methods	   described	   in	   the	   previous	   chapter.	   Initally,	   no	  optimization	   was	   carried	   and	   each	   data	   set	   was	   analysed	   as	   follows:	   each	   seizure	   was	  extracted	  with	  up	  to	  65	  minutes	  of	  data	  and	  analysed	  using	  parameters:	  Ngram	  =	  [10	  9	  8	  7]	  and	  Nbit	  =	  7bit,	  Time	  Window	  =	  1	  minutes.	  An	  example	  result	  is	  shown	  in	  Figure	  5.7	  where	  we	  see	  the	  spread	  of	  pattern	  counts	  for	  a	  specic	  case	  (Patient	  1,	  seizure	  1).	  	  
To	  automatically	  quantify	  detection	  we	  experimented	  with	  various	  thresholds	  based	  on	  the	  signals	  past	  standard	  deviation	  and	  mean.	  In	  general	  we	  found	  the	  mean	  to	  be	  more	  tolerant	   to	   fast	   changing	   signal	   components.	   Therefore,	   we	   calculated	   a	   moving	   average	  based	  on	  the	  previous	  N	  points.	  In	  this	  case	  N=5.	  	  	  	  
	   For	   a	   given	   patient	   and	   seizure	   an	   optimal	   value	   of	   the	   threshold	   is	   set	   for	   that	  seizure,	  then	  the	  same	  threshold	  is	  applied	  to	  the	  remaining	  seizures.	  This	  is	  done	  for	  each	  pattern	   length	   (4	   in	   this	   case).	   For	   example,	   if	   we	   have	   two	   seizures	   and	   four	   pattern	  lengths,	   four	   thresholds	   are	   determined	   that	   detects	   the	   first	   seizure	   in	   the	   four	   pattern	  counts	  (minimizing	  false	  detections),	  and	  then	  this	  same	  threshold	  is	  applied	  to	  the	  second	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seizure	  patterns.	  This	   is	   then	  reversed	  where	  the	  optimal	   threshold	   is	  determined	  for	   the	  second	  seizure	  and	  applied	  to	  the	  first.	  An	  example	  of	  thresholds	  is	  shown	  in	  Figure	  5.8.	  
	  Figure	  5.7	  -­‐	  Example	  of	  non-­‐optimised	  ngram	  analysis	  of	  EEG	  signal	  (top)	  and	  ngram	  pattern	  counts	  (bottom).	  Seizure	  occurs	  at	  approx.	  t	  =	  65mins.	  Doing	  this	  without	  any	  other	  optimisations	  results	  in	  Figure	  5.9.	  Although	  false	  detections	  are	   low,	   the	   sensitivity	   averages	   at	   55%	   (0-­‐100%	   range).	   Only	   in	   7	   out	   of	   the	   21	   cases	  (33%)	  do	  we	  see	  a	  sensitivity	  of	  100%.	  	  
	  Figure	  5.8	  -­‐	  Figure	  showing	  the	  thresholds	  as	  a	  function	  of	  signal	  moving	  mean.	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  Figure	  5.9	  -­‐	  Bar	  chart	  of	  the	  sensitivity	  (top)	  and	  false	  detections	  (bottom)	  of	  each	  Patient	  over	  all	  possible	  seizures	  used	  to	  determine	  the	  optimal	  threshold	  (“All”)	  and	  for	  the	  best	  case	  scenario	  (“Best”).	  These	  results	  are	  poor,	  and	  on	  closer	  inspection	  with	  the	  data,	  this	  is	  partly	  due	  to	  artefacts	  and	  power	  line	  noise	  (examples	  of	  which	  are	  shown	  in	  Figure	  5.10	  and	  Figure	  5.11).	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Figure	  5.10	  -­‐	  Showing	  EEG	  plagued	  with	  artefacts	  (all	  large	  amplitude	  spikes),	  including	  at	  seizure	  onset	  (~60	  minutes).	  Enclosed	  area	  indicates	  artifact	  shown	  in	  Figure	  5.11.
	  
Figure	  5.11	  -­‐	  A	  zoomed	  artifact	  of	  Figure	  5.10.	  
As	  such	  we	  decided	  to	  apply	  interfere	  removal	  using	  two	  combined	  methods.	  
5.4.2 Interference	  Removal	  The	  method	  we	  apply	  is	  to	  remove	  offsets,	  baseline	  drift	  and	  related	  electrode	  saturation.	  To	  do	   this	  we	  apply	  a	  similar	  method	  described	   in	   [5].	   In	   [5]	   they	  describe	  a	  method	  not	  dissimilar	  to	  a	  Savitzy-­‐Golay	  (SG)	  smoothing	  filter.	  	  
An	   SG	   filter	   takes	   the	   n	   points	   before	   and	   n	   points	   after	   signal	   point	   xi	  and	   fits	   a	  polynomial	   to	   it.	   The	   polynomial	   fit	   at	   point	   xi	   is	   effectively	   a	   filtered	   version	   (low	  frequency)	  component	  of	  the	  signal.	  Since	  both	  linear	  and	  quadratic	  functions	  may	  not	  be	  able	  to	  track	  the	  sharp	  changes	  associated	  with	  artefacts.	  We	  use	  a	  3rd	  order	  polynomial	  on	  an	  example	  of	  which	  is	  shown	  in	  Figure	  5.12.	  	  



















Neural	  Anomalies	  Monitoring:	  Applications	  to	  Epileptic	  Seizure	  Detection	  and	  Prediction	  	  
87	  
	  
Figure	  5.12	  -­‐	  Image	  showing	  (top)	  original	  EEG	  artifact	  signal,	  (middle)	  SG	  filter	  estimate	  of	  artifact	  and	  (bottom)	  EEG	  with	  artifact	  removed.	  To	  this	  signal	  we	  then	  apply	  a	  notch	  filter	  (4th	  order,	  -­‐80dB	  attenuation	  and	  quality	  factor	  10)	  to	  remove	  50Hz	  noise.	  	  
With	  this	  applied	  to	  all	  data	  we	  apply	  the	  same	  analyses	  as	  before	  using	  Ngram	  =	  [16	  
14	  12	  10	  8	  6	  4]	  and	  7	  bit	  quantisation.	  We	  do	  this	  for	  30	  and	  60	  second	  time	  windows	  where	  a	  pattern	  is	  chosen	  as	  optimum	  for	  each	  seizure.	  The	  results	  are	  shown	  in	  Figure	  5.13	  and	  Figure	  5.14	  respectively.	   	  These	  produce	  sensitivities	  of	  88.65%	  and	  86.11%	  and	  average	  false	  detections	  of	  6.42	  and	  3.73	  over	  the	  entire	  analysed	  period.	  


















Chapter	  5-­‐	  Clinical	  Studies	  and	  Results	  	  
88	  
	  Figure	  5.13	  -­‐Bar	  chart	  of	  the	  60	  second	  windows	  with	  artifact	  removed.	  If	  we	  combine	  the	  best	  results	  of	  these	  two	  we	  have	  a	  sensitivity	  of	  90.79%	  and	  mean	  false	  detection	   per	   hour	   of	   1.54	   (Figure	   5.15).	   Even	   here	   the	   results	   have	   not	   been	   fully	  optimized	   for	   different	   pattern	   sizes,	   quantisation	   levels	   and	   only	   partly	   with	   window	  length.	  We	  believe	  that	  many	  cases	  could	  be	  further	  optimized.	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  Figure	  5.14	  -­‐	  Bar	  chart	  of	  the	  30	  second	  windows	  with	  artifact	  removed.	  	  
	  Figure	  5.15	  -­‐	  Optimal	  results	  for	  combined	  30	  and	  60	  second	  windows.	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Several	  cases	  show	  poorer	  results,	  specifically,	  case	  6	  and	  8	  show	  low	  sensitivity	  while	  1,	  6,	  7,	  13	  an	  19	  show	  large	  false	  detections.	  	  
Closely	  analyzing	  these	  cases	  we	  find	  the	  following:	  
Sensitivity	  
Case	  6	   -­‐	  Second	  case	  of	  this	  data	  has	  several	  inter-­‐	  and	  pre-­‐ictal	  spiking.	  As	  such	  these	  abnormal	  patterns	  make	  it	  difficult	  to	  isolate	  the	  seizure.	  	  
Case	   8	   -­‐	   Both	   seizures	   are	   characterized	   by	   the	   large	   artefacts	   they	   create,	   meaning	  interference	  removal,	  which	  is	  imperfect	  in	  this	  case,	  results	  in	  reduction	  of	  results.	  Also,	  the	  optimal	  pattern	  length	  for	  both	  seizures	  is	  different.	  	  
False	  Detections	  
Case	  1	  -­‐	  The	  high	  false	  detections	  are	  due	  to	  the	  first	  two	  seizures,	  the	  second	  of	  which	  is	  not	   detected.	   The	   high	   false	   detections	   are	   due	   to	   the	   slow	   changes	   associated	   with	  pattern	  changes	  (Figure	  5.8).	  Possible	  removal	  of	  low	  frequency	  pattern	  changes	  would	  aid	  in	  this	  analysis.	  
Case	  6	   -­‐	  As	  in	  the	  sensitivity,	  the	  second	  case	  has	  a	  lot	  of	  spiking,	  causing	  variations	  in	  patterns	  that	  subsequently	  cause	  false	  detections.	  	  
Case	   7	   -­‐	   Here	   we	   could	   compromise	   sensitivity	   to	   reduce	   false	   detections.	   Reducing	  sensitivity	   to	   67%	   (2	   out	   of	   3)	   reduces	   false	   detections	   to	   0.	   This	   is	   because	   the	   last	  seizure	  appears	  to	  manifest	  just	  before	  the	  seizure	  index,	  thus	  biasing	  the	  threshold	  to	  be	  too	  low	  and	  have	  high	  false	  detections.	  	  
Case	   13	   -­‐	  Both	  seizures	  are	  detectable,	  but	  given	   the	  different	  pattern	  sizes	  and	  mean	  and	  variances,	  it	  would	  appear	  that	  a	  more	  optimal	  threshold	  may	  exits.	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Case	  17	  -­‐	  We	  can	  reduce	  sensitivity	  to	  50%	  and	  have	  lower	  false	  detections	  here.	  It	  does	  appear	  from	  the	  data	  that	  we	  could	  optimize	  better	  thresholds	  and	  pattern	  recognition	  parameters.	  	  
From	   this	   we	   have	   the	   following	   observations:	   (1)	   we	   can	   reduce	   sensitivity	   to	  minimize	   false	   detections	   considerably.	   This	   would	   completely	   depend	   on	   specific	  application	  requirements	  of	  detection.	  (2)	  There	  is	  a	  case	  for	  a	  more	  optimal	  threshold	  able	  to	   track	   the	  signal	  pattern	  changes	  better.	  We	  may	  not	  be	  able	   to	   improve	  sensitivity	  but	  would	   reduce	   false	   detections	   considerably.	  We	  must	   note	   that	   for	   this	   test,	   the	   optimal	  pattern	  was	   chosen	   for	  each	   seizure	   regardless	  of	   training	   seizure,	   showing	   the	  optimum	  results	  achievable.	  A	  more	  realistic	  situation	  aiming	  to	  match	  this	  is	  described	  next.	  	  
Our	  last	  methodology,	  then	  improves	  these	  results	  by	  optimizing	  for	  patterns.	  In	  the	  previous	   results	   a	   single	   pattern,	   for	   a	   single	   channel	   is	   chosen	   as	   the	   optimum	   for	   that	  patient.	  Here	  we	  use	  all	  channels	  that	  showed	  a	  detection	  of	  the	  training	  seizure.	  Detection	  is	  considered,	  whether	  false	  or	  seizure,	  only	  if	  a	  percentage	  of	  the	  patterns	  chosen	  show	  a	  detection.	  As	  we	  have	  7	  patterns,	   this	  meant	  that	   for	  different	  number	  of	  patterns	  chosen	  the	  following	  number	  of	  detections	  were	  required	  to	  be	  considered	  (Table	  5.3).	  
Table	  5.3	  -­‐	  Depiction	  of	  the	  number	  of	  detections	  need	  shared	  by	  multiple	  patterns	  to	  warrant	  a	  detection	  of	  seizure	  and/or	  false	  detection.	  	  
Number	  Patterns	  	   No.	  of	  Detections	  1	   1	  2	   1	  3	   2	  4	   3	  5	   3	  6	   4	  7	   4	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The	  results	  (Figure	  5.16)	  show	  us	  a	  couple	  of	  observations:	  (1)	  Assuming	  we	  only	  use	  the	   first	   seizure,	  we	  would	   have	   a	   sensitivity	   of	   71.3%	  with	   FDR	  of	   0.7	   per	   hour.	   This	   is	  primarily	  distorted	  by	   case	  18,	  which	  when	   removed	  we	  have	  a	   sensitivity	  of	  69.8%	  and	  FDR	  of	  0.178,	  and	  (2)	  assuming	  we	  have	  multiple	  seizures	  to	  fine	  tune	  the	  process	  we	  can	  achieve	  a	  sensitivity	  of	  92.2%	  with	  FDR	  of	  1.6.	  This	  can	  be	  improved	  to	  91.8%	  and	  0.22	  FDR	  with	  removal	  of	  case	  1.	  
A	   final	   comment	   on	   these	   results	   is	   to	   iterate	   that	   any	   combination	   of	   FDR	   and	  sensitivity	   can	   be	   implemented.	   For	   example,	   case	   1,	   a	   good	   result	   is	   using	   the	   second	  seizure	  for	  optimization,	  generates	  50%	  detection	  and	  an	  FDR	  of	  0.47.	  
	  
Figure	  5.16	  -­‐	  Optimal	  results	  using	  the	  combination	  of	  multiple	  pattern	  detections	  to	  determine	  if	  a	  detection	  should	  be	  considered.	  Our	   results	   overall	   show	   good	   detection	   results	   that	   has	   potential	   to	   be	   even	   further	  optimized	   to	   increase	   results.	   This	   requires	   a	   better	   understanding	   of	   seizure	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characteristics	   that	   include	   the	   type	   of	   seizures	   (clinical/subclinical),	   duration	   and	  localization.	  This	  will	  require	  a	  well	  annotated	  data	  set.	  	  
The	   second	   set	   of	   these	   results	   involves	   prediction.	   Here	   we	   decided	   to	   optimize	  pattern	  lengths	  and	  binary	  level	  by	  using	  interictal	  periods.	  	  
5.4.3 Prediction	  To	  quantify	  prediction	  we	  first	  carried	  out	  test	  comparing	  the	  interictal	  to	  preictal	  state	  of	  patients.	   The	   interictal	   period	   is	   used	   to	   define	   Ngram	   parameters	   that	   normalize	   the	  pattern	  count	  to	  a	  specific	   level.	  We	  initially	  applied	  this	  to	  the	  first	  seizure	  of	  each	  of	  the	  cases	  outlined	  in.	  	  
For	   6	   cases	   there	   was	   a	   clear	   variation	   of	   pattern	   counts	   prior	   to	   the	   seizure.	   An	  example	  of	  which	   is	  shown	   in	  Figure	  5.17.	  Of	  course	   there	   is	  no	  clear	   indication	  on	  when	  this	  variance	  occurs	  in	  the	  data	  so	  we	  chose	  to	  investigate	  this	  further.	  	  
As	   in	   the	  detection	   test,	   and	  based	  on	   the	  statistical	  prediction	  metrics	  described	   in	  Section	   3.4.6,	  we	   chose	   prediction	   horizons	   of	   5,	   15,	   30	   and	   60	  minutes,	  where	   possible.	  This	  was	  measured	  against	  the	  interictal	  periods	  to	  look	  at	  general	  (all	  patient)	  and	  specific	  patient	  deviations).	  An	  example	  of	  a	  case	  is	  shown	  in	  Figure	  5.18.	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Figure	  5.17	  -­‐	  Example	  of	  Case	  1,	  between	  (a)	  Interictal	  period	  and	  (b)	  the	  ictal	  period	  with	  seizure	  occurring	  at	  interval	  53	  (where	  the	  histogram	  initially	  rises).	  The	  thick	  (green)	  line	  	  shows	  the	  standard	  deviation	  threshold	  previously	  defined.	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  Figure	  5.18	  -­‐	  Patient	  1,	  all	  seizures	  with	  each	  of	  4	  seizures	  (red),	  the	  4	  preictal	  periods	  (in	  ascending	  order,	  green)	  and	  interictal	  (blue).	  The	  cross	  indicated	  the	  mean,	  with	  minimum	  and	  maximum	  indicated	  with	  the	  error	  bars.	  Each	  7	  plots	  are	  Ngram	  size	  16	  (top)	  to	  4	  (bottom)	  with	  intervals	  of	  2.	  We	  noticed	  the	  following	  observations:	  
1. For	  some	  specific	  pattern	  lengths,	  for	  example	  the	  5th-­‐7th	  subplots	  (ngram	  sizes	  8,	  6	  and	  4)	  we	  see	  that	  the	  ictal	  period	  is	  clearly	  differentiable	  from	  the	  interictal	  and	  preictal.	  Hence	  the	  seizure	  detection	  capability.	  2. In	  the	  same	  subplots	  the	  max/min	  separation	  appears	  to	  decrease	  as	  we	  move	  towards	  the	  seizure	  (60	  to	  5	  minutes).	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3. There	  are	  some	  cases,	  where	  this	  evolution	  of	  max/min	  matches	  the	  interictal	  spread	  and	  moves	  outside	  the	  interictal	  period.	  
	  Figure	  5.19	  -­‐	  Patient	  10,	  all	  seizures	  with	  each	  of	  4	  seizures	  (red),	  the	  4	  preictal	  periods	  (in	  ascending	  order,	  green)	  and	  interictal	  (blue).	  The	  cross	  indicated	  the	  mean,	  with	  minimum	  and	  maximum	  indicated	  with	  the	  error	  bars.	  Each	  7	  plots	  are	  Ngram	  size	  16	  (top)	  to	  4	  (bottom)	  with	  intervals	  of	  2.	  Another	  example	  case	   for	  patient	  10	   is	   shown	   in	  Figure	  5.19	  where	  some	  of	   the	  subplots	  show	  similar	  pattern	  evolutions.	  These	  correlate	  to	  previous	  studies	  indicating	  that	  a	  level	  of	   synchrony	  between	  neurons	  occurs	  prior	   to	   the	  seizure.	  However,	  we	  have	  derived	  no	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statistical	  proof	  for	  these	  case.	  Also	  the	  changes	  can	  be	  due	  to	  drifts	  in	  the	  signal	  leading	  up	  to	  the	  seizure.	  However,	  even	  a	  specific	  drift	  can	  be	  a	  preseizure	  warning.	  	  
First	   we	   look	   more	   closely	   at	   case	   1,	   to	   divulge	   if	   what	   we	   are	   observing	   is	   a	   true	  indication	  of	  a	  prediction.	  This	   is	  shown	  in	  Figure	  5.20	  with	   indication	  of	   interictal	  mean,	  maxima	  and	  minima.	  It	  is	  clear	  that	  there	  are	  shifts	  to	  the	  seizure	  onset.	  Deriving	  whether	  these	  are	  statistically	  significant	  requires	  quantification	  and	  statistical	  validation.	  	  
	  Figure	  5.20	  -­‐	  Case	  1,	  seizures	  1	  to	  4,	  and	  indication	  of	  inteictal	  mean,	  maxima	  and	  minima.	  	  To	  apply	  prediction	  in	  an	  automated	  fashion	  we	  first	  followed	  the	  same	  procedure	  as	  in	  our	  detection	  methods.	  We	  process	  each	  of	  the	  focal	  channels	  (three)	  separately.	  For	  a	  given	  patient	  and	  seizure	  an	  optimal	  value	  of	  the	  threshold	  is	  set	  for	  that	  seizure,	  then	  the	  same	  threshold	  is	  applied	  to	  the	  remaining	  seizures.	  The	  same	  multiple-­‐detection	  per	  pattern	  is	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followed.	  We	  repeated	  this	  using	  each	  seizure	  as	  the	  training	  seizure	  to	  have	  a	  statistical	  spread	  of	  the	  sensitivity	  and	  false	  predictions.	  The	  results	  are	  shown	  in	  Figure	  5.21	  and	  Figure	  5.22	  for	  a	  seizure	  prediction	  horizon	  of	  40	  and	  20	  minutes	  and	  occurrence	  period	  of	  10	  minutes	  (see	  Section	  3.4.6	  for	  details).	  	  We	  also	  computed	  a	  60	  minute	  and	  10	  minute	  IT.	  	  
	  Figure	  5.21	  -­‐	  Sensitivity	  and	  FDR	  for	  an	  IT	  of	  40	  minutes	  and	  SOP	  of	  10.	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  Figure	  5.22	  -­‐	  Sensitivity	  and	  FDR	  for	  an	  IT	  of	  20	  minutes	  and	  SOP	  of	  10.	  
	  For	  these	  IT	  periods	  we	  obtain	  sensitivities	  and	  FPR	  are:	  	  
IT	  (mins)	   60	   40	   20	   10	  
	  	   S	   FPR	   S	   FPR	   S	   FPR	   S	   FPR	  
Best	  case	   47.62%	   0.3	   36.43%	   0.18	   55.08%	   0.11	   55.95%	   0.28	  
1st	  case	   35.4%	   0.39	   22.46%	   0.24	   42.78%	   0.23	   36.35%	   0.32	  
	   S:	  Sensitivity,	  FPR:	  False	  Prediction	  Rate	  (per	  hour)	  Combining	  these	  results	  for	  the	  best	  of	  each	  patient,	  we	  obtain	  a	  sensitivity	  of	  51.83%	  and	  FPR	  0.08	  when	  minimizing	  FPR	  and	  65.32%	  and	  FPR	  of	  0.29	  when	  maximizing	  sensitivity.	  	  
5.4.4 Prediction	  Validation	  	   With	  these	  prediction	  results,	  we	  can	  now	  apply	  the	  probability	  of	  predicting	  the	  same	  seizures	  with	  the	  same	  IT/SPH	  and	  SOP	  (Section	  3.4.6).	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As	  described	  in	  [6]	  for	  a	  FPR	  of	  0.15	  /	  hour	  (which	  is	  clinically	  relevant)	  and	  an	  SOP	  of	  10	  minutes,	  this	  yields	  values	  for	  each	  patient	  of	  their	  minimal	  and	  upper	  critical	  sensivity	  value	  as	  outlined	  in	  Table	  5.4.	  
Table	  5.4	  -­‐	  Lower	  and	  upper	  sensitivity	  (%)	  for	  two	  different	  SOP	  values.	  The	  significance	  of	  a	  seizure	  prediction	  result	  should	  be	  ideally	  place	  above	  the	  upper	  value.	  	   SOP	  =	  10min	  
Patient	   Lower	  	   Upper	  1	   25.00	   25.00	  2	   33.33	   33.33	  3	   20.00	   20.00	  4	   20.00	   20.00	  5	   20.00	   20.00	  6	   33.33	   33.33	  7	   33.33	   33.33	  8	   0.00	   50.00	  9	   20.00	   20.00	  10	   20.00	   20.00	  11	   25.00	   25.00	  12	   25.00	   25.00	  13	   0.00	   50.00	  14	   25.00	   25.00	  15	   25.00	   25.00	  16	   20.00	   20.00	  17	   20.00	   20.00	  18	   20.00	   20.00	  19	   25.00	   25.00	  20	   20.00	   20.00	  21	   20.00	   20.00	  	  Knowing	  this	  we	  can	  construct	  a	  plot	  to	  determine	  if	  our	  prediction	  results	  are	  above	  these	  critical	  sensitivities.	  Taking	  the	  best	  case	  IT	  for	  each	  patient,	  we	  obtain	  Figure	  5.23.	  	  
Neural	  Anomalies	  Monitoring:	  Applications	  to	  Epileptic	  Seizure	  Detection	  and	  Prediction	  	  
101	  
	  Figure	  5.23	  -­‐	  Optimal	  sensitivity	  for	  each	  patient	  as	  a	  combination	  of	  all	  processed	  IT	  periods.	  Noted	  with	  an	  asterix	  (*)	  for	  the	  upper	  and	  circle	  (o)	  for	  the	  lower	  critical	  sensitivity	  values	  of	  Table	  5.4,	  SOP	  of	  10	  minutes.	  
	  Figure	  5.24	  -­‐	  FPR	  for	  the	  optimal	  sensitivity	  described	  in	  Figure	  5.23	  and	  the	  0.15	  FPR.	  These	  results	  show	  that	  17	  out	  of	  21	  exceed	  the	  upper	  critical	  sensitivity	  of	  which	  only	  11	  also	  have	  an	  FPR	  below	  the	  0.15	  rate	  required.	  These	  results	  are	  comparable	  to	  those	  presented	  in	  [6]	  where	  overall	  a	  mean	  sensitivity	  of	  35.2%	  (range	  16.7-­‐60%)	  for	  clinical	  seizures,	  34.9%	  (18.8-­‐83.3%)	  subclinical	  and	  29.8%	  (18.2-­‐58.3%)	  for	  both	  combined.	  	  Our	  results	  show	  larger	  numbers	  of	  patients	  exceeding	  the	  lower	  and	  upper	  critical	  value.	  Although	  they	  are	  not	  as	  high	  in	  sensitivity	  described	  in	  [7].	  However	  the	  results	  of	  an	  IT	  of	  5	  and	  10	  minutes	  are	  not	  clearly	  described.	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5.5 Discussions/Conclusions	  
In	  this	  chapter	  we	  have	  tested	  our	  methodologies	  to	  quantify	  seizure	  detection	  and	  prediction.	  We	  achieved	  this	  incrementally	  by	  analysing	  the	  data	  using	  various	  testing	  methods	  and	  criteria.	  	  	   The	  last	  test,	  where	  we	  quantifiy	  statistically	  both	  detection	  and	  prediction	  is	  the	  most	  significant.	  We	  showed	  that	  in	  detection	  we	  can	  obtain	  significant	  results,	  similarly	  with	  prediction,	  where	  we	  showed	  statistical	  significance	  above	  chance	  level	  and	  with	  adequate	  FPR	  for	  just	  over	  50%	  of	  cases.	  	  	   Although	  these	  results	  are	  significant,	  they	  can	  still	  be	  improved	  by:	  optimising	  over	  more	  channels	  and	  features,	  improving	  thresholding	  for	  detection/prediction,	  adaptations	  of	  the	  algorithm	  to	  improve	  pattern	  uniqueness	  and	  improved	  data	  sets	  with	  better	  annotations.	  The	  latter	  will	  allow	  better	  understanding	  of	  the	  types	  and	  locations	  of	  seizure	  onset	  relating	  to	  our	  results.	  	  	   On	  the	  other	  side	  of	  this	  we	  also	  must	  consider	  what	  the	  algorithm	  is	  doing	  and	  ways	  in	  which	  to	  improve	  it.	  Our	  pattern	  recognition	  technique	  involves	  extracting	  the	  counts	  of	  repeated	  sequence	  of	  electrical	  recordings.	  Hence,	  we	  are	  in	  effect	  measuring	  periodicity	  of	  features	   in	   a	   time	  window.	  Hence.	   It	  would	  make	   sense	  why	  we	   are	   able	   to	   detect	  most	  seizures,	  especially	  that	  those	  not	  detected	  lack	  clear	  periodic	  features.	  	  
	   Being	   periodic	   in	   this	   way	   we	   are	   partly	   resistant	   to	   single	   interictal	   spikes	   and	  artefacts	  of	  a	  similar	  sort.	  Also	  having	  removed	  baseline	  drift	  and	  some	  artefacts	  using	  the	  Savitzky-­‐Golay	  smoothing	  function,	  we	  can	  be	  confident	  in	  the	  ability	  of	  our	  methods	  ability	  to	  be	  extracting	  significant	  events	  related	  to	  seizures.	  This,	  we	  have	  further	  proven	  with	  the	  statistical	  significant	  results.	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Chapter	  6 -­‐	  Conclusions	  and	  Future	  Work	  
In	  this	  work	  we	  have	  explored	  a	  methodology	  for	  analyzing	  biosignals	  that	  combines	  both	  an	   ICT	   infrastructure	   with	   a	   novel	   algorithmic	   implementation	   to	   address	   the	   future	   of	  healthcare	   innovation.	   We	   first	   presented	   some	   initial	   work	   on	   designing	   a	   system	   to	  measure	  the	  urea:creatinine	  ratio.	  Following	  from	  this	  we	  presented	  the	  vision	  of	  this	  work,	  namely	  how	  databasing	  and	  methods	  of	  analysis	  can	  be	  combined	  to	   form	  a	  personalized	  view	  of	  our	  future	  healthcare.	  	  
We	  applied	  this	  strategy	  with	  a	  novel	  algorithm	  and	  a	  database	   for	  assessing	  neural	  signals	  in	  cases	  of	  Epilepsy	  and	  although	  preliminary,	  the	  results	  showed	  the	  power	  of	  this	  methodology.	   In	   this	   final	   chapter	  we	  would	   like	   to	   summarise	   the	   various	   findings	   and	  contribution	  of	  each	  chapter	  and	  discuss	  the	  implications	  for	  future	  work	  that	  I	  will	  pursue.	  	  
6.1 Results	  -­‐	  Discussions/Conclusions	  
Firstly	   we	   presented	   our	   work	   on	   a	   CMOS	   implementation	   of	   a	   urea	   to	   creatinine	   ratio	  sensor	  (Chapter	  2).	  This	  work	  primarily	  showed	  that	  we	  could	  innovate	  novel	  solutions	  to	  healthcare	  problems	  in	  very	  simple	  ways.	  It	  also	  led	  to	  the	  foundation	  of	  this	  work,	  where	  we	  soon	  came	  to	  realize	  that	  this	  type	  of	  technology	  is	  a	  small	  portion	  of	  the	  personalized	  healthcare	   space.	   In	   conventional	   medicine	   there	   is	   a	   large	   reliance	   on	   databases	   and	  Information	  Technology	  to	  produce	  more	  efficient	  healthcare	  solutions.	  With	  this	   in	  mind	  we	  looked	  to	  expand	  our	  framework	  to	  this	  environment	  and	  from	  a	  business	  perspective	  what	  is	  missing.	  
Our	   concept	   is	  based	  on	   the	  need	   to	  gather	  a	  multitude	  of	   information	  available	   for	  one	   person	   to	   understand	   the	   person’s	   health	   status	   as	   a	   whole.	   These	   would	   include	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genetic,	  blood	  work	  and	  even	  neurological	  data.	  We	  encompassed	   this	  vision	   in	  an	   image	  (Figure	  2.3)	   that	   shows	  how	  a	  person	  has	  many	   inputs	   and	  outputs	   that	   can	   feedback	   to	  form	  a	  critical	  evaluation	  of	  a	  person’s	  healthcare	  status.	  This	  model	   is	  applicable	  to	  both	  personalized	   healthcare	   in	   the	   sense	   of	   self-­‐evaluation	   to	   more	   in	   depth	   diagnostic	   and	  treatment	  solutions	  in	  the	  medical	   industry	  space.	  Technology	  such	  as	  the	  urea:creatinine	  sensor	  fall	  into	  this	  scope	  quite	  well.	  It	  is	  our	  aim	  to	  expand	  on	  this	  further	  and	  explore	  the	  need	  and	  model	  for	  such	  future	  generation	  of	  personalized	  healthcare	  systems.	  
With	   this	  vision	   in	  mind,	  we	  chose	  an	  application	  area	   to	  base	  our	  work	  on,	  namely	  neural	   signals	   (EEG	  and	  ECoG	  based)	   for	   the	  area	  of	   seizures	   in	  Epileptics.	  To	  do	   this	  we	  briefly	  covered	  the	  area	  (Chapter	  3),	  from	  the	  clinical	  interpretation	  to	  the	  state	  of	  the	  art	  algorithmic	   implementations,	   to	  some	  of	  the	  current	  databasing	  systems	  emerging	  for	  the	  community	  to	  use.	  What	  was	  generally	  clear	  from	  this,	  was	  that	  that	  there	  are	  still	  unsolved	  elements	   and	   that	   a	   common	   database	   in	   which	   researchers	   and	   clinicians	   can	   work	  together	  is	  paramount	  to	  this	  area.	  
The	  implementation	  of	  our	  novel	  algorithm,	  based	  on	  an	  ngram	  approach,	  came	  in	  two	  forms.	   First	   was	   the	   software	   implementation	   in	   a	  Matlab	   environment,	   where	  we	  were	  able	  to	  show	  the	  initial	  workings	  of	  the	  algorithm,	  adapt	  it	  using	  some	  novel	  methods.	  We	  soon	  adapted	   this	   to	   a	   general	   SQL	  database	  online	   server	   to	   facilitate	  mass	  data	  upload,	  databasing	   and	   processing.	   This	   in	   itself	   is	   the	   foundation	   to	   our	   vision,	   allowing	   neural	  anomaly	  monitoring	  to	  be	  combined	  with	  efficient	  databasing.	  	  
Finally	  we	  applied	  this	  to	  real	  EEG-­‐based	  data	  gathered	  from	  various	  sources	  (Chapter	  5)	  aiming	  to	  quantify	  prediction	  and	  detection.	  Indeed	  with	  detection	  the	  key	  aspect	  of	  the	  method	  is	  that	  it	  is	  able	  to	  extract	  very	  good	  seizure	  detection	  with	  low	  false	  detections	  due	  to	  its	  resilience	  to	  artefacts.	  	  
Chapter	  6-­‐	  Conclusions	  and	  Future	  Work	  	  
106	  
Prediction	   is	   a	   difficult	   one	   to	   solve	   and	   indeed	   we	   have	   shown	   some	   predictive	  capability	  of	  this	  work.	  For	  future	  development	  to	  truly	  quantify	  the	  predictive	  value	  of	  our	  methods	   would	   rely	   on	   (1)	   well	   annotated	   data	   sets	   (including	   artifacts	   and	   feature	  descriptions)	   and	   (2)	   expert	   guidance	   and	   development	   from	   a	   neurologist	   or	  epileptologist.	   Our	   future	  work	  will	   follow	   this	   path	   to	   develop	   detection	   and	   prediction	  using	  our	  methods.	  Collaborations	  are	  being	  formed	  and	  developed	  for	  this	  purpose.	  
6.2 Thesis	  Contributions	  	  This	  thesis	  has	  contributed	  in	  two	  key	  ways.	  It	  has:	  
1. Developed	  a	  novel	  pattern	  recogintion	  algorithm	  suitable	  of	  quantifying	  signal	  dynamics,	  and	  defining	  anomalous	  behaviour.	  2. A	  novel	  system	  implementation	  that	  integrates	  both	  databasing	  and	  algorithmic	  implementation	  to	  facilitate	  the	  study	  and	  real-­‐time	  analysis	  of	  patients	  biosignals.	  
These	  two	  contribution	  are	  both	  novel	  and	  succeeded	  in	  reaching	  the	  aims	  and	  objectives	  of	  this	   work.	   By	   providing	   both	   parts	   we	   now	   have	   a	   fully	   workable	   system	   to	   analyse	  biosignals	  in	  real-­‐time	  for	  several	  applications.	  	  
6.3 Future	  work	  
Based	  on	   these	   contributions	  we	   aim	   to	   further	  develop	   this	  work	   in	   two	  parallel	   fronts.	  The	   first	   is	   in	   pursuit	   of	   our	   neural	   signal	   analysis	   for	   quantifying	   seizure	   detection	   and	  prediction.	  We	  shall	  pursue	  this	  with	  collaborations	  from	  leading	  Epilepsy	  clinics,	  including	  EPI	  Zurich	  and	  King’s	  College	  London.	  With	  better	  annotated	  data	  and	  clinical	  expertise	  to	  guide	  the	  analysis	  we	  can	  create	  a	  system	  for	  all	  researchers	  and	  clinicians	  to	  use.	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   Another	   keen	   interest	   that	   has	   developed	   from	   this	   work,	   is	   the	   integration	   of	  personal	   biomarkers	   as	   a	   whole	   (including	   neural	   state)	   into	   diagnosis.	   This	   includes	  genetic	  traits,	  physiological	  parameters	  and	  metadata	  (family	  history)	  all	  integrated	  into	  a	  system	   that	   defines	   your	   personalized	   healthcare	   status.	   In	   the	   next	   section	   we	   briefly	  describe	  a	  project	  that	  works	  towards	  this	  aim	  that	  we	  will	  aim	  to	  pursue.	  	  
6.4 WiNORM	  
Personalised	   healthcare	   is	   rapidly	  moving	   beyond	   theoretical	   application	   into	   real-­‐world	  medicine.	   Advances	   in	   understanding	   how	   genetic	   differences	   influence	   treatment	   and	  prevention	   of	   disease	   have	   leapt	   forward	   based	   on	   the	   understanding	   of	   the	   human	  genome.	  DNA	  sequencing	  and	  genetic	  profiles	  that	  used	  to	  take	  rather	  long	  to	  generate	  can	  now	  be	  defined	   in	  a	  short	  period	  of	   time.	  At	   this	   rate	  of	  discovery,	   sequencing	  a	  person’s	  whole	   genome	   at	   a	   price	   lower	   than	   $10,000	   is	   now	   achievable.	   However,	   despite	   these	  advances	   in	  understanding	   the	  genetic	  basis	  of	  disease,	   the	  post-­‐genome	  era	  will	  need	   to	  focus	   on	   understanding	   how	   gene	   and	   protein	   networks	   interact	   with	   environmental	  stimuli	   to	   create	   complex	   human	   diseases.	   Here	   we	   emphasized	   the	   importance	   of	  predictive,	   preventive	   and	  personalized	  healthcare	   for	  patients.	  Greater	  understanding	  of	  the	   immediate	   application	   and	   future	   potential	   of	   these	   tools	   is	   necessary	   to	   affect	   the	  transformational	   benefit	   for	   patients	   receiving	   individualized	   genetically-­‐based	   medical	  care.	  	  
Our	  aim	  is	  to	  create	  a	  database	  that	  generates	  the	  “normal	  values”	  for	  each	  individual.	  Human	   illness	   is	   not	   solely	   determined	   by	   genetic	   inheritance.	   Interaction	   with	  environment	  and	  behaviour	  using	  sensor	  data	   is	  needed.	   Integrating	  results	   from	  various	  data	   modalities	   and	   knowledge	   retrieval	   engines	   are	   still	   challenging	   for	   clinically	  meaningful	  use.	  This	  database	  will	  take	  in	  account	  every	  specificity	  of	  each	  patient	  (Blood	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test,	  genetic	  test,	  disease	  markers,	  ethnicity	  and	  lifestyle),	  combine	  intelligibly	  and	  provide	  this	   patient	   with	   new	   unique	   “normal	   value”	   applicable	   for	   diagnosis	   or	   simply	   health	  monitoring	  and	  management.	  
There	  will	  be	  two	  major	  application	  of	  this	  database;	  
1 Business	  application	  
• NHS	  government	  /	  clinicians	  	  or	  GPs	  
• Better	  handling	  of	  patients	  results	  and	  ease	  the	  analysis.	  Cost	  effective	  	  2 Patient	  benefit	  
Considering	   the	   patient	   benefits,	   here	   we	   propose	   to	   consider	   the	   uniqueness	   of	   the	  individual	   patient	   and	   use	   the	   full	   range	   of	   the	   sciences	   and	   knowledge	   to	   provide	   the	  patient	  with	  personalised	  “normal	  values”.	  This	  knowledge	  will	  provide	  the	  patient	  with	  an	  appropriate	  and	  unique	  solution	  to	  manage	  their	  own	  health.	  The	  health	  management	  will	  consist	  of	  data	  consultation	  among	  peers	  and	  the	  giving	  of	  advice	  based	  on	  expertise,	  rather	  than	   the	   normal	  model	   as	   used	  nowadays.	  Decision	   support	  would	   consist	   of	   access	   to	   a	  wide	   variety	   of	   knowledge	   resources	   in	   the	   databases,	   as	   well	   as	   to	   tools	   for	   creative	  problem	  solving	  and	  research.	  
A	  few	  key	  numbers:	  
The	  databases	  we	  are	  designing	  have	  great	  potential	  to	  help	  Medical	  professionals	  to	  do	  the	  best	   diagnosis.	   Indeed	   the	  NHS	   published	   a	   few	   results	   about	   the	   lack	   of	   good	   diagnosis	  within	  different	  departments.	  
• 50%	  of	  medicaton	  errors	  are	  a	  result	  of	  insufficient	  information.	  	  
• 1	  in	  16	  hospital	  admissions	  are	  a	  result	  of	  a	  mistaken	  diagnosis.	  	  
• 10.8%	  of	  patients	  experience	  an	  adverse	  event	  on	  medical	  wards.	  	  
• 3rd	  most	  common	  patient	  safety	  incident:	  medication	  errors.	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Genetic	  disorders	  
Both	   environmental	   and	   genetic	   factors	   have	   roles	   in	   the	   development	   of	   any	   disease.	   A	  genetic	   disorder	   is	   a	   disease	   caused	   by	   abnormalities	   in	   an	   individual’s	   genetic	  material	  (genome).	   The	   four	   different	   types	   of	   genetic	   disorders	   are	   (1)	   single-­‐gene,	   (2)	  multifactorial,	  (3)	  chromosomal,	  and	  (4)	  mitochondrial.	  
(1)	  Single-­‐gene	  (also	  called	  Mendelian	  or	  monogenic)	  -­‐	  This	  type	  is	  caused	  by	  changes	  or	   mutations	   that	   occur	   in	   the	   DNA	   sequence	   of	   one	   gene.	   Genes	   code	   for	   proteins,	   the	  molecules	  that	  carry	  out	  most	  of	  the	  work,	  perform	  most	  life	  functions,	  and	  even	  make	  up	  the	  majority	  of	  cellular	  structures.	  When	  a	  gene	  is	  mutated	  so	  that	  its	  protein	  product	  can	  no	   longer	  carry	  out	   its	  normal	   function,	  a	  disorder	  can	  result.	  There	  are	  more	   than	  6,000	  known	   single-­‐gene	   disorders,	   which	   occur	   in	   about	   1	   out	   of	   every	   200	   births.	   Some	  examples	  are	  cystic	  fibrosis,	  sickle	  cell	  anemia,	  Marfan	  syndrome,	  Huntington’s	  disease,	  and	  hereditary	  hemochromatosis.	  
Single-­‐gene	   disorders	   are	   inherited	   in	   recognizable	   patterns:	   autosomal	   dominant,	  autosomal	  recessive,	  and	  X-­‐linked.	  More	  information	  on	  the	  different	  modes	  of	  inheritance	  is	  available	  from	  the	  following	  Web	  sites:	  
• Inheritance	   of	   Single	   Gene	   Defects	   -­‐	   From	   the	   The	   Merck	   Manual	   of	   Diagnosis	   and	  
Therapy.	  	  
• Inheritance	  Patterns	  of	  Monogenic	  Disorders	   -­‐	  From	  the	  Genetic	   Interest	  Group	   in	   the	  U.K.	  	  
• Genetics	  -­‐	  From	  the	  Medical	  Encyclopedia	  at	  MEDLINEplus.	  	  
(2)	   Multifactorial	   (also	   called	   complex	   or	   polygenic)	   -­‐	   This	   type	   is	   caused	   by	   a	  combination	   of	   environmental	   factors	   and	   mutations	   in	   multiple	   genes.	   For	   example,	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different	   genes	   that	   influence	   breast	   cancer	   susceptibility	   have	   been	   found	   on	  chromosomes	   6,	   11,	   13,	   14,	   15,	   17,	   and	   22.	   Its	  more	   complicated	   nature	  makes	   it	  much	  more	   difficult	   to	   analyze	   than	   single-­‐gene	   or	   chromosomal	   disorders.	   Some	   of	   the	   most	  common	   chronic	   disorders	   are	  multifactorial.	   Examples	   include	  heart	   disease,	   high	  blood	  pressure,	   Alzheimer’s	   disease,	   arthritis,	   diabetes,	   cancer,	   and	   obesity.	   Multifactorial	  inheritance	  also	  is	  associated	  with	  heritable	  traits	  such	  as	  fingerprint	  patterns,	  height,	  eye	  color,	  and	  skin	  color.	  	  
(3)	   Chromosomal	   -­‐	   Chromosomes,	   distinct	   structures	  made	   up	   of	   DNA	   and	   protein,	   are	  located	   in	  the	  nucleus	  of	  each	  cell.	  Because	  chromosomes	  are	  carriers	  of	  genetic	  material,	  such	  abnormalities	  in	  chromosome	  structure	  as	  missing	  or	  extra	  copies	  or	  gross	  breaks	  and	  rejoinings	   (translocations)	   can	   result	   in	   disease.	   Some	   types	   of	   major	   chromosomal	  abnormalities	  can	  be	  detected	  by	  microscopic	  examination.	  Down	  syndrome	  or	  trisomy	  21	  is	  a	  common	  disorder	  that	  occurs	  when	  a	  person	  has	  three	  copies	  of	  chromosome	  21.	  
(4)	  Mitochondrial	  -­‐	  This	  relatively	  rare	  type	  of	  genetic	  disorder	  is	  caused	  by	  mutations	  in	  the	   nonchromosomal	   DNA	   of	   mitochondria.	   Mitochondria	   are	   small	   round	   or	   rod-­‐like	  organelles	  involved	  in	  cellular	  respiration	  and	  found	  in	  the	  cytoplasm	  of	  plant	  and	  animal	  cells.	  Each	  mitochondrion	  may	  contain	  5	  to	  10	  circular	  pieces	  of	  DNA.	  
An	   increasing	   number	   of	   gene	   tests	   are	   becoming	   available	   commercially,	   although	   the	  scientific	  community	  continues	  to	  debate	  the	  best	  way	  to	  deliver	  them	  to	  the	  public	  and	  to	  medical	   communities	   that	   are	   often	   unaware	   of	   their	   scientific	   and	   social	   implications.	  While	   some	   of	   these	   tests	   have	   greatly	   improved	   and	   even	   saved	   lives,	   scientists	   remain	  unsure	  of	  how	  to	  interpret	  many	  of	  the	  test	  results.	  Also,	  patients	  taking	  the	  tests	  may	  face	  significant	  risks,	  including	  jeopardizing	  their	  employment	  or	  insurance	  status.	  And	  because	  genetic	  information	  is	  shared,	  these	  risks	  can	  extend	  to	  family	  members	  as	  well.	  Developing	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Winorm	  we	  propose	  to	  give	  a	  full	  understanding	  of	  these	  genetics	  tests	  by	  combining	  them	  with	  other	  markers	  and	  translating	  them	  in	  real	  normal	  value	  for	  the	  one	  specific	  patient.	  	  
Disease	  Markers	  
To	  make	  an	  accurate	  diagnosis	  a	  great	  deal	  of	  effort	  has	  been	  made	  in	  search	  of	  noninvasive	  tests	  for	  early	  identification	  and	  classification	  of	  the	  type	  of	  disease,	  to	  predict	  the	  severity	  and	   outcome	   as	   well	   as	   the	   patients’	   response	   to	   treatment.	   A	   major	   goal	   has	   been	   to	  identify	  biomarkers	  (proteins	  and	  molecules)	  that	  can	  be	  measured	  inexpensively	  for	  early	  diagnosis	  of	  disease	  in	  patients.	  So	  far	  a	  list	  of	  biomarkers	  for	  each	  disease	  is	  available	  and	  will	  be	  one	  of	  WiNorm	  input.	  
Bench	  mark	  Blood	  test	  
• Blood	  Lipids	  
o Total	  Cholesterol	  in	  Vegans	  in	  the	  United	  States	  
o Total	  Cholesterol	  in	  Western	  Vegans	  
o Total	  Cholesterol:	  Do	  Vegan	  Men	  and	  Women	  Differ?	  
o Why	  Are	  Vegans'	  Cholesterol	  Levels	  Lower?	  
o LDL	  &	  HDL	  Cholesterol	  of	  Western	  Vegans	  
o Triglycerides	  
• Blood	  Pressure	  	  
• Body	  Mass	  Index	  	  
• Body	  Fat	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Databases	  already	  available	  
Database	   efforts	   have	  kept	  pace	  with	   the	   rapid	   rate	   at	  which	   this	   sequence	  data	   is	   being	  generated,	   providing	   investigators	   access	   to	   all	   public	   data	   in	   a	   practically	   instantaneous	  fashion.	  While	  most	  biologists	  are	  familiar	  with	  the	  databases	  comprising	  the	  International	  Nucleotide	  Sequence	  Database	  Collaboration	  (DDBJ,	  EMBL	  and	  GenBank),	  numerous	  other	  specialised	   databases	   have	   emerged.	   These	   specialized	   databases	   often	   arise	   out	   of	   a	  particular	   need,	  whether	   it	   is	   to	   address	   a	   particular	   biological	   question	   of	   interest	   or	   to	  better	  serve	  a	  particular	  segment	  of	  the	  biological	  community.	  So	  far	  no	  database	  is	  able	  to	  give	  an	  easy	  readout	   to	   the	  patient.	  Although	  we	  saw	  companies	   like	  23andme7	  giving	  an	  idea	   about	   gene	   susceptibility	   to	   disease	   our	   database	   will	   go	   much	   further	   providing	  specific	  and	  customized	  information	  directly	  to	  the	  patients	  or	  medical	  professionals.	  
System	  
To	   create	   this	   database	  we	   are	   using	   the	   same	   strategy	   of	   system	   biology.	   The	   aim	   is	   to	  understand	  the	  body	  as	  a	  whole.	  
• Translation	  
We	  will	   use	   experimental	   therapeutics	   results	   to	   implement	   data	   base	   and	   device	  design.	  
• Application	  and	  implementation	  
Application	  and	  implementation	  –	  health	  care	  delivery	  
• Dissemination	  
Provide	  personalized	  medicine	  at	  the	  community	  and	  individual	  user	  level	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  https://www.23andme.com/	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Applied	  Methods	  
We	  designed	  one	  model	  to	  organize	  a	  comprehensive	  collection	  of	  data	  based	  on	  3	  different	  levels;	   blood	   test	   results,	   diseases	   markers	   and	   genes	   analysis	   (Figure	   6.1).	   In	   order	   to	  obtain	   a	   readable	   output	   we	   will	   analyse	   the	   input,	   by	   applying	   logic	   and	   linking	   the	  contents	  using	  an	  algorithm	  (Figure	  6.2).	  The	  following	  steps	  comprise	  a	  proof	  of	  concept.	  We	  will	  do	  a	  case	  control	  study	  with	  one	  disease	  and	  validate	  the	  results.	  
	  
	  Figure	  6.1	  -­‐	  WiNorm	  Database	  concept	  
Database	  design	  
The	  Database	  Design	  Process	  is	  a	  strategic	  decision	  making	  and	  business	  planning	  require	  accurate	  and	  manageable	  data.	  In	  order	  to	  build	  this	  database	  we	  needed	  to	  follow	  the	  steps	  presented	  here	  (Figure	  6.3	  and	  Figure	  6.3).	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1)	  Formulate	  an	  idea	  for	  a	  solution	  
• Identify	  an	  existing	  problem	  that	  could	  be	  improved	  with	  a	  database.	  
• Have	  a	  clear	  purpose	  in	  mind.	  
• Identify	  the	  problem:	  	  
• Describe	  existing	  difficulties:	  	  
• Propose	   a	   solution:	  Describe	  what	   can	  be	  done	   to	  make	   this	  data	   easier	   to	  utilize.	  Should	  anything	  else	  be	  a	  focus	  here?	  
2)	  Gather	  information	  and	  clarify	  needs.	  
• Talk	  to	  people	  currently	  involved	  with	  the	  data	  and	  anyone	  else	  who	  may	  have	  the	  potential	  to	  be	  a	  user	  of	  the	  application.	  
• Ask	  questions	  such	  as	  what	  information	  is	  available?	  Is	  it	  adequate	  to	  meet	  needs?	  
• How	  is	  the	  available	  information	  being	  used?	  
• Who	  maintains	  current	  data?	  
• Sketch	   out	   formatting	   of	   possible	   forms	   and/or	   reports	   (mailing	   labels,	   rosters,	  course	  offerings	  list,	  etc.)	  to	  make	  sure	  they	  are	  useful	  to	  users.	  
3)	  Develop	  a	  list	  of	  all	  useful	  fields.	  
• List	  all	  of	  the	  possible	  attributes	  that	  will	  be	  available	  within	  the	  database	  
• Break	  down	  information	  into	  the	  smallest	  meaningful	  units	  possible	  
• Eliminate	  redundancy	  	  
• Determine	  if	  all	  proposed	  fields	  will	  be	  needed	  	  
4)	  Organize	  the	  fields	  into	  logical	  tables.	  
• Divide	   fields	   into	   categories	   or	   subjects.	   Each	   of	   these	   categories	  will	   represent	   a	  table.	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• Assign	   key	   fields.	   A	   key	   field	   or	   primary	   key	   is	   a	   unique	   identifier	   for	   a	  record/entity	  	  
• Consider	  normalization	  rules.	  
• Organize	  fields	  into	  tables:	  Create	  table	  names	  and	  list	  fields	  for	  each	  table.	  
5)	  Determine	  and	  define	  table	  relationships.	  
• Identify	  fields	  that	  match	  among	  tables	  
• Decide	  how	  data	  is	  related	  based	  on	  these	  matching	  fields	  
• Define	  relationships	  between	  the	  primary	  key	  of	  one	  table	  and	  the	  related	  or	  foreign	  key	   of	   another.	   These	   matching	   fields	   can	   have	   the	   exact	   same	   name	   or	   slightly	  different	  names,	  yet	  hold	  the	  same	  data.	  
• Add	  new	  fields	  and/or	  tables	  as	  needed	  to	  clarify	  relationships.	  
• Consider	  how	  relationships	  may	  be	  used	  to	  make	  queries	  and	  reports	  more	  efficient.	  
• Focus	  on	  the	  three	  types	  of	  table	  relationships.	  
Three	   Types	   of	   Table	   Relationships:	  There	  are	   three	   types	  of	   table	   relationships.	  Each	  has	   its	   own	   unique	   purpose	   in	   helping	   to	   organize	   the	   data	   within	   the	   database.	   These	  relationships	  can	  be	  used	  to	  determine	  joins	  in	  queries	  as	  well.	  
1)	  One-­‐to-­‐One	  Relationships:	  one	  record	  in	  a	  table	  is	  related	  to	  one	  
record	  in	  a	  related	  table;	  creates	  equally	  dependent	  tables	  
2)	  One-­‐to-­‐Many	  Relationships:	  one	  record	  in	  a	  primary	  table	  is	  
related	  to	  many	  records	  in	  a	  related	  table;	  however,	  a	  record	  in	  the	  
related	  table	  has	  only	  one	  related	  record	  in	  the	  primary	  table	  
3)	  Many-­‐to-­‐Many	  Relationships:	  several	  records	  in	  the	  primary	  table	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are	  related	  to	  several	  records	  in	  a	  related	  table	  
Define	  relationships	  among	  tables:	  Draw	  lines	  to	  connect	  primary	  and	  foreign	  
key	   fields	   on	   related	   tables.	   This	   diagramming	   is	   referred	   to	   as	   Entity	   Relationship	  diagramming	  because	  it	  connects	  entities	  based	  on	  similarities.	  
6)	  Test,	  refine	  and	  improve.	  
• Analyze	  the	  overall	  database	  design	  to	  check	  for	  errors	  as	  well	  as	  to	  see	  that	  needs	  are	  being	  met.	  
• Review	   table	   structure	   to	   make	   sure	   all	   needed	   fields	   are	   present	   and	   existing	  relationships	  are	  valid	  and	  useful.	  
• Test	  table	  design	  by	  adding	  records	  and	  observing	  functionality.	  
• List	  points	  to	  consider	  when	  testing,	  refining,	  and	  improving	  design:	  
• Describe	  possible	  issues	  and	  resolutions.	  
7)	  Develop	  queries,	  forms,	  and	  reports.	  
• Look	  back	  at	  information	  gathered	  to	  get	  ideas	  for	  what	  type	  of	  queries,	  forms,	  and	  reports	  are	  needed.	  
• Consider	  table	  relationships	  and	  how	  they	  can	  be	  utilized.	  
• Try	   drafts	   of	   queries,	   forms,	   and	   reports	   to	   see	   if	   they	   show	   the	   expected	   data	  results.	  
• Modify	  as	  needed	  to	  meet	  needs.	  
• Consider	  this	  development	  process	  as	  ongoing	  throughout	  the	  use	  of	  the	  database.	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  Figure	  6.2	  -­‐	  Database	  design	  concept	  
	  Figure	  6.3	  -­‐	  Diagram	  of	  WiNorm	  database	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6.5 Final	  Comments	  
What	  we	   have	   been	   able	   to	   show	   in	   this	  work	   is	   that	   by	   combining	   novel	  methods	  with	  efficient	  databasing	  we	  can	  successfully	  apply	  this	  to	  real	  data,	  for	  high	  impact	  applications.	  This	  work	  has	  a	  lot	  of	  future	  potential	  that	  we	  aim	  to	  leverage	  on	  and	  follow	  through	  with.	  	  Overall,	  I	  am	  confident	  that	  with	  the	  strong	  inter-­‐disciplinary	  group	  that	  I	  have	  worked	  with	  on	  this	  thesis	  we	  will	  produce	  life-­‐changing	  healthcare	  solutions	  for	  the	  future	  of	  medicine.	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Appendix A – Matlab Code 	  This	  code	  was	  developed	  in	  collaboration	  Dr.	  Amir	  Eftekhar	  at	  the	  Centre	  for	  Bio-­‐Inspired	  Technology.	  	  
DATA	  ADC	  	  
function [x_ADC] = dataADC(x,Vmax,Vmin,Nbit,plot_chk) 
  
if nargin < 4 
    Nbit = 8; 
    plot_chk = 0; 
end 
  
x = x + abs(Vmin); 
  
x_ADC = ADC(x,Nbit,0,Vmax-Vmin); 
  
x_ADC = x_ADC - (2^Nbit)/2; 
  
x_ADC = round(x_ADC); 
  
%plot(x_ADC); 
if plot_chk == 1 
    figure; 
    subplot(211) 
    plot(x); 
     
    subplot(212) 





function y = ADC(x,N,Vlow,Vhigh) 
  
ADC_high = 2^N; 
  
value = ((x - Vlow)./(Vhigh - Vlow)).*(ADC_high-1); 
  
y = value; 	  
HEX	  CONVERSION	  	  
function [DATA_HEX] = HEX_CONVERT(DATA,DATA_MAX,DATA_MIN,BITS) 
  
%CONVERT DATA to HEX as defined from BIT_SIZE 
  
%Variable s contains the HEX arrays for each 
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% DATA_MAX = 32767; 
% DATA_MIN = -32768; 
  
  
DATA_HEX = data2HEX(DATA,DATA_MAX,DATA_MIN,BITS,0); 
     
  
function [s] = data2HEX(x,Vmax,Vmin,Nbit,plot_chk) 
  
if nargin < 4 
    Nbit = 8; 
    plot_chk = 0;  
end 
  
x = x + abs(Vmin); 
  
x_ADC = ADC(x,Nbit,0,Vmax-Vmin); 
  
x_ADC = x_ADC - (2^Nbit)/2; 
  
x_ADC = round(x_ADC); 
  
%plot(x_ADC); 
if plot_chk == 1 
    figure; 
    plot(x); 
    hold on 
    plot(x_ADC,'--r') 
end 
  
s = sdec2hex(x_ADC,Nbit); 
  
function y = ADC(x,N,Vlow,Vhigh) 
  
ADC_high = 2^N; 
  
  
value = ((x - Vlow)./(Vhigh - Vlow)).*(ADC_high-1); 
  
y = value; 
  
function [y] = sdec2hex(x,N) 
  
max_N = (2^N) - 1; 
  
ind = find(x<0); 




y = repmat(char(M),1,length(x)*M); 
if any(round(x) < 0) 
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    print('Ahhhhh'); 
end 
  
s = char(dec2hex(round(x),M)); 
  
indx = 1:length(x); 
for i=1:M 
    indy = (indx.*M) - (M - i); 
    y(indy) = s(:,i)'; 
end 	  
SIGNED	  DECIMAL	  to	  HEX	  	  
function [y] = sdec2hex(x,N) 
  
max_N = (2^N) - 1; 
  
ind = find(x<0); 




y = repmat(char(M),1,M*length(x)); 
  
if any(round(x) < 0) 
    print('Ahhhhh'); 
end 
  
s = char(dec2hex(round(x),M)); 
  
indx = 1:length(x); 
  
for i=1:M 
    indy = (indx.*M) - (M - i); 
    y(indy) = s(:,i)'; 
end 	  
NW	  ALGORITHM	  	  
function [Score,Mx] = nw_alg(seq1,seq2) 
  
Sij = 2; 
nSij = 0; 
w = -1; 
  
ls1 = length(seq1); 
ls2 = length(seq2); 
  
Mx = zeros(ls1+1,ls2+1); 




for i = 2:ls1+1 
    for j = 2:ls2+1 
         
        if strmatch(seq1(i-1),seq2(j-1)) 
            S = Sij; 
        else 
            S = nSij; 
        end 
    
        Mx(i,j) = max([Mx(i-1,j-1)+S Mx(i,j-1)+w Mx(i-1,j)+w]); 
     
    end 
end 
  
Score = Mx(ls1+1,ls2+1)/sum([ls1 ls2]); 
 
BASIC	  SINGLE	  PATTERN	  NGRAM	  
function [NGRAM_array,NGRAM_cnt] = NGRAM(HEXdata,Nhex,Ngram_size) 
%% Function NGRAM 
% 
% Inputs:  
%   HEXdata - characters of hex in array Nx1 
%   Nhex - The data HEX size to use 
%   Ngram_size - Token length to use 
% 
% Outputs: 
%   NGRAM_array - Array of HEX patterns found (Ngram_size*Nhex)xM 
%   Ngram_cnt - number of times each of M patterns repeats 
% 
% Designed by Amir Eftekhar on 8th February 2010 
  
LEN_data = size(HEXdata,1); 
  
Nforloop = floor(LEN_data/Nhex); 
  
iarray = 1; 
N = Ngram_size; 
NGRAM_array = repmat(char(0),LEN_data,N*Nhex); 
NGRAM_cnt = ones(1,LEN_data); 
  
k=1; 
%NGRAM_cnt = zeros(1,length(HEXdata)); 
  
for i = 1:(Nforloop- N+1) 
    PAT_array = HEXdata(k:(k+(Ngram_size*Nhex)-1),:)'; 
  
    if i == 1 
        NGRAM_array(iarray,:) = PAT_array; 
        NGRAM_cnt(1) = 1; 
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        iarray = iarray+1; 
    else 
         
        indx = strmatch(PAT_array,NGRAM_array(1:iarray-
1,:),'exact'); 
         
        if ~isempty(indx) 
            NGRAM_cnt(indx) = NGRAM_cnt(indx)+1; 
        else 
            NGRAM_array(iarray,:) = PAT_array; 
            NGRAM_cnt(iarray) = 1; 
            iarray = iarray+1; 
        end 
    end    
     
    k = k + 2; 
end 
  
NGRAM_array = NGRAM_array(1:iarray-1,:); 
NGRAM_cnt = NGRAM_cnt(1:iarray-1); 
 	  
BASIC	  MULTIRESOLUTION	  NGRAM	  IMPLEMENTATION	  	  
function [NGRAM_array,NGRAM_cnt] = NGRAMv3(DATA,Ngram_size,Nbit) 
%% Function NGRAM 
% 
% Inputs: 
%   HEXdata - characters of hex in array Nx1 
%   Nhex - The data HEX size to use 
%   Ngram_size - Token length to use 
% 
% Outputs: 
%   NGRAM_array - Array of HEX patterns found (Ngram_size*Nhex)xM 
%   Ngram_cnt - number of times each of M patterns repeats 
% 
HEXdata = HEX_CONVERT(DATA,10000,-10000,Nbit)'; 
  
LEN_data = length(HEXdata); 
Nhex = LEN_data/length(DATA); 
  
Nforloop = floor(LEN_data/Nhex); 
  
iarray = ones(1,length(Ngram_size)); 
N = min(Ngram_size); 
NGRAM_array = cell(1,length(Ngram_size)); % 
repmat(char(0),LEN_data,N); 
NGRAM_SIZE = 0; 
NGRAM_cnt = cell(1,length(Ngram_size)); % ones(1,LEN_data); 
NGRAM_cellarray = cell(Nforloop- N+1,length(Ngram_size)); 
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min_i =  Nforloop - Ngram_size +1; 
  
k=1; 
%NGRAM_cnt = zeros(1,length(HEXdata)); 
  
for i = 1:(Nforloop- N+1) 
     
    stop_flag = 0; 
    for j = 1:length(Ngram_size) 
         
        if (stop_flag == 0) && (k <= Nhex*min_i(j)) 
  
            ind = k:(k+(Ngram_size(j)*Nhex)-1); 
            PAT_array = HEXdata(ind,:)'; 
             
            if i == 1 
                NGRAM_array{j}(iarray(j),:) = PAT_array; 
                NGRAM_cellarray{iarray(j),j} = PAT_array;   
                NGRAM_cnt{j}(1) = 1; 
                iarray(j) = iarray(j)+1; 
            else 
                 
                %indx = strmatch(PAT_array,NGRAM_array(1:iarray-
1,j),'exact'); 
                indx = strcmp(PAT_array,NGRAM_cellarray(:,j)); 
                indx = find(indx ~= 0); 
                 
                if indx ~= 0 
                    NGRAM_cnt{j}(indx) = NGRAM_cnt{j}(indx)+1; 
                    NGRAM_SIZE = Ngram_size(j); 
                    stop_flag = 1; 
                else 
                    NGRAM_array{j}(iarray(j),:) = PAT_array; 
                    NGRAM_cellarray{iarray(j),j} = PAT_array; 
                    NGRAM_cnt{j}(iarray(j)) = 1; 
                    iarray(j) = iarray(j)+1;                     
                end 
            end 
             
        end 
         
    end 
    %k = k + Ngram_size*Nhex; 
    if stop_flag == 1 
        k = k + NGRAM_SIZE*Nhex; 
    else 
        k = k + Nhex; 
    end 
end 
%NGRAM_array = NGRAM_array(1:iarray-1,:); 
%NGRAM_cnt = NGRAM_cnt(1:iarray-1); 
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PROCESS	  NGRAM	  WITH	  WINDOWED	  ANALYSIS	  	  
function [RAT1,RAT2,T,NGRAM_array,NGRAM_cnt] = 
NGRAM_realtime(x,TH) 
  
WIN_LENGTH = 256*60; 
x_LENGTH = length(x); 
  
Nloop = floor(x_LENGTH/WIN_LENGTH); 
  
NGRAMs = [10:-1:7]; 
BINARY = [7]; 
MIN_PAT_CNT = 2; 
NORMALISE = 0; 
  
if nargin < 2 
   TH = 0.95*ones(1,length(NGRAMs)); 
   %TH = round(NGRAMs .*(2/3))./NGRAMs; 
else 
   TH = round(NGRAMs .*(TH))./NGRAMs; 
end 
  
%RAT1 = zeros(Nloop,length(NGRAMs)); 
%RAT2 = zeros(Nloop,length(NGRAMs)); 
%disp(Nloop); 
n = round(Nloop.*([10 20 30 40 50 60 70 80 90]/100)); 
N = length(NGRAMs); 
  
RAT2 = zeros(length(NGRAMs),Nloop); 
RAT1 = zeros(length(NGRAMs),Nloop); 
  
parfor i = 1:Nloop 
    disp(i) 
%     if any(i == n) 
%         disp(round((i/Nloop)*100)); 
%     end 
%      
    ind = ((i-1)*WIN_LENGTH + 1) : (i*WIN_LENGTH ); 
    
    [NGRAM_array{i},NGRAM_cnt{i}] = 
NGRAMv3(x(ind),NGRAMs,BINARY);     
     
%     for j = 1:length(NGRAMs) 
%         ind2 = find(NGRAM_cnt{j} > MIN_PAT_CNT); 
%         CNT2 = CNT2 + sum(NGRAM_cnt{j}(ind2)); 
%         CNT1 = CNT1 + length(ind2);       
%          
%     end 
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%      
%     RAT1(i) = CNT1; 
%     RAT2(i) = CNT2; 
%     for j = 1:length(NGRAMs) 
%        ind2 = find(NGRAM_cnt{i}{j} > MIN_PAT_CNT); 
%        RAT2(j,i) = sum(NGRAM_cnt{i}{j}(ind2));    
%        RAT1(j,i) = length(ind2);    
%     end 
    for j = 1:N 
       ind2 = find(NGRAM_cnt{i}{j} > MIN_PAT_CNT); 
       RAT2(j,i) = sum(NGRAM_cnt{i}{j}(ind2));    
       RAT1(j,i) = length(ind2);     
    end 
     
end 
  
%T = 1:WIN_LENGTH:length(x); 	  
PROCESS	  DETECTION	  CRITERIA	  OF	  RESULTS	  
 
load('/Volumes/Neural Data/Freiburg/Tests 12th July - All Preictal 
Available/ascii_file_info_and_prepost_seiz.mat') 
cd('/Volumes/Neural Data/Freiburg/Tests 12th July - All Preictal 
Available/NGRAM_processed_v1_256smooth_60s'); 
iiDataDir = ('/Volumes/Neural Data/Freiburg/Tests 12th July - All Preictal 
Available/interIctal_Processed_v1_256smooth_60s'); 
   
  
detected_final = cell(1,21); 
fd_final = cell(1,21); 




for i = 1:21 
     
     
    m = k; 
     
    cdir = pwd; 
     
    cd(iiDataDir) 
    d = dir(['Case' int2str(i) '_*.mat']); 
     
    ii_ind2use = 1; 
  
    disp('Loading Interictal Data...'); 
    xii = cell(1,length(d)); 
     
    for g = 1:size(d,1) 
         xii{g} = load(d(g).name); 
     end 
     
    disp('Done'); 
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    cd(cdir); 
     
     
    for j = 1:seiz_num(i) 
        disp(['Patient' int2str(i) '_Seiz' int2str(j)]) 
         
        for p = 1:3 
             
            disp(['channel' int2str(p)]); 
             
            load(['Case' int2str(i) '_seiz' int2str(j) '_ch' int2str(p) 
'_NGRAM_processed.mat']); 
            range = ((preseizure_available(k) + (0:(seiz_ind_end(k)-
seiz_ind_start(k)))) / (256*60)); 
            range = [range(1)-1 range range(end)+1]; 
             
             
            ind_RAT2use = 1:min([ceil(range(end))+1 length(RAT2)]); 
             
            detected = zeros(1,size(RAT2,1)); 
            fd = ones(1,size(RAT2,1)); 
            fdii = ones(1,size(RAT2,1)); 
             
            n = zeros(1,size(RAT2,1)); 
            TYPE = cell(1,size(RAT2,1)); 
             
            for v = 1:size(RAT2,1) 
                 
                th = smooth_amir(RAT2(v,ind_RAT2use),5); 
                thii = smooth_amir(xii{ii_ind2use}.RAT2{p}(v,:),5); 
                 
                % USE CURRENT SEIZURE AS TRAINING 
                STOP = 1; 
                 
                fd1 = 1; 
                fd2 = 1; 
                fdii1 = 1; 
                fdii2 = 1; 
                 
                detected1 = 0; 
                detected2 = 0; 
                 
                iter = 1; 
                n1 = 0; 
                n2 = 0; 
                 
                 
                 
                while ~((detected(v) == 1) && (fd(v) == 0))  && STOP 
                     
                    thtn = th/(1+n1); 
                    thtp = th*(1+n2); 
                     
                    thtnii = thii/(1+n1); 
                    thtpii = thii*(1+n2); 
                     
                    detected_prev1 = detected1; 
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                    fdp1 = fd1; 
                     
                    detected_prev2 = detected2; 
                    fdp2 = fd2; 
                     
                    [detected1,fd1] = 
det_seiz(RAT2(v,ind_RAT2use),thtn,range,'Neg'); 
                    [detected2,fd2] = 
det_seiz(RAT2(v,ind_RAT2use),thtp,range,'Pos'); 
                     
                     
                    [~,fpii1] = 
det_seiz(xii{ii_ind2use}.RAT2{p}(v,:),thtnii,range,'Neg'); 
                    [~,fpii2] = 
det_seiz(xii{ii_ind2use}.RAT2{p}(v,:),thtpii,range,'Pos'); 
                     
                    if ~((detected1 == 1) && (fd1 == 0) && (fdii1 == 0)) 
                        n1 = n1 + 0.01; 
                    else 
                        detected(v) = detected1; 
                        fd(v) = fd1; 
                        fdii(v) = fdii1; 
                        TYPE{v} = 'Neg'; 
                        n(v) = n1; 
                    end 
                     
                    if ~((detected2 == 1) && (fd2 == 0) && (fdii2 == 0)) 
                        n2 = n2 + 0.01; 
                    else 
                        detected(v) = detected2; 
                        fd(v) = fd2; 
                        fdii(v) = fdii2; 
                        TYPE{v} = 'Pos'; 
                        n(v) = n2; 
                    end 
                     
                    if (detected_prev1 == 1) && (detected1 == 0) && (detected2 
== 0) 
                        detected(v) = detected_prev1; 
                        fd(v) = fdp1; 
                        fdii(v) = fdii1; 
                        n(v) = n1 - 0.02; 
                        STOP = 0; 
                        TYPE{v} = 'Neg'; 
                    elseif (detected_prev2 == 1) && (detected2 == 0) && 
(detected1 == 0) 
                        detected(v) = detected_prev2; 
                        fd(v) = fdp1; 
                        fdii(v) = fdii2; 
                        n(v) = n2 - 0.02; 
                        STOP = 0; 
                        TYPE{v} = 'Pos'; 
                    end 
                     
                    iter = iter + 1; 
                    if iter > 10000 
                        STOP = 0; 
                        disp('Iterations too high'); 
                    end 
                     
                end 
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            end 
             
            ind_fd = find((fd< 5) & (detected == 1)); 
                 
            if isempty(ind_fd) 
                [M,ind_fd] = min(fd); 
            end 
             
                         
            fdii_temp = zeros(length(ind_fd),size(d,1)); 
ind_fdii = []; 
           int_fdii = zeros(1,size(d,1)); 
           cdir = pwd; 
           cd(iiDataDir)     
           disp('Processing Interictal Data'); 
           for g = 1:size(d,1) 
                
                
               for u = 1:length(ind_fd) 
                    
                   if strmatch(TYPE{ind_fd(u)},'Neg') 
                       thii = smooth_amir(xii{g}.RAT2{p}(ind_fd(u),:),5) / 
(1+n(ind_fd(u))); 
                   else 
                       thii = smooth_amir(xii{g}.RAT2{p}(ind_fd(u),:),5) * 
(1+n(ind_fd(u))); 
                   end 
                    
                    
                   [~,fdii_temp(u,g),temp] = 
det_seiz(xii{g}.RAT2{p}(ind_fd(u),:),thii,range,TYPE{ind_fd(u)}); 
                    
                   ind_fdii = [ind_fdii temp]; 
                    
               end 
                
                
               un = unique(ind_fdii); 
                
               for q = 1:length(un) 
                   temp = sum(ind_fdii == un(q)); 
                    
                   if temp >= round(length(ind_fd)/1.6) 
                        int_fdii(g) = int_fdii(g) + 1; 
                   end 
               end                
                
end 
             
           cd(cdir);      
                        
             
            %PROCESS THE REMAINING 
            for l = 1:seiz_num(i) 
                 
                 
                load(['Case' int2str(i) '_seiz' int2str(l) '_ch' 
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'_NGRAM_processed.mat']); 
                range = ((preseizure_available(m+l-1) + (0:(seiz_ind_end(m+l-
1)-seiz_ind_start(m+l-1)))) / (256*60)); 
                range = [range(1)-1 range range(end)+1]; 
                 
                ind_RAT2use = 1:min([ceil(range(end)) length(RAT2)]); 
                 
                detected_temp = zeros(1,length(ind_fd)); 
                fd_temp = zeros(1,length(ind_fd)); 
                ind_fdi = cell(1,length(ind_fd)); 
                 
                for u = 1:length(ind_fd) 
                     
                    if strmatch(TYPE{ind_fd(u)},'Neg') 
                        th = smooth_amir(RAT2(ind_fd(u),ind_RAT2use),5) / 
(1+n(ind_fd(u))); 
                    else 
                        th = smooth_amir(RAT2(ind_fd(u),ind_RAT2use),5) * 
(1+n(ind_fd(u))); 
                    end 
                     
                    [detected_temp(u),fd_temp(u),ind_fdi{u}] = 
det_seiz(RAT2(ind_fd(u),ind_RAT2use),th,range,TYPE{ind_fd(u)}); 
                           
                end 
                 
                                 
                for q = 1:length(ind_fdi)-1 
                     
                    if q == 1 
                        temp = intersect(ind_fdi{1},ind_fdi{2}); 
                    else 
                        temp = intersect(temp,ind_fdi{q+1}); 
                    end                    
                end 
                 
               if isempty(temp) 
                   int_fdi = 0; 
               else 
                   int_fdi = length(temp); 
               end  
                 
                
                
                
               if sum(detected_temp) >= round(length(detected_temp)/1.6) 
                   detected_final{i}{p}(j,l) = 1; 
               else 
                    detected_final{i}{p}(j,l) = 0; 
               end 
                 
                 
                fd_temp_total = sum([int_fdi ; int_fdii']); 
                 
%                 [M,I] = min(fd_temp_total(detected_temp == 1)); 
%                                  
%                  
%                 if isempty(I) 
%                     [M,ind_fd] = min(fd_temp_total); 
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%                 else 
%                     ind_fd = find(fd_temp_total == M,1,'last'); 
%                 end 
                 
                 
                 
                fd_final{i}{p}(j,l) = fd_temp_total; 
                                 
            end 
             
        end 
         
         
        k = k +1; 
    end 
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Appendix B - Urea:Creatinine Schematics 	  Below	  is	  a	  schematic	  screenshot	  of	  our	  Cadence	  (version	  IC5)	  schematic,	  described	  in	  chapter	  2.	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The WiNAM Project: Neural Data Analysis with
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Abstract—This work presents a novel algorithmic method
based on an ngram approach and applies it ECoG and deep
brain neural data for analysis of epileptic seizures. This is part
of a project (WiNAM) to design an analysis framework suitable
for analysing brain dynamical changes. By first exploring the
ngram model and its traditional use we describe how to apply
it to biological data for pattern recognition. We then use this
methodology and apply it to neurological data to show good
sensitivity to seizure onset. Through these tests we explore the
parameters used when computing the ngram to evaluate what is
needed to maintain this sensitivity. Additionally, we present the
analysis framework (an online system) that is being developed to
carry out the ngram analysis and database the data and results.
I. INTRODUCTION
Over the last several decades neuroscientists have interfaced
with the nervous system through technology for a multi-
tude of application spaces. These advanced neural interfaces
have allowed us to capture single-neuron recordings and in
depth spatial mappings of brain function. One of the key
challenges with handling these recordings is extracting the
spatio-temporal signatures related to activity and neurolog-
ical function. To vercome this challenge, signal processing
techniques have acted as the bridge between recording and
understanding, whether through statistical methods or complex
nonlinear state-space mapping.
One area that has seen a multitude of algorithmic strategies
applied to it is epilepsy. Epilepsy is a neurological disorder
that affects approximately 1% of the world’s population [1],
has been analysed through linear, nonlinear (state-space) or
multivariate analysis techniques. In the brain, it manifests as
hypersynchronous neuronal firing that can result in loss of con-
sciousness and in some cases, death. As well as hoping to open
a window of understanding into brain function epilepsy studies
have aimed to extract features from neurological recordings
for prediction and/or detection of seizures. However, although
excellent work has emerged, predicting seizures is still an open
problem with mixed results as to the optimum approach [2]–
[5]. One of the bottlenecks of the research in this area has been
data consistency; having data sets well annotated, defined and
databased. This is being tackled by many groups including
through European Union FP7 grant1.
Regardless, the field is still open for new methods applied
to neurological signals that can give insight into the signal
1http://www.epilepsiae.eu/
dynamics surrounding epileptic seizures. In this work we use
a pattern recognition technique based on an ngram model and
apply it to EEG-based signals (electrocortiograms (ECoG) and
deep brain recordings). In Section II we will briefly describe
the system framework we aim to develop and implement this
algorithm into. In Section III we will overview the workings
of the ngram approach and the way in which it can be used for
biological data. After establishing this, we apply this method
to real electrocortiogram (ECoG) data to identify seizure
to non-seizure transitions (Section IV). We will continue to
show how these changes can be captured in real-time to map
pattern changes associated with seizure onset. Finally, we will
describbe the system framework we have developed through
an online interface for further studies of this method and for
neurological data.
II. GENERAL SYSTEM
We have mentioned how one of the bottlenecks of analysis
of epileptic seizure activity has been the ability to work with
consistent data, well annotated and databased. Part of this
work is to establish such a framework for future work and
to support signal processing methods. Any biomedical signal
processing technique needs to be built into a framework that
allows effcient processing and storage (databasing) of results.
We envision a system which follows the trends of biomedical
healthcare in bringing sensor front-end to processing and back-
end visualisation (or closed-loop functionality) into a modular











mobile platform DatabaseOffline Data
data source
Fig. 1: General system overview envisioned for implementing
a signal processing method for biological data.
Here we have data acquisition, user interface and processing
blocks. In theory each of these components could be placed
in a different technological implementation, such as the ac-
quisition being an implantable neural monitoring device, user
interface on mobile phone or PC and processing units being
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Fig. 5: Figure showing the graphical interface designed to analyse further data sets- from www.winam.net.
are implementing other importing functionality and reporting
documentation to further visualise and analyse the results.
VI. CONCLUSION
In this paper we have shown a unique methodology for
applying ngram models to biological data by taking advantage
of the traditional acquisition and storage of the data. Through
development of this analysis scheme we have shown initial
results for seizure detection capabilities. Although the results
are preliminary they show pattern count changes that further
justify the study of this methodology. Further study will also
be needed to understand how what these patterns reflect on
in the data itself and what physiological interpretation can be
made from them. To this end we have presented a recent online
databasing and analysis tool for use with such data. This tool
works through a framework that allows modular design.
There are many avenues to explore with such work, but first
is to validate the ngram methodology on multiple data sets and
quantify the optimum parameters. We have not quantified any
preictal activity in this work but in several cases particular
pattern changes were clear which we will investigate further.
Overall, this paper has presented the initial steps to this project,
named the WiNAM project, for neurological data analysis.
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ISFET based Urea:Creatinine translinear
sensor
W. Juffali, P. Georgiou and C. Toumazou
Presented is an ion-sensitive field-effect transistor (ISFET) based
circuit capable of continuous analogue computation of the urea:creati-
nine ratio, a marker important for the prediction of pre-renal failure.
The designed circuit utilises the weak-inversion of operation to
derive sensor currents directly related to the urea and creatinine concen-
trations, as well as to implement linear division at extremely low power
by using a translinear cell.
Introduction: Ion-sensitive field-effect transistor (ISFET) based sensors
are becoming increasingly popular for use in integrated biochemical
processing platforms used for the early detection and diagnosis of
medical conditions. With their implementation in an unmodified
CMOS technology [1], this has been made possible owing to the advan-
tages of integration, scalability and low cost due to batch fabrication. In
addition, ISFETs operating in the weak-inversion region of operation
show great promise for processing biochemical signals owing to the
inherent linearisation capability of the device [2]. This is mainly due
to exponentially driven drain currents, governed by the diffusion of
electrons across the channel of the device in weak-inversion, which
linearise biochemical processes governed mostly by Boltzmann diffu-
sion of ions. In this Letter we present a transilinear cell comprising
two ISFETs, one for sensing the urea and one for the creatinine,
capable of computing the Urea:Creatinine ratio, a marker important
for the prediction of pre-renal failure.
Urea-Creatinine ratio: Measurements of the urea and the creatinine are
vital markers for assessing kidney function. It is recognised that
although a raised urea concentration primarily indicates renal failure,
this may not always be the case. Therefore, by combining the measure-
ment with the creatinine and looking at the ratio allows renal failure to be
distinguished and also predicted [3]. The normal physiological ranges of
these markers should be the urea between 2.5–8.3 mM and the creati-
nine 44–106 mM. Any deviation from these values is assessed medi-
cally according to the ratios of Table 1, indicating the type of renal
disease. The urea is usually measured as blood urea nitrogen and the
relation is urea ¼ BUN∗2.14.
Table 1: BUN:Creatinine ranges and significance
BUN:Cr ratio Location of renal disorder
.20:1 Pre-renal disease (before glomeruli)
10–20:1 Normal or post-renal disease (within ureter)
,10:1 Intrarenal disease (within kidneys)
ISFETs for urea and creatinine in weak-inversion: When the ISFET is
biased with a stable reference electrode (typically Ag/AgCl), ions in
solution bind to the passivation causing an accumulation of charge
which in turn modulates the threshold voltage of the device [4]. This
results in a dependence of the ISFET threshold voltage on pH which
can be observed as a shift in the threshold voltage of the device.
Using this mechanism, the ISFET, however, can be modified to
sense various other analytes and more specifically the urea and the
creatinine by immobilisation of urease and creatinase on the surface,
respectively [5].
Biasing the ISFET in weak-inversion has the advantage of low power
chemical sensing, linearisation of naturally log compressed chemical
signals and implementation of biochemical translinear circuits [6]. The
generalised drain current of the device biased in weak-inversion is
given by (1) whereby VGS is the gate source voltage of the device, I0
is the intrinsic current, n is the weak-inversion slope coefficient, Ut is
the thermal voltage, Kchem is a grouping of constant chemical potentials,
a is the sensitivity parameter and [ionX ] is the concentration of ions in
solution. Equations (2) and (3) show the specific equations for the urea
and creatinine ISFETs:









Translinear cell: Circuits which exploit the exponential relationship
between current and voltage in bipolar and weak-inversion MOS transis-
tors are known as translinear circuits. These circuits exploit the linear
relation between transconductance and drain current and can be used



































Fig. 2 Simulation of translinear sensor
Fig. 1 shows an ISFET based translinear cell capable of computing
the division between the drain currents given by the urea and creatinine
ISFETs, respectively. By performing a KVL on the loop shown we may
write:
VGS1 + VGS2 = VGS3 + VGS4 (4)





+ nUt ln IureaI0
( )
= nUt ln ICrI0
( )
+ nUt ln IoutI0
( ) (5)
and using the basic relation of addition of natural logs:
ln(a) + ln(b) = ln(a b) (6)
we can compute the output current as follows:
Iout = Igain IureaICr (7)
whereby Igain is a gain term on the ratio. Substituting (2) and (3) into (7)
the output of our Urea:Creatinine sensor is now defined as follows:






Simulated results: The circuit was designed in a typical 0.35 mm tech-
nology. Device size of W/L ¼ 10 mm/10 mm was used for all transis-
tors. Data from weak-inversion ISFETs for urea and creatinine in [5]
were used for simulating the translinear cell. It was found that for
10 mg/dl of BUN, i.e. urea ¼ 21.4 mg/dl, a 14 nA current was given
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and likewise for 1 mg/dl of creatinine gave 25 nA of drain current.
Considering this should give a ratio of 10:1, by setting Igain to
17.85 nA can give an output indicative of this range as in Table 2.
Fig. 2 shows the simulated results of the cell for ICr ¼ 25 nA and a
urea current ranging from 0–20 nA. What we can see is that for
Iurea ¼ 14 nA, Iout ¼ 10 nA, meeting the specifications of Table 2 (con-
sidering urea ¼ BUN∗2.14). In addition, the cell shows good linearity
during the division.
Table 2: BUN:Creatinine output of translinear cell
BUN:Cr ratio Iout
.20:1 .20 nA
10–20:1 10 nA–20 nA
,10:1 ,10 nA
Conclusion: We present a novel circuit capable of continuous low-
power computation of the BUN:Creatinine ratio for the diagnosis of
kidney function. The proposed circuit is capable of mapping the ratio
directly as a division of the currents from urea and creatinine based
ISFETs. This may be used in a system continually monitoring these
markers for the early detection of renal degeneration.
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